HOW TO SUCCEED IN THE PSYCHIATRY CLERKSHIP

w2 fense CR

The psychiatry clerkship can be very exciting. Depending on the type of ward or facility, you may see behavior and psychiatric profiles that are profoundly interesting as well as disturbing. A key to doing well in this clerkship is find- ing the balance between drawing a firm boundary of professionalism with your patients and creating a relationship of trust and comfort. After all, your pa- tients need to share their innermost thoughts with you.

Why Spend Time on Psychiatry?

For most of you reading this book, your medical school psychiatry clerkship will encompass the entirety of your formal training in psychiatry during your career in medicine. You will see things during this rotation usually kept from the mainstream of society and medical wards. This exposure will expand your understanding of the spectrum of human cognition and behavior. Your aware- ness of the characteristics of mental dysfunction in psychiatric patients will serve you well in recognizing more subtle psychiatric symptoms that develop in your future patients.

The degree to which anxiety and mood disorders contribute to some patient’s medical presentation cannot be overstated. In some cases there is no underly- ing medical problem whatsoever. Recognizing the psychiatric features of a pa- tient’s complaints can defer significant unnecessary medical workup. Further- more, true medical illness imposes significant psychological stress, often revealing a previously subclinical psychiatric condition. Medical conditions alone and the incessant disturbances of hospitalization can stress normal cog- nitive function beyond its adaptive reserve, resulting in transient psychiatric symptoms.

Psychotropic medications are common in the general population. Many of these drugs have significant potential medical side effects and drug interac- tions. You will become familiar with these during your clerkship and will en- counter them in practice regardless of your field of medicine.

Many of your patients, despite true medical illness, will benefit more from your “bedside manner” than from your prescriptions. The time you spend in this clerkship will enhance your ability to discern which of your patients require this extra attention. Providing it is the right thing for the patient and, in the long run, will require less of your energy.

And finally, it may as well be said, that generally speaking it is relatively easy to do well in this clerkship if one puts a little time into it.

􏰀 HOW TO BEHAVE ON THE WARDS Respect the Patients

If you are in a city hospital and working in an inpatient ward, you will meet some people with severe mental illness. Sometimes you may want to laugh, and other times you may want to get away from them. Whatever your reac- tion, maintain professionalism and show the patients respect. This rule should extend to your discussions with residents and attendings; do not burst into laughter in conference, for example, while describing a patient’s tendency to talk to his penis. This can be very challenging.

Respect the Field of Psychiatry

One thing a psychiatry attending hates most is a medical student who does not take the rotation seriously. Saying things like “This isn’t real medicine” or “I like more scientific stuff” may drive a psychiatrist into a rage that results in a deadly evaluation. Regardless of your feelings, keep such thoughts to yourself.

Maintain Boundaries with Your Patients

It is your job to show compassion, patience, and understanding to your pa- tients. Some might decide that you are the best doctor in the world and the only one who they will talk to. They will demand to talk to you when some- thing does not go their way. This is a trap. Do not play the good guy when the attending decides to postpone the discharge date. True, you have to be caring, but you also have to show a unified front and make it clear that you are part of the treatment team and support the decision.

Dress in a Professional Manner

Even if the resident wears scrubs and the attending wears stiletto heels, you must dress in a professional, conservative manner. Wear a short white coat over your clothes unless discouraged (as in pediatrics).

Men should wear long pants, with cuffs covering the ankle; a long col- lared shirt; and a tie. No jeans, no sneakers, no short-sleeved shirts. Women should wear long pants or knee-length skirt and a blouse or dressy sweater. No jeans, no sneakers, no heels greater than 11⁄2 inches, no open- toed shoes.

Both men and women may wear scrubs occasionally, during overnight call for example. Do not make this your uniform.

Act in a Pleasant Manner

It can be stressful to be around psychiatric patients. Smooth out your experi- ence by being nice to be around. Smile a lot and learn everyone’s name. If you do not understand or disagree with a treatment plan or diagnosis, do not “challenge.” Instead, say “I’m sorry, I don’t quite understand, could you please explain. . . .” Be empathetic toward patients.

Be Aware of the Hierarchy

The way in which this will affect you will vary from hospital to hospital and team to team, but it is always present to some degree. In general, address your questions regarding ward functioning to interns or residents. Address your medical questions to attendings; make an effort to be somewhat informed on your subject prior to asking attendings medical questions.

Address Patients and Staff in a Respectful Way

Address patients as Sir, Ma’am, or Mr., Mrs., or Miss. Try not to address pa- tients as “honey,” “sweetie,” and the like. Although you may feel these names are friendly, patients will think you have forgotten their name, that you are being inappropriately familiar, or both. Address all physicians as “doctor,” un- less told otherwise.

IN THE PSYCHIATRY CLERKSHIP

HOW TO SUCCEED

HOW TO SUCCEED IN THE PSYCHIATRY CLERKSHIP

Take Responsibility for Your Patients

Know everything there is to know about your patients: their history, test re- sults, details about their psychiatric and medical problems, and prognosis. Keep your intern or resident informed of new developments that they might not be aware of, and ask them for any updates you might not be aware of. As- sist the team in developing a plan; speak to consultants and family. Never de- liver bad news to patients or family members without the assistance of your supervising resident or attending.

Respect Patients’ Rights

1. All patients have the right to have their personal medical information kept private. This means do not discuss the patient’s information with family members without that patient’s consent, and do not discuss any patient in hallways, elevators, or cafeterias.

2. All patients have the right to refuse treatment. This means they can refuse treatment by a specific individual (you, the medical student), or of a specific type (no electroconvulsive therapy). Patients can even refuse life-saving treatment. The only exceptions to this rule are if the patient is deemed to not have the capacity to make decisions or under- stand situations, in which case a health care proxy should be sought, or if the patient is suicidal or homicidal.

3. All patients should be informed of the right to seek advanced direc- tives on admission. Often, this is done by the admissions staff, in a booklet. If your patient is chronically ill or has a life-threatening ill- ness, address the subject of advanced directives with the assistance of your attending.

Volunteer

Be self-propelled, self-motivated. Volunteer to help with a procedure or a diffi- cult task. Volunteer to give a 20-minute talk on a topic of your choice. Volun- teer to take additional patients. Volunteer to stay late.

Be a Team Player

Help other medical students with their tasks; teach them information you have learned. Support your supervising intern or resident whenever possible. Never steal the spotlight or make a fellow medical student look bad.

Keep Patient Information Handy

Use a clipboard, notebook, or index cards to keep patient information, includ- ing a miniature history and physical, and lab and test results, at hand.

Present Patient Information in an Organized Manner

Here is a template for the “bullet” presentation:

“This is a [age]-year-old [gender] with a history of [major history such as bipolar disorder] who presented on [date] with [major symptoms, such as auditory hallucinations] and was found to have [working diagnosis]. [Tests done] showed [results]. Yesterday, the patient [state important

changes, new plan, new tests, new medications]. This morning the pa- tient feels [state the patient’s words], and the psychiatric and physical exams are significant for [state major findings]. Plan is [state plan].

The newly admitted patient generally deserves a longer presentation following the complete history and physical format.

Some patients have extensive histories. The whole history should be present in the admission note, but in ward presentation, it is often too much to ab- sorb. In these cases, it will be very much appreciated by your team if you can generate a good summary that maintains an accurate picture of the patient. This usually takes some thought, but it’s worth it.

􏰀 HOW TO PREPARE FOR THE CLERKSHIP (SHELF) EXAM

If you have read about your core psychiatric illnesses and core symptoms, you will know a great deal about psychiatry. To study for the clerkship or shelf exam, we recommend:

2 or 3 weeks before exam: Read this entire review book, taking notes.

10 days before exam: Read the notes you took during the rotation on your core content list and the corresponding review book sections.

5 days before exam: Read this entire review book, concentrating on lists and mnemonics.

2 days before exam: Exercise, eat well, skim the book, and go to bed early.

1 day before exam: Exercise, eat well, review your notes and the mnemonics, and go to bed on time. Do not have any caffeine after 2 P.M.

Other helpful studying strategies include:

Study with Friends

Group studying can be very helpful. Other people may point out areas that you have not studied enough and may help you focus on the goal. If you tend to get distracted by other people in the room, limit this to less than half of your study time.

Study in a Bright Room

Find the room in your house or in your library that has the best, brightest light. This will help prevent you from falling asleep. If you don’t have a bright light, get a halogen desk lamp or a light that stimulates sunlight (not a tan- ning lamp).

Eat Light, Balanced Meals

Make sure your meals are balanced, with lean protein, fruits and vegetables, and fiber. A high-sugar, high-carbohydrate meal will give you an initial burst of energy for 1 to 2 hours, but then you’ll drop.

IN THE PSYCHIATRY CLERKSHIP

HOW TO SUCCEED

HOW TO SUCCEED IN THE PSYCHIATRY CLERKSHIP

Take Practice Exams

The point of practice exams is not so much the content that is contained in the questions, but the training of sitting still for 3 hours and trying to pick the best answer for each and every question.

SECTION II

High-Yield Facts

􏰀 Examination and Diagnosis

􏰀 Psychotic Disorders

􏰀 Mood Disorders

􏰀 Anxiety and Adjustment Disorders

􏰀 Personality Disorders

􏰀 Substance-Related

Disorders

􏰀 Cognitive Disorders

􏰀 Geriatric Psychiatry

􏰀 Psychiatric Disorders in Children

􏰀 Dissociative Disorders

􏰀 Somatoform Disorders

􏰀 Impulse Control Disorders

􏰀 Eating Disorders

􏰀 Sleep Disorders

􏰀 Sexual Disorders

􏰀 Psychotherapies

􏰀 Psychopharmacology

􏰀 Legal Issues in Psychiatry

HIGH-YIELD FACTS IN

Examination and Diagnosis

􏰀 PSYCHIATRIC HISTORY AND MENTAL STATUS EXAM

Interviewing

MAKING THE PATIENT COMFORTABLE

The initial interview is of utmost importance to the psychiatrist. Here, he or she has the opportunity to gather vital information by maintaining a relaxed and comfortable dialogue. During the first meeting, the psychiatrist must es- tablish a meaningful rapport with the patient. This requires that questions be asked in a quiet, comfortable setting so that the patient is at ease. The patient should feel that the psychiatrist is interested, nonjudgmental, and compas- sionate. Establishing trust in this manner will enable a more productive and effective interview, in turn facilitating an accurate diagnosis and treatment plan.

Taking the History

The psychiatric history follows a similar format as the history for other types of patients. It should include the following:

􏱦 Identifying data

􏱦 Chief complaint (in the patient’s own words, no matter how odd sound-

ing)

􏱦 History of present illness

􏱦 Past psychiatric history

􏱦 Past medical history

􏱦 Medications

􏱦 Allergies

􏱦 Family history

􏱦 Social history (occupation, education, living situation, substance abuse,

etc.)

􏱦 Mental status exam

WHAT SHOULD THE HISTORY OF PRESENT ILLNESS INCLUDE?

􏱦 Information about current episode:

􏱦 Why the patient came to the doctor

􏱦 Description of current episode

􏱦 Events leading up to current moment (precipitating events)

􏱦 How work and relationships have been affected

HIGH-YIELD FACTS

Examination and Diagnosis

To assess mood, just ask, “How are you feeling today?” It is also helpful to have patients rate their stated mood on a scale of 1 to 10.

􏱦 The patient’s support system (who the patient lives with, distance and level of contact with friends and relatives)

􏱦 Relationship between physical and psychological symptoms

􏱦 Vegetative symptoms (i.e., insomnia, loss of appetite, problems with

concentration)

􏱦 Psychotic symptoms (i.e., auditory and visual hallucinations)

􏱦 Information about past episodes:

􏱦 Chronological account of past psychiatric problems/episodes

􏱦 Establishing a baseline of mental health:

􏱦 Patient’s functioning when “well”

􏱦 Developmental history—physical and intellectual ability at various

stages of life (outpatient setting only)

􏱦 Life values, goals (outpatient setting)

􏱦 Evidence of secondary gain

Mental Status Examination

This is analogous to performing a physical exam in internal medicine. It is the nuts and bolts of the psychiatric exam. The mental status exam assesses the following:

􏱦 Appearance/Behavior

􏱦 Mood/Affect

􏱦 Speech

􏱦 Perception

􏱦 Thought process/Thought content

􏱦 Sensorium/Cognition

􏱦 Insight/Judgment

􏱦 Suicidal/Homicidal ideation

The mental status exam tells only about the mental status at that moment; it can change every hour or every day, etc.

APPEARANCE

􏱦 Physical appearance—clothing, hygiene, posture, grooming

􏱦 Behavior—mannerisms, tics, eye contact

􏱦 Attitude—cooperative, hostile, guarded, seductive, apathetic

SPEECH

􏱦 Rate—slow, average, rapid, or pressured (Pressured speech is continuous, fast, and uninterruptible.)

􏱦 Volume—soft, average, or loud

􏱦 Articulation—well articulated versus lisp, stutter, mumbling

􏱦 Tone—angry versus pleading, etc.

MOOD

Mood is the emotion that the patient tells you he feels or is conveyed nonver- bally.

AFFECT

Affect is an assessment of how the patient’s mood appears to the examiner, including the amount and range of emotional expression. It is described with the following dimensions:

􏱦 Quality describes the depth and range of the feelings shown. Parameters: Flat (none)—blunted (shallow)—constricted (limited)—full (aver- age)—intense (more than normal)

􏱦 Motility describes how quickly a person appears to shift emotional states. Parameters: Sluggish—supple—labile

􏱦 Appropriateness to content describes whether the affect is congruent with the subject of conversation. Parameters: Appropriate—not appropriate

THOUGHT PROCESS

This is the patient’s form of thinking—how he or she uses language and puts ideas together. It describes whether the patient’s thoughts are logical, mean- ingful, and goal-directed. It does not comment on what the patient thinks, only how the patient expresses his or her thoughts.

Examples of disorders:

Loosening of associations—no logical connection from one thought to another

Flight of ideas—a fast stream of very tangential thoughts. Neologisms—made-up words

Word salad—incoherent collection of words

Clang associations—word connections due to phonetics rather than ac- tual meaning. “My car is red. I’ve been in bed. It hurts my head.” Thought blocking—abrupt cessation of communication before the idea is finished

Tangentiality—point of conversation never reached due to lack of goal- directed associations between ideas

Circumstantiality—point of conversation is reached after circuitous path

THOUGHT CONTENT

This describes the types of ideas expressed by the patient.

Examples of disorders:

Poverty of thought versus overabundance—too few versus too many ideas expressed

Delusions—fixed, false beliefs that are not shared by the person’s culture and cannot be changed by reasoning

Suicidal and homicidal thoughts—Ask if the patient feels like harming him/herself or others. Identify if the plan is well formulated. Ask if the pa- tient has intent (i.e., if released right now, would he go and kill himself or harm others?).

Phobias—persistent, irrational fears

Obsessions—repetitive, intrusive thoughts

Compulsions—repetitive behaviors (usually linked with obsessive thoughts)

PERCEPTION

􏱦 Hallucinations—sensory experiences not based in reality (visual, audi- tory, tactile, gustatory, olfactory)

􏱦 Illusions—inaccurate perception of existing sensory stimuli (Example of illusion: Wall appears as if it’s moving)

Assess the quality, motility, and appropriateness in describing the affect: “Patient’s affect was constricted, sluggish,

and inappropriate to content. . . .”

A patient who remains expressionless and monotone even when discussing extremely sad or happy moments in his life has a flat affect.

A patient who is laughing one second and crying the next has a labile affect.

A patient who giggles while telling you that he set his house on fire and is facing criminal charges has an inappropriate affect.

HIGH-YIELD FACTS

Examination and Diagnosis

Examples of delusions:

􏱦 Grandeur—beliefthat one has special powers

or is someone important

(Jesus, president)

􏱦 Paranoid—beliefthat

one is being persecuted

􏱦 Reference—beliefthat some event is uniquely

related to patient (e.g., a TV show character is sending patient messages)

􏱦 Thoughtbroadcasting— belief that one’s thoughts can be heard by others

􏱦 Religious—conventional beliefs exaggerated (e.g., Jesus talks to me)

HIGH-YIELD FACTS

Examination and Diagnosis

To test ability to abstract, ask:

1. Similarities: How are an

apple and orange alike? (Normal answer: “They are fruits.” Concrete answer: “They are round.”)

2. Proverb testing: What is meant by the phrase, “You can’t judge a book by it’s cover?” (Normal answer: “You can’t judge people just by how they look.” Concrete answer: “Books have different covers.”)

SENSORIUM AND COGNITION

Sensorium and cognition are assessed in the following ways:

􏱦 Consciousness—patient’s level of awareness; possible range includes: Alert—drowsy—lethargic—stuporous—coma

􏱦 Orientation—to person, place, and time

􏱦 Calculation—ability to add/subtract

􏱦 Memory—

􏱦 Immediate—can repeat several digits or recall three words 5 minutes later

􏱦 Recent—events within past few days

􏱦 Recent past—events within past few months

􏱦 Remote—events from childhood

􏱦 Fund of knowledge—level of knowledge in the context of the patient’s culture and education (Who is the president? Who was Picasso?)

􏱦 Attention/Concentration—ability to subtract serial 7s from 100 or to spell “world” backwards

􏱦 Reading/Writing—simple sentences (must make sure the patient is lit- erate first!)

􏱦 Abstract concepts—ability to explain similarities between objects and understand the meaning of simple proverbs

INSIGHT

This is the patient’s level of awareness and understanding of his or her prob- lem. Problems with insight include complete denial of illness or blaming it on something else.

JUDGMENT

This is the patient’s ability to understand the outcome of his or her actions and use this awareness in decision making. You can ask, “What would you do if you smelled smoke in a crowded theater?”

Mini Mental State Examination (MMSE)

The MMSE is a simple, brief test used to assess gross cognitive functioning. See Cognitive Disorders chapter for detailed description. The areas tested in- clude:

􏱦 Orientation (to person, place, and time)

􏱦 Memory (short term)

􏱦 Concentration and attention (serial 7s, spell “world” backwards)

􏱦 Language (naming, repetition, comprehension)

􏱦 Reading and writing

􏱦 Visuospatial ability (copy of design)

􏰀 INTERVIEWING SKILLS

General Approaches to Types of Patients

VIOLENT PATIENT

One should avoid being alone with a potentially violent patient. To assess vi- olence or homicidality, one can simply ask, “Do you feel like you want to hurt someone or that you might hurt someone?” If the patient expresses imminent

threats against friends, family, or others, the doctor should notify potential victims and/or protection agencies when appropriate (Tarasoff rule).

DELUSIONAL PATIENT

Although the psychiatrist should not directly challenge a delusion or insist that it is untrue, he should not imply he believes it either. He should simply acknowledge that he understands the patient believes the delusion is true.

DEPRESSED PATIENT

A depressed patient may be skeptical that he or she can be helped. It is impor- tant to offer reassurance that he or she can improve with appropriate therapy. Inquiring about suicidal thoughts is crucial; a feeling of hopelessness, sub- stance use, and/or a history of prior suicide attempts reveal an increased risk for suicide. If the patient is planning or contemplating suicide, he or she must be hospitalized or otherwise protected.

􏰀 DIAGNOSIS AND CLASSIFICATION

Diagnosis as per DSM-IV-TR Multiaxial Classification Scheme

The American Psychiatric Association uses a multiaxial classification system for diagnoses. Criteria and codes for each diagnosis are outlined in their Diag- nostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR).

Axis I: All diagnoses of mental illness (including substance abuse and de- velopmental disorders), not including personality disorders and mental re- tardation

Axis II: Personality disorders and mental retardation

Axis III: General medical conditions

Axis IV: Psychosocial and environmental problems (e.g., homelessness, divorce, etc.)

Axis V: The Global Assessment of Function (GAF), which rates overall level of daily functioning (social, occupational, and psychological) on a scale of 0 to 100. (See table on next page.) Rate current GAF vs. high GAF during the past year.

􏰀 DIAGNOSTIC TESTING Intelligence Tests

Aspects of intelligence include memory, logical reasoning, ability to assimilate factual knowledge, understanding of abstract concepts, etc.

INTELLIGENCE QUOTIENT (IQ)

IQ is a test of intelligence with a mean of 100 and a standard deviation of 100. These scores are adjusted for age and sometimes gender. An IQ of 100 signifies that mental age equals chronological age and corresponds to the 50th percentile in intellectual ability for the general population.

In assessing suicidality, do not simply ask, “Do you want to hurt yourself?” because this does not directly address suicidality (he may plan on dying

in a painless way). Ask directly about killing self or suicide. If contemplating suicide, ask the patient if hehasaplanofhowtodo it and if he has intent; a detailed plan, intent, and the means to accomplish it suggest a serious threat.

HIGH-YIELD FACTS

Examination and Diagnosis

Global Assessment of Function (GAF) Scale

1–10 11–20 21–30 31–40 41–50 51–60 61–70 71–80 81–90 91–100

No symptoms

Absent or

If symptoms are

Some mild

Moderate

Serious

Some

before an exam.

psychosocial

insomnia.

occasional panic speech, attacks.

ideation, severe rituals, frequent obsessional shoplifting.

times illogical, Speech is at obscure, or irrelevant.

hallucinations.

incoherent or Largely mute.

argument with family members.

minimal

present, they are

symptoms.

impairment in

symptoms.

Mild anxiety

Generally

satisfied with

No more than

life.

concerns. Occasional problems or everyday

argument.

influenced by considerably Behavior is delusions or

communication.

Gross

impairment in

transient and reactions to expectable

stressors.

concentrating after family Difficulty

reality testing or

Depressed

Flat affect and

Suicidal

communication.

mood, mild

circumstantial

Persistent danger

hurting self or

of severely

others.

Recurrent

violence.

Some difficulty

occupational, or

school

functioning. Occasional

functioning

some meaningful pretty well, has interpersonal

relationships.

Any serious impairment in

occupational, or social, school

functioning.

functioning. No friends,

unable to keep a

mood.

job.

functioning in a

wide range of functioning in interested and involved in a activities, all areas,

get out of hand.

socially

truancy, or theft household, but within the

Few friends, co-workers. conflicts with

impairment in

Major

Serious

Some danger of

hurting self or

others.

such as work or

or judgment.

school, family

Suicide attempts

Depressed man

preoccupation.

avoids friends,

neglects family,

and is unable to

frequently beats

and is failing in

work. Child

up younger

defiant at home

children, is

school.

impairment in

communication

relations,

Sometimes

inappropriately,

grossly

suicidal

Serious suicidal

act with clear

expectation of

death.

wide range of

activities.

Life’s problems

never seem to

Superior

Good

No more than

slight

in social,

occupational, or difficulty in Moderate social, school

effective.

Temporarily falling behind in

impairment in

occupational, or social, school

functioning.

school work.

generally

several areas,

thinking, or

judgment,

incoherent, acts

death, frequently

without clear

expectation of

violent, manic

excitement.

many positive others because Sought out by of his or her qualities.

Inability to

Occasionally

function in

fails to maintain

almost all areas.

minimal

Stays in bed all

day, no job,

Smears feces.

home, or friends.

Persistent

inability to

maintain

minimal

personal

hygiene.

personal hygiene

HIGH-YIELD FACTS

Examination and Diagnosis

Intelligence tests assess cognitive function by evaluating comprehension, fund of knowledge, math skills, vocabulary, picture assembly, and other verbal and performance skills. Two common tests are:

Wechsler Adult Intelligence Scale (WAIS)

􏱦 Most common test for ages 16 to 75

􏱦 Assesses overall intellectual functioning

􏱦 Two parts: Verbal and visual-spatial Stanford–Binet Test

􏱦 Tests intellectual ability in patients ages 2 to 18

Objective Personality Assessment Tests

These tests are questions with standardized-answer format that can be objec- tively scored. The following is an example:

Minnesota Multiphasic Personality Inventory (MMPI-2)

􏱦 Tests personality for different pathologies and behavioral patterns

􏱦 Most commonly used

Projective (Personality) Assessment Tests

Projective tests have no structured-response format. The tests often ask for in- terpretation of ambiguous stimuli. Examples are:

Thematic Apperception Test (TAT)

􏱦 Test-taker creates stories based on pictures of people in various situa- tions.

􏱦 Used to evaluate motivations behind behaviors Rorschach Test

􏱦 Interpretation of ink blots

􏱦 Used to identify thought disorders and defense mechanisms

IQ Chart

Very superior: > 130 Superior: 120–129 High average: 110–119 Average: 90–109

Low average: 80–89 Borderline: 70–79

Mild mental retardation: 50–70

Moderate mental retardation: 35–49 Severe mental retardation: 25–34

Profound mental retardation: < 25

HIGH-YIELD FACTS

Examination and Diagnosis

NOTES

HIGH-YIELD FACTS

Examination and Diagnosis

HIGH-YIELD FACTS IN

Psychotic Disorders

􏰀 PSYCHOSIS

Psychosis is a break from reality involving delusions, perceptual disturbances, and/or disordered thinking. Schizophrenia and substance-induced psychosis are examples of commonly diagnosed psychotic disorders.

􏰀 DISORDERED THOUGHT

Includes disorders of thought content and thought process (see chapter on Ex- amination and Diagnosis for further clarification):

􏱦 Disorders of thought content reflect the patient’s beliefs, ideas, and inter- pretations of his or her surroundings. (Examples: Paranoid delusions, ideas of reference, and loss of ego boundaries)

􏱦 Disorders of thought process involve the manner in which the patient links ideas and words together. (Examples: Tangentiality, circumstan- tiality, loosening of associations, thought blocking, perseveration, etc.)

􏰀 DELUSIONS

Fixed, false beliefs that cannot be altered by rational arguments and cannot be

accounted for by the cultural background of the individual

Types

􏱦 Paranoid delusion—irrational belief that one is being persecuted (“The

CIA is after me and taps my phone.”)

􏱦 Ideas of reference—belief that some event is uniquely related to the

individual (“Jesus is speaking to me through TV characters.”)

􏱦 Thought broadcasting—belief that one’s thoughts can be heard by oth-

ers

􏱦 Delusions of grandeur—belief that one has special powers beyond

those of a normal person (“I am the all-powerful son of God and I shall

bring down my wrath on you if I cannot have a smoke.”)

􏱦 Delusions of guilt—false belief that one is guilty or responsible for

something (“I caused the flood in Mozambique.”)

Clinically, one can quickly tell that a person is psychotic by the presence of any one of the following:

􏱦 Perceptualdisturbances

(hallucinations)

􏱦 Delusionalthinking

􏱦 Disorderedthought

process

HIGH-YIELD FACTS

Loss of ego boundaries:

Unawareness of where one’s mind and body end and those of others begin

Differential of Psychosis

􏱦 Psychosissecondaryto

general medical

condition

􏱦 Substance-induced

psychotic disorder

􏱦 Delirium/Dementia

􏱦 Bipolardisorder

􏱦 Majordepressionwith

psychotic features

􏱦 Briefpsychoticdisorder

􏱦 Schizophrenia

􏱦 Schizophreniform

disorder

􏱦 Schizoaffectivedisorder

􏱦 Delusionaldisorder

Always be sure to include the importance of ruling out medical, neurological, or substance-induced conditions.

Psychotic Disorders

􏰀 PERCEPTUAL DISTURBANCES (HALLUCINATIONS VERSUS ILLUSIONS) Hallucination

Sensory perception without an actual external stimulus

Types

􏱦 Auditory hallucination—most commonly exhibited by schizophrenic

patients

􏱦 Visual hallucination—commonly seen with drug intoxication

􏱦 Olfactory hallucination—usually an aura associated with epilepsy

􏱦 Tactile hallucination—usually secondary to drug abuse or alcohol with-

drawal

Illusion

Misinterpretation of an existing sensory stimulus (such as mistaking a shadow for a cat)

􏰀 DIFFERENTIAL DIAGNOSIS OF PSYCHOSIS

􏱦 Psychosis secondary to general medical condition

􏱦 Substance-induced psychotic disorder

􏱦 Delirium/Dementia

􏱦 Bipolar disorder

􏱦 Major depression with psychotic features

􏱦 Brief psychotic disorder

􏱦 Schizophrenia

􏱦 Schizophreniform disorder

􏱦 Schizoaffective disorder

􏱦 Delusional disorder

􏰀 PSYCHOSIS SECONDARY TO GENERAL MEDICAL CONDITION Medical causes of psychosis include:

1. CNS disease (cerebrovascular disease, multiple sclerosis, neoplasm, Parkinson’s disease, Huntington’s chorea, temporal lobe epilepsy, encephalitis, prion disease)

2. Endocrinopathies (Addison’s/Cushing’s disease, hyper/hypothyroidism, hyper/hypocalcemia, hypopituitarism)

3. Nutritional/Vitamin deficiency states (B12, folate, niacin)

4. Other (connective tissue disease [systemic lupus erythematosus, tempo-

ral arteritis], porphyria)

DSM-IV criteria for psychotic disorder secondary to a general medical condi- tion include:

􏱦 Prominent hallucinations or delusions

􏱦 Symptoms do not occur only during episode of delirium

􏱦 Evidence to support medical cause from lab data, history, or physical

􏰀 PSYCHOSIS SECONDARY TO MEDICATION OR SUBSTANCE USE

Causes of medication/substance-induced psychosis include antidepressants, antiparkinsonian agents, antihypertensives, antihistamines, anticonvulsants, digitalis, beta blockers, antituberculosis agents, corticosteroids, hallucinogens, amphetamines, opiates, bromide, heavy metal toxicity, and alcohol.

DSM-IV Criteria

􏱦 Prominent hallucinations or delusions

􏱦 Symptoms do not occur only during episode of delirium

􏱦 Evidence to support medication or substance-related cause from lab

data, history, or physical

􏱦 Disturbance is not better accounted for by a psychotic disorder that is

not substance-induced.

􏰀 SCHIZOPHRENIA

Schizophrenia is a psychiatric disorder characterized by a constellation of ab- normalities in thinking, emotion, and behavior. There is no single symptom that is pathognomonic, and the disease can produce a wide spectrum of clini- cal pictures. It is usually chronic and debilitating.

Positive and Negative Symptoms

In general, the symptoms of schizophrenia are broken up into two categories:

􏱦 Positive symptoms—hallucinations, delusions, bizarre behavior, or

thought disorder

􏱦 Negative symptoms—blunted affect, anhedonia, apathy, and inatten-

tiveness. Although negative symptoms are the less dramatic of the two types, they are considered by some to be at the “core” of the disorder.

Three Phases

Symptoms of schizophrenia usually present in three phases:

1. Prodromal—decline in functioning that precedes the first psychotic episode. The patient may become socially withdrawn and irritable. He or she may have physical complaints and/or newfound interest in reli- gion or the occult.

2. Psychotic—perceptual disturbances, delusions, and disordered thought process/content

3. Residual—occurs between episodes of psychosis. It is marked by flat af- fect, social withdrawal, and odd thinking or behavior (negative symp- toms). Patients can continue to have hallucinations even with treat- ment.

HIGH-YIELD FACTS

To make the diagnosis of schizophrenia, a patient must have symptoms of the disease for at least 6 months.

Psychotic Disorders

A 22-year-old college student has been staying in his room most of the time and avoiding his social activities. His friends have noticed that over the past 9 months, “he has been very religious” and often talks about the meaning of life. He reveals to you that he is “Jesus” and his purpose of existence is to save the human race. Think: Schizophrenia.

5 As of schizophrenia (negative symptoms): 1. Anhedonia

2. Affect (flat)

3. Alogia (poverty of speech)

4. Avolition (apathy) 5. Attention (poor)

HIGH-YIELD FACTS

Psychotic Disorders

Echolalia—repeats words or phrases EchoPRAxia—mimics behavior (PRActices behavior)

Diagnosis of Schizophrenia

DSM-IV Criteria

􏱦 Two or more of the following must be present for at least 1 month: 1. Delusions

2. Hallucinations

3. Disorganized speech

4. Grossly disorganized or catatonic behavior

5. Negative symptoms (such as flattened affect)

􏱦 Must cause significant social or occupational functional deterioration

􏱦 Duration of illness for at least 6 months (including prodromal or resid-

ual periods in which above criteria may not be met)

􏱦 Symptoms not due to medical, neurological, or substance-induced disor-

der

Subtypes of Schizophrenia

Patients are further subdivided into the following five subtypes:

1. Paranoid type—highest functioning type, older age of onset. Must meet the following criteria:

􏱦 Preoccupation with one or more delusions or frequent auditory hal-

lucinations

􏱦 No predominance of disorganized speech, disorganized or catatonic

behavior, or inappropriate affect

2. Disorganized type—poor functioning type, early onset. Must meet the

following criteria:

􏱦 Disorganized speech

􏱦 Disorganized behavior

􏱦 Flat or inappropriate affect

3. Catatonic type—rare. Must meet at least two of the following criteria:

􏱦 Motor immobility

􏱦 Excessive purposeless motor activity

􏱦 Extreme negativism or mutism

􏱦 Peculiar voluntary movements or posturing

􏱦 Echolalia or echopraxia

4. Undifferentiated type—characteristic of more than one subtype or

none of the subtypes

5. Residual type—prominent negative symptoms (such as flattened affect

or social withdrawal) with only minimal evidence of positive symp- toms (such as hallucinations or delusions)

Psychiatric Exam of Schizophrenics

The typical findings in schizophrenic patients on exam include:

􏱦 Disheveled appearance

􏱦 Flattened affect

􏱦 Disorganized thought process

􏱦 Intact memory and orientation

􏱦 Auditory hallucinations

􏱦 Paranoid delusions

􏱦 Ideas of reference (feel references are being made to them by the televi-

sion or newspaper, etc.)

􏱦 Concrete understanding of similarities/proverbs

􏱦 Lack insight into their disease

Epidemiology

􏱦 Schizophrenia affects approximately 1% of people over their lifetime.

􏱦 Men and women are equally affected but have different presentations

and outcomes:

􏱦 Men tend to present around 20 years of age.

􏱦 Women present closer to 30 years of age.

􏱦 The course of the disease is generally more severe in men, as men

tend to have more negative symptoms and are less able to function in

society.

􏱦 Schizophrenia rarely presents before age 15 or after age 45.

􏱦 There is a strong genetic predisposition:

􏱦 50% concordance rate among monozygotic twins

􏱦 40% risk of inheritance if both parents have schizophrenia

􏱦 12% risk if one first-degree relative is affected

􏱦 There is a strong association with substance use which may be a form of self medication and depression. Postpsychotic depression occurs in 50% of patients.

Downward Drift

Lower socioeconomic groups have higher rates of schizophrenia. This may be due to the downward drift hypothesis, which postulates that people suffering from schizophrenia are unable to function well in society and hence enter lower socioeconomic groups. Many homeless people in urban areas suffer from schizophrenia.

Pathophysiology of Schizophrenia: The Dopamine Hypothesis

Though the exact cause of schizophrenia is not known, it appears to be partly related to increased dopamine activity in certain neuronal tracts. Evidence to support this hypothesis is that most antipsychotics that are successful in treat- ing schizophrenia are dopamine receptor antagonists. In addition, cocaine and amphetamines increase dopamine activity and can lead to schizophrenic-like symptoms.

Theorized Dopamine Pathways Affected in Schizophrenia

􏱦 Prefrontal cortical—responsible for negative symptoms

􏱦 Mesolimbic—responsible for positive symptoms

Other Important Dopamine Pathways Affected by Neuroleptics

􏱦 Tuberoinfundibular—blocked by neuroleptics, causing hyperprolactine- mia

􏱦 Nigrostriatal—blocked by neuroleptics, causing extrapyramidal side ef- fects

Other Neurotransmiter Abnormalities Implicated in Schizophrenia

Elevated serotonin—some of the atypical antipsychotics (such as risperi- done and clozapine) antagonize serotonin (in addition to their effects on dopamine).

Elevated norepinephrine—long-term use of antipsychotics has been shown to decrease activity of noradrenergic neurons.

Decreased gamma-aminobutyric acid (GABA)—recent data support the 21

People born in winter and early spring have a higher incidence of schizophrenia for unknown reasons. (One theory involves seasonal variation in viral infections of mothers during pregnancy.)

HIGH-YIELD FACTS

It is often impossible to differentiate an acute psychotic episode related to schizophrenia from one related to cocaine or amphetamine abuse, as these drugs excite dopaminergic pathways.

Psychotic Disorders

CT scans of patients with schizophrenia often show enlargement of the ventricles and diffuse cortical atrophy.

HIGH-YIELD FACTS

Psychotic Disorders

Significant improvement is noted in 70% of schizophrenic patients who take antipsychotic medication.

hypothesis that schizophrenic patients have a loss of GABAergic neurons in the hippocampus; this loss might indirectly activate dopaminergic and noradrenergic pathways.

PROGNOSTIC FACTORS

Schizophrenia is usually chronic and debilitating. Forty to 50% of patients re- main significantly impaired after their diagnosis, while only 20 to 30% func- tion fairly well in society with medication. Several factors are associated with a better or worse prognosis:

Associated with Better Prognosis

􏱦 Later onset

􏱦 Good social support

􏱦 Positive symptoms

􏱦 Mood symptoms

􏱦 Acute onset

􏱦 Female sex

􏱦 Few relapses

􏱦 Good premorbid functioning

Associated with Worse Prognosis

􏱦 Early onset

􏱦 Poor social support

􏱦 Negative symptoms

􏱦 Family history

􏱦 Gradual onset

􏱦 Male sex

􏱦 Many relapses

􏱦 Poor premorbid functioning (social isolation, etc.)

TREATMENT

A multimodality approach is the most effective, and therapy must be tailored to the needs of the specific patient. Pharmacologic treatment consists primar- ily of antipsychotic medications, otherwise known as neuroleptics. (For more detail, see Psychopharmacology chapter.)

􏱦 Typical neuroleptics: Chlorpromazine, thioridazine, trifluoperazine, haloperidol. These are dopamine (mostly D2) antagonists. They are clas- sically better at treating positive symptoms than negative. They have important side effects and sequelae such as extrapyramidal symptoms, neuroleptic malignant syndrome, and tardive dyskinesia (see below).

􏱦 Atypical neuroleptics: Risperidone, clozapine, olanzapine, quetiapine, aripiprazole, ziprosidone. These antagonize serotonin receptors (5-HT2) as well as dopamine receptors. Atypical neuroleptics are classically bet- ter at treating negative symptoms than traditional neuroleptics. They have a much lower incidence of extrapyramidal side effects.

􏱦 Medications should be taken for at least 4 weeks before efficacy is deter- mined. If the medication fails, it is appropriate to switch to another medication in a different class.

Behavioral therapy attempts to improve patients’ ability to function in soci- ety. Patients are helped through a variety of methods to improve their social skills, become self-sufficient, and act appropriately in public. Family therapy and group therapy are also useful adjuncts.

Important Side Effects and Sequelae of Antipsychotic Medications

Side effects of antipsychotic medications include:

1. Extrapyramidal symptoms (especially with the use of high-potency tra- ditional antipsychotics):

􏱦 Dystonia (spasms) of face, neck, and tongue

􏱦 Parkinsonism (resting tremor, rigidity, bradykinesia)

􏱦 Akathisia (feeling of restlessness)

Treatment: Antiparkinsonian agents (benztropine, amantadine, etc.), benzodiazepines

2. Anticholinergic symptoms (especially low-potency traditional antipsy- chotics and atypical antipsychotics):

􏱦 Dry mouth, constipation, blurred vision

Treatment: As per symptom (eyedrops, stool softeners, etc.)

3. Tardive dyskinesia (high-potency antipsychotics):

􏱦 Darting or writhing movements of face, tongue, and head Treatment: Discontinue offending agent and substitute atypical neu- roleptic. Benzodiazepines, beta blockers, and cholinomimetics may be used short term. The movements often persist despite withdrawal of the offending drug.

4. Neuroleptic malignant syndrome (high-potency antipsychotics):

􏱦 Confusion, high fever, elevated blood pressure, tachycardia, “lead

pipe” rigidity, sweating, and greatly elevated creatine phosphokinase

(CPK) levels

􏱦 Can be life-threatening. Is not an “allergic” reaction to a drug.

5. Weight gain, sedation, orthostatic hypotension, electrocardiogram changes, hyperprolactinemia (leading to gynecomastia, galactorrhea, amenorrhea, diminished libido, and impotence), hematologic effects (agranulocytosis may occur with clozapine, necessitating weekly blood draws when this medication is used), ophthalmologic conditions (thior- idazine may cause irreversible retinal pigmentation at high doses; de- posits in lens and cornea may occur with chlorpromazine), dermatologic conditions (such as rashes and photosensitivity), hyperlipemia, and glucose intolerance.

􏰀 SCHIZOPHRENIFORM DISORDER DIAGNOSIS AND DSM-IV CRITERIA

The diagnosis of schizophreniform disorder is made using the same DSM-IV criteria as schizophrenia. The only difference between the two is that in schiz- ophreniform disorder the symptoms have lasted between 1 and 6 months, whereas in schizophrenia the symptoms must be present for more than 6 months.

PROGNOSIS

One third of patients recover completely; two thirds progress to schizoaffec- tive disorder or schizophrenia.

TREATMENT

Hospitalization, 3- to 6-month course of antipsychotics, and supportive psy- chotherapy

High-potency neuroleptics (such as haloperidol and trifluoperazine) have a higher incidence of extrapyramidal side effects than anticholinergic, while low-potency neuroleptics (such as chlorpromazine and thioridazine) have primarily anticholinergic side effects.

Tardive dyskinesia occurs most often in older women after at least 6 months of medication. Though 50% of patients will experience spontaneous remission, prompt discontinuation of the agent is important because the condition may become permanent.

HIGH-YIELD FACTS

Psychotic Disorders

Neuroleptic malignant syndrome is most common in men who have recently begun medication. It is considered a medical emergency, as it is associated with a 20% mortality rate. Discontinue medication immediately.

For the past 7 weeks, a 25- year-old medical student has been living in his car despite having adequate housing. He claims that the FBI has put cameras in his dorm room to monitor his every action. His friends state that lately he has been withdrawn and rarely shows up for lectures. He exhibits looseness of association, poor insight, and is concrete to proverbs. Think: Schizophreniform disorder.

HIGH-YIELD FACTS

A 33-year-old male is brought in because he tried to light his body on fire. He tearfully states that satan is trying to freeze his body. In the past winter, he never went outside for this reason and describes feeling sad to a point that he wanted to kill himself. Further questioning reveals that he had a few similar episodes over the last 10 years. When he was treated with risperidone and sertraline, his mood symptoms resolves but his delusions persisted. Think: Schizoaffective disorder.

Psychotic Disorders

SchizophreniFORM = the FORMation of a schizophrenic, but not quite there (i.e., < 6 months).

􏰀 SCHIZOAFFECTIVE DISORDER DIAGNOSIS AND DSM-IV CRITERIA

The diagnosis of schizoaffective disorder is made in patients who:

􏱦 Meet criteria for either major depressive episode, manic episode, or

mixed episode (during which criteria for schizophrenia are also met)

􏱦 Have had delusions or hallucinations for 2 weeks in the absence of mood disorder symptoms (this condition is necessary to differentiate

schizoaffective disorder from mood disorder with psychotic features)

􏱦 Have mood symptoms present for substantial portion of psychotic ill-

ness

􏱦 Symptoms not due to general medical condition or drugs

PROGNOSIS

Better than schizophrenia but worse than mood disorder

TREATMENT

􏱦 Hospitalization and supportive psychotherapy

􏱦 Medical therapy: Antipsychotics as needed for short-term control of

psychosis; mood stabilizers, antidepressants, or electroconvulsive ther- apy (ECT) as needed for mania or depression

􏰀 BRIEF PSYCHOTIC DISORDER DIAGNOSIS AND DSM-IV CRITERIA

Patient with psychotic symptoms as defined for schizophrenia; however, the symptoms last from 1 day to 1 month. Symptoms must not be due to general medical condition or drugs. This is a rare diagnosis, much less common than schizophrenia.

PROGNOSIS

Fifty to 80% recovery rate; 20 to 50% may eventually be diagnosed with schiz- ophrenia or mood disorder.

TREATMENT

Brief hospitalization, supportive psychotherapy, course of antipsychotics for psychosis itself and/or benzodiazepines for agitation

Comparing Time Courses and Prognoses of Psychotic Disorders

Time Course

< 1 month—brief psychotic disorder 1–6 months—schizophreniform disorder > 6 months—schizophrenia

Prognosis from Best to Worst

Mood disorder > brief psychotic disorder > schizoaffective disorder > schizophreniform disorder > schizophrenia

􏰀 DELUSIONAL DISORDER

Delusional disorder occurs more often in older patients (after age 40), immi-

grants, and the hearing impaired.

DIAGNOSIS AND DSM-IV CRITERIA

To be diagnosed with delusional disorder, the following criteria must be met (see Table 3-1):

􏱦 Nonbizarre, fixed delusions for at least 1 month

􏱦 Does not meet criteria for schizophrenia

􏱦 Functioning in life not significantly impaired

Types of Delusions

Patients are further categorized based on the types of delusions they experi- ence:

􏱦 Erotomanic type—delusion revolves around love (Eros is the goddess of love)

􏱦 Grandiose type—inflated self-worth

􏱦 Somatic type—physical delusions

􏱦 Persecutory type—delusions of being persecuted

􏱦 Jealous type—delusions of unfaithfulness

􏱦 Mixed type—more than one of the above

PROGNOSIS

50% full recovery, 20% decreased symptoms, and 30% no change

TREATMENT

Psychotherapy may be helpful. Antipsychotic medications are often ineffec- tive, but a course of them should be tried (usually a high-potency traditional antipsychotic or one of the newer atypical antipsychotics is used).

Two weeks after the death of her 6-month-old infant, a 30-year-old female is brought into the ER because she says she hears the infant crying in the next room. She often carries a pillow in her arms and sings nursery rhymes to it. Think: Brief psychotic disorder.

Nonbizarre delusions: Beliefs that might occur in real life but are not currently true (such as having a disease, having an unfaithful spouse, etc.) Bizarre delusions: Beliefs that have no basis in reality (such as aliens living in the attic, etc.)

HIGH-YIELD FACTS

Psychotic Disorders

Schizophrenia

􏱦 Bizarredelusions(ornonbizarre)

􏱦 Dailyfunctioningsignificantlyimpaired

􏱦 Musthavetwoormoreofthefollowing: 􏱦 Delusions

􏱦 Hallucinations

􏱦 Disorganizedspeech

􏱦 Disorganizedbehavior 􏱦 Negativesymptoms

TABLE 3-1. Schizophrenia vs. Delusional Disorder

Delusional Disorder

􏱦 Nonbizarredelusions(neverbizarre)

􏱦 Dailyfunctioningnotsignificantlyimpaired

􏱦 Doesnotmeetthecriteriaforschizophreniaasdescribedinleftcolumn

A 48-year-old pathology professoor says that the students constantly complain about him to the head of the department in attempts to get rid of him. Despite reassurance from the department, he states he knows he “is right.” He is married and has held this job for the past 15 years. Think: Delusional disorder.

HIGH-YIELD FACTS

Psychotic Disorders

A 28-year-old woman taking care of her schizophrenic husband starts believing her husband’s claim that he invented the telephone. When she went abroad for a few months, her beliefs disappeared. Think: Shared psychotic disorder.

􏰀 SHARED PSYCHOTIC DISORDER DIAGNOSIS AND DSM-IV CRITERIA

Also known as folie à deux, shared psychotic disorder is diagnosed when a pa- tient develops the same delusional symptoms as someone he or she is in a close relationship with. Most people suffering from shared psychotic disorder are family members.

PROGNOSIS

Twenty to 40% will recover upon removal from the inducing person.

TREATMENT

The first step is to separate the patient from the person who is the source of shared delusions (usually a family member with an underlying psychotic disor- der). Psychotherapy should be undertaken, and antipsychotic medications should be used if symptoms have not improved in 1 to 2 weeks after separa- tion.

􏰀 CULTURE-SPECIFIC PSYCHOSES

These are psychoses seen only within certain cultures:

Koro Amok

Brain fag

Psychotic Manifestation

Patient believes that his penis is shrinking and will disappear, causing his death. Sudden unprovoked outbursts of violence of which the person has no recollection. Person often commits suicide afterwards. Headache, fatigue, and visual disturbances in male students

Culture

Asia

Malaysia, Southeast Asia

Africa

􏰀 QUICK AND EASY DISTINGUISHING FEATURES

􏱦 Schizophrenia—lifelong psychotic disorder

􏱦 Schizophreniform—schizophrenia for < 6 months

􏱦 Schizoaffective—schizophrenia + mood disorder

􏱦 Schizotypal (personality disorder)—paranoid, odd or magical beliefs,

eccentric, lack of friends, social anxiety. Criteria for true psychosis are

not met.

􏱦 Schizoid (personality disorder)—withdrawn, lack of enjoyment from so-

cial interactions, emotionally restricted

HIGH-YIELD FACTS IN

Mood Disorders

􏰀 CONCEPTS IN MOOD DISORDERS

A mood is a description of one’s internal emotional state. Both external and internal stimuli can trigger moods, which may be labeled as sad, happy, angry, irritable, and so on. It is normal to have a wide range of moods and to have a sense of control over one’s moods.

Patients with mood disorders experience an abnormal range of moods and lose some level of control over them. Distress may be caused by the severity of their moods and their resulting impairment in social and occupational func- tioning.

Mood disorders have also been called affective disorders. Mood Disorders Versus Mood Episodes

Mood episodes are distinct periods of time in which some abnormal mood is present. Mood disorders are defined by their patterns of mood episodes.

Types of Mood Episodes

􏱦 Major depressive episode

􏱦 Manic episode

􏱦 Mixed episode

􏱦 Hypomanic episode

The Main Mood Disorders

􏱦 Major depressive disorder (MDD)

􏱦 Bipolar I disorder

􏱦 Bipolar II disorder

􏱦 Dysthymic disorder

􏱦 Cyclothymic disorder

Some may have psychotic features (delusions or hallucinations).

Major depressive episodes

can be present in either major depressive disorder or bipolar I/II disorder.

HIGH-YIELD FACTS

Symptoms of major depression:

Sleep

Interest

Guilt Energy

Concentration Appetite Psychomotor activity Suicidal ideation

A manic episode is a

psychiatric emergency;

severely impaired judgment makes patient dangerous to self and others.

Mood Disorders

Symptoms of mania: DIG FAST Distractability

Insomnia

Grandiosity

Flight of ideas Activity/agitation Speech (pressured) Thoughtlessness

Irritability is usually the predominant mood state in mixed episodes. Patients with mixed episodes have a poorer response to lithium. Anticonvulsants may help.

􏰀 MOOD EPISODES

Major Depressive Episode (DSM-IV Criteria)

Must have at least five of the following symptoms (must include either num- ber 1 or number 2) for at least a 2-week period:

1. Depressed mood

2. Anhedonia (loss of interest in pleasurable activities)

3. Change in appetite or body weight (increased or decreased)

4. Feelings of worthlessness or excessive guilt

5. Insomnia or hypersomnia

6. Diminished concentration

7. Psychomotor agitation or retardation (i.e., restlessness or slowness) 8. Fatigue or loss of energy

9. Recurrent thoughts of death or suicide

Symptoms cannot be due to substance use or medical conditions, and they must cause social or occupational impairment.

SUICIDE AND MAJOR DEPRESSIVE EPISODES

A person who has been previously hospitalized for a major depressive episode has a 15% risk of committing suicide later in life.

Manic Episode (DSM-IV Criteria)

A period of abnormally and persistently elevated, expansive, or irritable mood, lasting at least 1 week and including at least three of the following (four if mood is irritable):

1. Distractibility

2. Inflated self-esteem or grandiosity

3. Increase in goal-directed activity (socially, at work, or sexually)

4. Decreased need for sleep

5. Flight of ideas or racing thoughts

6. More talkative or pressured speech (rapid and uninterruptible)

7. Excessive involvement in pleasurable activities that have a high risk of

negative consequences (e.g., buying sprees, sexual indiscretions)

These symptoms cannot be due to substance use or medical conditions, and they must cause social or occupational impairment. Seventy-five percent of manic patients have psychotic symptoms.

Mixed Episode

Criteria are met for both manic episode and major depressive episode. These criteria must be present nearly every day for at least 1 week. As with a manic episode, this is a psychiatric emergency.

Hypomanic Episode

A hypomanic episode is a distinct period of elevated, expansive, or irritable mood that includes at least three of the symptoms listed for the manic episode criteria (four if mood is irritable). There are significant differences between mania and hypomania (see below).

Differences Between Manic and Hypomanic Episodes

Mania

Lasts at least 7 days

Causes severe impairment in social

or occupational functioning May necessitate hospitalization to

prevent harm to self or others May have psychotic features

􏰀 MOOD DISORDERS

Hypomania

Lasts at least 4 days

No marked impairment in social or

occupational functioning Does not require hospitalization No psychotic features

Mood disorders often have chronic courses that are marked by relapses with relatively normal functioning between episodes. Like most psychiatric diag- noses, they may be triggered by a medical condition or drug (prescribed or il- licit). Always investigate medical or substance-induced causes (see below) be- fore making a diagnosis.

Differential Diagnosis of Mood Disorders Secondary to General Medical Conditions

Medical Causes of a Depressive Episode

Cerebrovascular disease Endocrinopathies (Cushing’s

syndrome, Addison’s disease, hypoglycemia, hyper/ hypothyroidism, hyper/hypocalcemia)

Parkinson’s disease

Viral illnesses (e.g., mononucleosis) Carcinoid syndrome

Cancer (especially lymphoma and

pancreatic carcinoma) Collagen vascular disease (e.g.,

systemic lupus erythematosus)

Medical Causes of a Manic Episode

Metabolic (hyperthyroidism) Neurological disorders (temporal

lobe seizures, multiple sclerosis) Neoplasms

HIV infection

Mood Disorders Secondary to Medication or Substance Use

Medication/Substance-Induced Depressive Episodes

EtOH

Antihypertensives

Barbiturates

Corticosteroids

Levodopa

Sedative–hypnotics Anticonvulsants

Antipsychotics

Diuretics

Sulfonamides

Withdrawal from psychostimulants

Medication/Substance-Induced Mania

Corticosteroids Sympathomimetics

Dopamine Agonists Antidepressants Bronchodilators Levodopa

(e.g., cocaine, amphetamines)

HIGH-YIELD FACTS

Mood Disorders

A 65-year-old widow has been put into a geriatric home because she has “not been taking care of herself.” Lately, she wakes up earlier than she normally does and sits around all day “doing nothing.” She has stopped attending her Thursday bingo meetings and says that there’s not much for her in her life now. Think: Major depressive disorder (MDD).

HIGH-YIELD FACTS

Triad for seasonal affective disorder:

􏱦 Irritability

􏱦 Carbohydratedrawing 􏱦 Hypersomnia

Mood Disorders

􏰀 MAJOR DEPRESSIVE DISORDER (MDD)

MDD is marked by episodes of depressed mood associated with loss of interest in daily activities. Patients may be unaware of their depressed mood or may express vague, somatic complaints.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 At least one major depressive episode (see above)

􏱦 No history of manic or hypomanic episode

Seasonal affective disorder is a subtype of MDD in which major depressive episodes occur only during winter months (fewer daylight hours). Patients re- spond to treatment with light therapy.

EPIDEMIOLOGY

􏱦 Lifetime prevalence: 15%

􏱦 Onset at any age, but average age of onset is 40

􏱦 Twice as prevalent in women than men

􏱦 No ethnic or socioeconomic differences

􏱦 Prevalence in elderly from 25 to 50%

SLEEP PROBLEMS ASSOCIATED WITH MDD

􏱦 Multiple awakenings

􏱦 Initial and terminal insomnia (hard to fall asleep and early morning

awakenings)

􏱦 Hypersomnia

􏱦 Rapid eye movement (REM) sleep shifted to earlier in night and stages

3 and 4 decreased

ETIOLOGY

The exact cause of depression is unknown, but biological, genetic, environ- mental, and psychosocial factors each contribute.

Abnormalities of Serotonin/Catecholamines

1. Decreased brain and cerebrospinal fluid (CSF) levels of serotonin and its main metabolite, 5-hydroxyindolacetic acid (5-HIAA), are found in depressed patients. Abnormal regulation of beta-adrenergic recep- tors has also been shown.

2. Drugs that increase availability of serotonin, norepinephrine, and dopamine often alleviate symptoms of depression.

Other Neuroendocrine Abnormalities

1. High cortisol: Hyperactivity of hypothalamic–pituitary–adrenal axis as shown by failure to suppress cortisol levels in dexamethasone sup- pression test.

2. Abnormal thyroid axis: Thyroid disorders are associated with depres- sive symptoms, and one third of patients with MDD who have other- wise normal thyroid hormone levels show blunted response of thyroid- stimulating hormone (TSH) to infusion of thyrotropin-releasing hormone (TRH).

These abnormalities are also associated with other psychiatric disorders; they are not specific for major depression.

Many other neurotransmitters and hormonal factors have also shown poten- tial involvement in the pathophysiology of mood disorders, including gamma- aminobutyric acid (GABA) and endogenous opiates.

Psychosocial/Life Events

Loss of a parent before age 11 is associated with the later development of ma- jor depression. Stable family and social functioning have been shown to be good prognostic indicators in the course of major depression.

Genetic Predisposition

First-degree relatives are two to three times more likely to have MDD. Con- cordance rate for monozygotic twins is about 50%, and 10 to 25% for dizy- gotic twins.

COURSE AND PROGNOSIS

If left untreated, depressive episodes are self-limiting but usually last from 6 to 13 months. Generally, episodes occur more frequently as the disorder progresses. The risk of a subsequent major depressive episode is 50% within the first 2 years after the first episode. About 15% of patients eventually commit suicide.

Antidepressant medications significantly reduce the length and severity of symptoms. They may be used prophylactically between major depressive episodes to reduce the risk of subsequent episodes. Approximately 75% of pa- tients are treated successfully with medical therapy.

TREATMENT

Hospitalization

􏱦 Indicated if patient is at risk for suicide, homicide, or is unable to care for self.

Pharmacotherapy

Antidepressant Medications

􏱦 Selective serotonin reuptake inhibitors (SSRIs)—safer and better toler- ated than other classes of antidepressants; side effects mild but include headache, gastrointestinal disturbance, sexual dysfunction, and rebound anxiety.

􏱦 Tricyclic antidepressants (TCAs)—most lethal in overdose; side effects include sedation, weight gain, orthostatic hypotension, and anticholin- ergic effects. Can aggravate prolonged QTC syndrome.

􏱦 Monoamine oxidase inhibitors (MAOIs)—useful for treatment of re- fractory depression; risk of hypertensive crisis when used with sympa- thomimetics or ingestion of tyramine-rich foods (such as wine, beer, aged cheeses, liver, and smoked meats); risk of serotonin syndrome when used in combination with SSRIs. Most common side effect is orthosta- tic hypotension. (Tyramine is an intermediate in the conversion of ty- rosine to norepinephrine.)

Adjuvant Medications

􏱦 Stimulants (such as methylphenidate) may be used in certain patients, such as the terminally ill or patients with refractory symptoms. Though action is rapid, potential for dependence limits use.

MDD may have psychotic features (delusions or hallucinations).

About two thirds of all depressed patients contemplate suicide, and 10 to 15% commit suicide.

HIGH-YIELD FACTS

Only half of patients with MDD ever receive treatment.

Mood Disorders

All antidepressant medications are equally effective but differ in side effect profiles. Medications usually take 4 to 8 weeks to work.

Serotonin syndrome is marked by autonomic instability, hyperthermia, and seizures. Coma or death may result.

HIGH-YIELD FACTS

Patients who may not be able to tolerate side effects of antidepressant medications include the elderly and pregnant women.

MAOIs are often useful in treatment of “atypical” depression.

Mood Disorders

The catatonic type of major depression is usually treated with antidepressants and antipsychotics concurrently.

Bipolar I disorder may have

psychotic features

(delusions or hallucinations); these can occur during major depressive or manic episodes. Always remember to include bipolar disorder in your differential of a psychotic patient.

􏱦 Antipsychotics—useful in patients with psychotic features

􏱦 Liothyronine (T3), levothyroxine (T4), lithium, or L-tryptophan (sero- tonin precursor) may be added to convert nonresponders to responders.

Psychotherapy

􏱦 Behavioral therapy, cognitive therapy, supportive psychotherapy, dy- namic psychotherapy, and family therapy

􏱦 May be used in conjunction with pharmacotherapy

Electroconvulsive therapy (ECT)

􏱦 Indicated if patient is unresponsive to pharmacotherapy, if patient can- not tolerate pharmacotherapy, or if rapid reduction of symptoms is de- sired (suicide risk, etc.)

􏱦 ECT is safe and may be used alone or in combination with pharma- cotherapy.

􏱦 ECT is performed by premedication with atropine, followed by general anesthesia and administration of a muscle relaxant. A generalized seizure is then induced by passing a current of electricity across the brain (either unilateral or bilateral); the seizure lasts < 1 minute.

􏱦 Approximately eight treatments are administered over a 2- to 3-week period, but significant improvement is often noted after the first treat- ment.

􏱦 Retrograde amnesia is a common side effect, which usually disappears within 6 months.

Unique Types and Features of Depressive Disorders

Melancholic—40 to 60% of hospitalized patients with major depression. Characterized by anhedonia, early morning awakenings, psychomotor dis- turbance, excessive guilt, and anorexia. For example, you may diagnose “major depressive disorder with melancholic features.” Atypical—characterized by hypersomnia, hyperphagia, reactive mood, leaden paralysis, and hypersensitivity to interpersonal rejection Catatonic—features include catalepsy (immobility), purposeless motor ac- tivity, extreme negativism or mutism, bizarre postures, and echolalia. May also be applied to bipolar disorder.

Psychotic—10 to 25% of hospitalized depressions. Characterized by the presence of delusions or hallucinations.

􏰀 BIPOLAR I DISORDER

Bipolar I disorder involves episodes of mania and of major depression; how- ever, episodes of major depression are not required for the diagnosis. It is tradi- tionally known as manic depression.

DIAGNOSIS AND DSM-IV CRITERIA

The only requirement for this diagnosis is the occurrence of one manic or mixed episode (10 to 20% of patients experience only manic episodes). Be- tween manic episodes, there may be interspersed euthymia, major depressive episodes, dysthymia, or hypomanic episodes, but none of these are required for diagnosis.

EPIDEMIOLOGY

􏱦 Lifetime prevalence: 1%

􏱦 Women and men equally affected

􏱦 No ethnic differences seen

􏱦 Onset usually before age 30

ETIOLOGY

Biological, environmental, psychosocial, and genetic factors are all important. First-degree relatives of patients with bipolar disorder are 8 to 18 times more likely to develop the illness. Concordance rates for monozygotic twins are ap- proximately 75%, and rates for dizygotic twins are 5 to 25%.

COURSE AND PROGNOSIS

Untreated manic episodes generally last about 3 months. The course is usually chronic with relapses; as the disease progresses, episodes may occur more fre- quently. Only 7% of patients do not have a recurrence of symptoms after their first manic episode.

Bipolar disorder has a worse prognosis than MDD, as only 50 to 60% of pa- tients treated with lithium experience significant improvement in symptoms. Lithium prophylaxis between episodes helps to decrease the risk of relapse.

TREATMENT

Pharmacotherapy

􏱦 Lithium—mood stabilizer

􏱦 Anticonvulsants(carbamazepineorvalproicacid)—alsomoodstabilizers,

especially useful for rapid cycling bipolar disorder and mixed episodes

􏱦 Olanzapine—atypicalantipsychotic

Psychotherapy

􏱦 Supportive psychotherapy, family therapy, group therapy (once the acute manic episode has been controlled)

ECT

􏱦 Works well in treatment of manic episodes

􏱦 Usually requires more treatments than for depression

􏰀 BIPOLAR II DISORDER

Alternatively called recurrent major depressive episodes with hypomania

DIAGNOSIS AND DSM-IV CRITERIA

History of one or more major depressive episodes and at least one hypomanic episode. Remember: If there has been a full manic episode even in the past, then the diagnosis is not bipolar II disorder, but bipolar I.

A 35-year-old male is brought in by his wife because he has been taking out various loans to start a few small businesses. Over the past 2 weeks, he comes home at 3 A.M. from work and leaves at 6 A.M. and often compares his business ventures to those of Bill Gates. In the past, he has had a few episoodes in which he felt hopeless and tried to commit suicide. Think: Bipolar disorder.

HIGH-YIELD FACTS

Rapid cycling is defined by the occurrence of four or more mood episodes in 1 year (major depressive, manic, mixed, etc.).

Mood Disorders

Side effects of lithium include:

􏱦 Weightgain

􏱦 Tremor

􏱦 Gastrointestinal disturbances

􏱦 Fatigue

􏱦 Arrhythmias

􏱦 Seizures

􏱦 Goiter/hypothyroidism

􏱦 Leukocytosis(benign)

􏱦 Coma

􏱦 Polyuria

􏱦 Polydipsia

􏱦 Alopecia

􏱦 Metallictaste

MDD tends to be episodic, while dysthymic disorder is generally persistent.

Dysthymic disorder: CHASES

􏱦 Poorconcentrationor

difficulty making

decisions

􏱦 Feelingsofhopelessness

􏱦 Poorappetiteor

overeating

􏱦 Insomniaor

hypersomnia

􏱦 Lowenergyorfatigue

􏱦 Low self-esteem

HIGH-YIELD FACTS

Mood Disorders

Dysthymic disorder (DD) = 2 Ds

2 years of depression

2 listed criteria

Never asymptomatic for > 2 months

Dysthymia can never have psychotic features. If a patient has delusions or hallucinations with “depression,” consider another diagnosis (e.g., major depression with psychotic features, schizoaffective, etc.).

EPIDEMIOLOGY

􏱦 Lifetime prevalence: 0.5%

􏱦 Slightly more common in women

􏱦 Onset usually before age 30

􏱦 No ethnic differences seen

ETIOLOGY

Same as bipolar I disorder (see above)

COURSE AND PROGNOSIS

Tends to be chronic, requiring long-term treatment

TREATMENT

Same as bipolar I disorder (see above)

􏰀 DYSTHYMIC DISORDER

Patients with dysthymic disorder have chronic, mild depression most of the

time with no discrete episodes. They rarely need hospitalization.

DIAGNOSIS AND DSM-IV CRITERIA

1. Depressed mood for the majority of time of most days for at least 2 years (in children for at least 1 year)

2. At least two of the following:

􏱦 Poor concentration or difficulty making decisions

􏱦 Feelings of hopelessness

􏱦 Poor appetite or overeating

􏱦 Insomnia or hypersomnia

􏱦 Low energy or fatigue

􏱦 Low self-esteem

3. During the 2-year period:

􏱦 The person has not been without the above symptoms for > 2

months at a time.

􏱦 No major depressive episode

The patient must never have had a manic or hypomanic episode (this would make the diagnosis bipolar disorder or cyclothymic disorder, respectively).

Double depression: Patients with major depressive disorder with dysthymic disorder during residual periods

EPIDEMIOLOGY

􏱦 Lifetime prevalence: 6%

􏱦 Two to three times more common in women

􏱦 Onset before age 25 in 50% of patients

COURSE AND PROGNOSIS

Twenty percent of patients will develop major depression, 20% will develop bipolar disorder, and > 25% will have lifelong symptoms.

TREATMENT

􏱦 Cognitive therapy and insight-oriented psychotherapy are most effec- tive.

􏱦 Antidepressant medications are useful when used concurrently (SSRIs, TCAs, or MAOIs).

􏰀 CYCLOTHYMIC DISORDER

Alternating periods of hypomania and periods with mild to moderate depres-

sive symptoms

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Numerous periods with hypomanic symptoms and periods with depres- sive symptoms for at least 2 years

􏱦 The person must never have been symptom free for > 2 months during those 2 years.

􏱦 No history of major depressive episode or manic episode EPIDEMIOLOGY

􏱦 Lifetime prevalence: < 1%

􏱦 May coexist with borderline personality disorder

􏱦 Onset usually age 15 to 25

􏱦 Occurs equally in males and females

COURSE AND PROGNOSIS

Chronic course; one third of patients eventually diagnosed with bipolar disor- der

TREATMENT

Antimanic agents as used to treat bipolar disorder (see above)

􏰀 OTHER DISORDERS OF MOOD IN DSM-IV

􏱦 Minor depressive disorder—episodes of depressive symptoms that do not meet criteria for major depressive disorder; euthymic periods are also seen, unlike in dysthymic disorder.

􏱦 Recurrent brief depressive disorder

􏱦 Premenstrual dysphoric disorder

􏱦 Mood disorder due to a general medical condition

􏱦 Substance-induced mood disorder

􏱦 Mood disorder not otherwise specified (NOS)

A 28-year-old accountant has felt sad since her adolescence. She does not remember the last time she “did something fun.” She denies any suicidal thoughts or having any episodes of hopelessness or impaired sleep pattern. Think: Dysthymia.

HIGH-YIELD FACTS

A 28-year-old graduate student says that she has her “ups and downs.” Further questioning reveals that at times over the past 2 years, she has had episodes of extreme happiness in which she would party every day and felt as if “she was full of energy.” She also describes being “down in the dumps” at times for no apparent reason. Think: Cyclothymia.

Mood Disorders

NOTES

HIGH-YIELD FACTS

Mood Disorders

HIGH-YIELD FACTS IN

Anxiety and Adjustment Disorders

􏰀 NORMAL VERSUS PATHOLOGICAL ANXIETY

Anxiety is the subjective experience of fear and its physical manifestations. Autonomic symptoms of anxiety include palpitations, perspiration, dizziness, mydriasis, gastrointestinal disturbances, and urinary urgency and frequency. An anxious person may also experience trembling, “butterflies” in the ab- domen, and tingling in the peripheral extremities. There is often a shortness of breath or choking sensation.

Anxiety is a common, normal response to a perceived threat. It is important for clinicians to be able to distinguish normal from pathological anxiety. When anxiety is pathological, it is inappropriate; there is either no real source of fear or the source is not sufficient to account for the severity of the symp- toms. In people with anxiety disorders, the symptoms interfere with daily functioning and interpersonal relationships.

􏰀 ANXIETY DISORDERS ETIOLOGY

Anxiety disorders are caused by a combination of genetic, environmental, bi- ological, and psychosocial factors. They are associated with neurotransmitter imbalances, including increased activity of norepinephrine and decreased ac- tivity of gamma-aminobutyric acid (GABA) and serotonin.

EPIDEMIOLOGY

Anxiety disorders are very common. Women have a 30% lifetime prevalence rate, and men have a 19% lifetime prevalence rate. Anxiety disorders develop more frequently in higher socioeconomic groups.

Types of Anxiety Disorders

The primary anxiety disorders are: 􏱦 Panic disorder

􏱦 Agoraphobia

􏱦 Specific and social phobias

HIGH-YIELD FACTS

Anxiety and Adjustment

Panic attack criteria: PANIC

Palpitations

Abdominal distress Numbness, nausea Intense fear of death Choking, chills, chest pain,

sweating, shaking, shortness of breath

A panic attack may be mistaken by patient for a myocardial infarction; sufferer may seek help in the emergency department (ED).

􏱦 Obsessive–compulsive disorder

􏱦 Posttraumatic stress disorder

􏱦 Acute stress disorder

􏱦 Generalized anxiety disorder

􏱦 Anxiety disorder secondary to general medical condition

􏱦 Substance-induced anxiety disorder

Medical Causes of Anxiety Disorders

Hyperthyroidism

Vitamin B12 deficiency Hypoxia

Neurological disorders (epilepsy, brain tumors, multiple sclerosis, etc.)

Cardiovascular disease Anemia Pheochromocytoma Hypoglycemia

Panic Attack

Medication- or Substance-Induced Anxiety Disorders

Caffeine intake and withdrawal Amphetamines

Alcohol and sedative withdrawal Other illicit drug withdrawal Mercury or arsenic toxicity Organophosphate or benzene toxicity Penicillin

Sulfonamides Sympathomimetics Antidepressants

Panic attacks are discrete periods of heightened anxiety that classically occur in patients with panic disorder; however, they may occur in other mental dis- orders, especially phobic disorders and posttraumatic stress disorder.

Panic attacks often peak in several minutes and subside within 25 minutes. They rarely last > 1 hour. Attacks may be either unexpected or provoked by specific triggers. They may be described as a sudden rush of fear.

DIAGNOSIS AND DSM-IV CRITERIA

A panic attack is a discrete period of intense fear and discomfort that is ac- companied by at least four of the following:

􏱦 Palpitations

􏱦 Sweating

􏱦 Shaking

􏱦 Shortness of breath

􏱦 Choking sensation

􏱦 Chest pain

􏱦 Nausea

􏱦 Light-headedness

􏱦 Depersonalization (feeling detached from oneself)

􏱦 Fear of losing control or “going crazy”

􏱦 Fear of dying

􏱦 Numbness or tingling

􏱦 Chills or hot flushes

Panic Disorder

Panic disorder is characterized by the experience of panic attacks accompa- nied by persistent fear of having additional attacks.

DIAGNOSIS AND DSM-IV CRITERIA

1. Spontaneous recurrent panic attacks (see above) with no obvious pre- cipitant

2. At least one of the attacks has been followed by a minimum of 1 month of the following:

􏱦 Persistent concern about having additional attacks

􏱦 Worry about the implications of the attack (“Am I out of control?”)

􏱦 A significant change in behavior related to the attacks (avoid situa-

tions that may provoke attacks)

Two types of diagnoses: Always specify panic disorder with agoraphobia or

panic disorder without agoraphobia (see definition of agoraphobia below). PRESENTATION

The first panic attack is usually unexpected by the patient, but it may follow a period of stress or physical exertion. In addition to physical symptoms (such as tachycardia, sweating, and shortness of breath), the patient experiences ex- treme fear without understanding the source or trigger of that fear. The pa- tient may sense impending death or harm and may worry that he or she is “go- ing crazy.”

Subsequent attacks usually occur spontaneously but may be associated with specific situations. Attacks occur an average of two times per week but may range from several times per day to a few times per year. They usually last be- tween 20 and 30 minutes, and anticipatory anxiety about having another attack is common between episodes.

ETIOLOGY

Biological, genetic, and psychosocial factors contribute to the development of panic disorder. Research has revealed dysregulation of the autonomic nervous system, central nervous system, and cerebral blood flow in patients with panic disorder. Increased activity of norepinephrine and decreased activity of sero- tonin and GABA have also been shown in these patients.

PANIC-INDUCING SUBSTANCES

Certain substances have been shown to induce panic attacks in patients with panic disorder and only infrequently trigger them in people without the disor- der. For example, hyperventilation or its treatment/inhalation of carbon diox- ide (CO2) (breathing in and out of a paper bag)

In addition, caffeine and nicotine have been shown to exacerbate anxiety symptoms in patients suffering from panic disorder.

EPIDEMIOLOGY

􏱦 Lifetime prevalence: 2 to 5%

􏱦 Two to three times more common in females than males

􏱦 Strong genetic component: Four to eight times greater risk of panic dis-

order if first-degree relative is affected

􏱦 Onset usually from late teens to early thirties (average age 25), but may

occur at any age

Consider the panic disorder diagnosis if medical workup shows no abnormalities. Studies have shown that 43% of patients presenting with chest pain and normal angiograms were diagnosed with panic disorder.

HIGH-YIELD FACTS

A 24-year-old female comes to the ER complaining of a pounding heart, shortness of breath, and sweating that began while she was shopping and lasted 20 minutes. She expresses that she thought she was going to die. Further questioning reveals that she has had six of these episodes in the last month and fears having another one. Think: Panic disorder.

Anxiety and Adjustment

HIGH-YIELD FACTS

Anxiety and Adjustment

Always start SSRIs at low dose and increase slowly in panic disorder patients, as they are prone to develop activation side effects from these medications (anxiety symptoms that mimic those of panic).

Beta blockers are not as effective as benzodiazepines in controlling anxiety symptoms in patients with panic disorder.

ASSOCIATED CONDITIONS

The following conditions are frequently associated with both panic disorder and agoraphobia:

1. Major depression (depressive symptoms found in 40 to 80% of pa- tients)

2. Substance dependence (found in 20 to 40% of patients)

3. Social and specific phobias

4. Obsessive–compulsive disorder

DIFFERENTIAL DIAGNOSIS

There is a vast differential diagnosis for panic disorder, including general med- ical conditions, substance use or withdrawal, and other mental disorders that may cause panic-like symptoms. It is important to rule out these conditions before making the diagnosis of panic disorder.

Medical: Congestive heart failure; angina; myocardial infarction; thyro- toxicosis; temporal lobe epilepsy; multiple sclerosis; pheochromocytoma; carcinoid syndrome; chronic obstructive pulmonary disease (COPD); and other cardiac, pulmonary, neurological, and endocrine abnormalities Mental: Depressive disorders, phobic disorders, obsessive–compulsive dis- order, and posttraumatic stress disorder

Drug: Amphetamine, caffeine, nicotine, cocaine, and hallucinogen intox- ication; alcohol or opiate withdrawal

COURSE AND PROGNOSIS

Panic disorder has a variable course but is often chronic. Relapses are com- mon with discontinuation of medical therapy:

􏱦 10 to 20% of patients continue to have significant symptoms that inter- fere with daily functioning.

􏱦 50% continue to have mild, infrequent symptoms.

􏱦 30 to 40% remain free of symptoms after treatment.

TREATMENT

Pharmacological

Acute Initial Treatment of Anxiety

Benzodiazepines (only short course if necessary, as dependence may occur with long-term use); Dose should be tapered as treatment with selective sero- tonin reuptake inhibitors (SSRIs) is instituted.

Maintenance

SSRIs, especially paroxetine and sertraline, are the drugs of choice for long- term treatment of panic disorder. These drugs typically take 2 to 4 weeks to become effective, and higher doses are required than for depression. Clomipramine, imipramine, or other antidepressants may also be used. Treat- ment should continue for at least 8 to 12 months, as relapse is common after discontinuation of therapy.

Other Treatments

􏱦 Relaxation training

􏱦 Biofeedback

􏱦 Cognitive therapy

􏱦 Insight-oriented psychotherapy

􏱦 Family therapy

Agoraphobia

Agoraphobia is the fear of being alone in public places. It often develops sec- ondary to panic attacks due to apprehension about having subsequent attacks in public places where escape may be difficult. It can be diagnosed alone or as panic disorder with agoraphobia; 50 to 75% of patients have coexisting panic disorder.

DIAGNOSIS AND DSM-IV CRITERIA

The following criteria must be met for diagnosis:

􏱦 Anxiety about being in places or situations from which escape might be difficult, or in which help would not be readily available in the event of a panic attack

􏱦 The situations are either avoided, endured with severe distress, or faced only with the presence of a companion.

􏱦 These symptoms cannot be better explained by another mental disor- der.

TYPICAL FEARS

Characteristic situations are avoided, including being outside the home alone; being on a bridge or in a crowd; or riding in a car, bus, or train.

RELATIONSHIP BETWEEN PANIC ATTACKS AND AGORAPHOBIA

Clinical progression: A person who has a panic attack while shopping in a large supermarket subsequently develops a fear of entering that supermarket. As the person experiences more panic attacks in different settings, he or she develops a progressive and more general fear of public spaces (agoraphobia).

TREATMENT

Since agoraphobia is usually associated with panic disorder, SSRIs are also considered first-line treatment. Behavioral therapy may also be indicated. As coexisting panic disorder is treated, agoraphobia usually resolves. When ago- raphobia is not associated with panic disorder, it is usually chronic and debili- tating.

Specific and Social Phobias

A phobia is defined as an irrational fear that leads to avoidance of the feared object or situation. A specific phobia is a strong, exaggerated fear of a specific object or situation; a social phobia (also called social anxiety disorder) is a fear of social situations in which embarrassment can occur.

DIAGNOSIS AND DSM-IV CRITERIA

The diagnostic criteria for specific phobias is as follows:

1. Persistent excessive fear brought on by a specific situation or object

2. Exposure to the situation brings about an immediate anxiety response.

3. Patient recognizes that the fear is excessive.

4. The situation is avoided when possible or tolerated with intense anxi-

ety.

5. If person is under age 18, duration must be at least 6 months.

Agoraphobia: Agora—open place Phobia—fear

A 35-year-old female complains of a pounding heart, shortness of breath, and sweating that occur when she takes the train to work. She states that these symptoms also occur when she is in crowded waiting areas. She has decided to avoid the train and get a ride from her friend to work. Think: Panic disorder with agorophobia.

HIGH-YIELD FACTS

Anxiety and Adjustment

Common Specific Phobias

􏱦 Fearofanimals

􏱦 Fearofheights

􏱦 Fearofbloodorneedles 􏱦 Fearofillnessorinjury 􏱦 Fearofdeath

􏱦 Fearofflying

Common Social Phobias

􏱦 Speakinginpublic

􏱦 Eatinginpublic

􏱦 Usingpublicrestrooms

A 32-year-old construction worker states that he is terrified of heights. He came in to your office because he recently started a project on the 50th floor and has had trouble doing his job. Think: Specific phobia.

HIGH-YIELD FACTS

Substance-related disorders are found more commonly in phobic patients, especially alcohol-related disorders. Up to one third of phobic patients also have associated major depression.

Anxiety and Adjustment

A 20-year-old college student has always felt “shy” and avoids answering questions in her literature class. Last Monday, she stayed home although she had to give a speech in class, because she did not want to make a “fool out of herself” in front of her classmates. Think: Social phobia.

The diagnosis of social phobia has the same criteria as above except that the feared situation is related to social settings in which the patient might be em- barrassed or humiliated in front of other people.

EPIDEMIOLOGY

Phobias are the most common mental disorders in the United States. At least 5 to 10% of the population is afflicted with a phobic disorder, and some studies report as high as 25% of the population. The diagnosis of specific pho- bia is more common than social phobia. Onset can be as early as 5 years old for phobias such as seeing blood, and as old as 35 for situational fears (such as a fear of heights). The average age of onset for social phobias is mid-teens.

Women are two times as likely to have specific phobia as men; social phobia occurs equally in men and women.

ETIOLOGY

The cause of phobias is most likely multifactorial, with the following compo- nents playing important parts:

􏱦 Genetic: Fear of seeing blood often runs in families and may be associ- ated with an inherited, exaggerated vasovagal response. First-degree rel- atives of patients with social phobia are three times more likely to de- velop the disorder.

􏱦 Behavioral: Phobias may develop through association with traumatic events. For example, people who were in a car accident may develop a specific phobia for driving.

􏱦 Neurochemical: An overproduction of adrenergic neurotransmitters may contribute to anxiety symptoms. This has led to the successful treat- ment of some phobias. (Most notably, performance anxiety is often suc- cessfully treated with beta blockers).

COURSE AND PROGNOSIS

The course and prognosis are not clearly defined due to their recent recogni- tion.

TREATMENT

Specific Phobia

Pharmacological treatment has not been found effective. Systemic desensiti- zation (with or without hypnosis) and supportive psychotherapy are often use- ful. If necessary, a short course of benzodiazepines or beta blockers may be used during desensitization to help control autonomic symptoms.

Systemic desensitization: Gradually expose patient to feared object or situa- tion while teaching relaxation and breathing techniques.

Social Phobia

Paroxetine (Paxil), an SSRI, is FDA approved for the treatment of social anx- iety disorder. Beta blockers are frequently used to control symptoms of perfor- mance anxiety. Cognitive and behavioral therapies are useful adjuncts.

Obsessive–Compulsive Disorder (OCD)

Obsession—a recurrent and intrusive thought, feeling, or idea

Compulsion—a conscious repetitive behavior linked to an obsession that, when performed, functions to relieves anxiety caused by the obsession

OCD is an Axis I disorder in which patients have recurrent intrusive thoughts (obsessions) that increase their anxiety level. They usually relieve this anxiety with recurrent standardized behaviors (compulsions). Patients are generally aware of their problems and realize that their thoughts and behaviors are irra- tional (they have insight). The symptoms cause significant distress in their lives, and patients wish they could get rid of them (i.e., their obsessions and compulsions are ego-dystonic).

OCD can cause significant impairment of daily functioning, as behaviors are often time consuming and interfere with routines, work, and interpersonal re- lationships.

DIAGNOSIS AND DSM-IV CRITERIA

1. Either obsessions or compulsions as defined below: Obsessions

􏱦 Recurrent and persistent intrusive thoughts or impulses that cause marked anxiety and are not simply excessive worries about real prob- lems

􏱦 Person attempts to suppress the thoughts.

􏱦 Person realizes thoughts are product of his or her own mind.

Compulsions

􏱦 Repetitive behaviors that the person feels driven to perform in re- sponse to an obsession

􏱦 The behaviors are aimed at reducing distress, but there is no realistic link between the behavior and the distress.

2. The person is aware that the obsessions and compulsions are unreason- able and excessive.

3. The obsessions cause marked distress, are time consuming, or signifi- cantly interfere with daily functioning.

COMMON PATTERNS OF OBSESSIONS AND COMPULSIONS

1. Obsessions about contamination followed by excessive washing or compulsive avoidance of the feared contaminant

2. Obsessions of doubt (forgetting to turn off the stove, lock the door, etc.) followed by repeated checking to avoid potential danger

3. Obsessions about symmetry followed by compulsively slow perfor- mance of a task (such as eating, showering, etc.)

4. Intrusive thoughts with no compulsion. Thoughts are often sexual or violent.

EPIDEMIOLOGY

􏱦 Lifetime population prevalence: 2 to 3%

􏱦 Onset is usually in early adulthood, and men are equally likely to be af-

fected as women.

􏱦 OCD is associated with major depressive disorder, eating disorders,

other anxiety disorders, and obsessive–compulsive personality disorder.

􏱦 The rate of OCD is higher in patients with first-degree relatives who

have Tourette’s disorder.

A 28-year-old medical student comes to your office because he is distressed by his repetitive checking of thecardoortoseeifitis locked. He states that after he parks the car and gets to his house, he feels as if the car door is not locked and goes back to check on it. This happens several times and has led to his being late for his clerkships and getting yelled at by his chief. Think: Obsessive– compulsive disorder.

HIGH-YIELD FACTS

Seventy-five percent of OCD patients have both obsessions and compulsions.

Anxiety and Adjustment

Obsessive–Compulsive Personality Disorder: Don’t get this mixed up with OCD! This is a personality disorder (therefore Axis II) in which the person is excessively preoccupied with details, lists, and organization. He or she is overconscientious and inflexible and perceives no problem (symptoms are ego-syntonic, and patients lack insight).

Four most common mental disorders:

1. Phobias

2. Substance-induced

disorders

3. Major depression

4. OCD

HIGH-YIELD FACTS

Patients with OCD often initially seek help from nonpsychiatric physicians. For example, they may visit a dermatologist complaining of skin problems on their hands (related to their frequent hand washing).

Anxiety and Adjustment

Treatment of OCD often requires high doses of SSRIs.

ETIOLOGY

􏱦 Neurochemical: OCD is associated with abnormal regulation of sero- tonin.

􏱦 Genetic: Rates of OCD are higher in first-degree relatives and monozy- gotic twins than in the general population.

􏱦 Psychosocial: The onset of OCD is triggered by a stressful life event in approximately 60% of patients.

COURSE AND PROGNOSIS

The course is variable but usually chronic, with only about 30% of patients showing significant improvement with treatment. Forty to 50% of patients have moderate improvement, and 20 to 40% remain significantly impaired or experience worsening of symptoms.

TREATMENT

Pharmacologic

􏱦 SSRIs are the first line of treatment, but higher-than-normal doses may be required to be effective.

􏱦 Tricyclic antidepressants (TCAs) (clomipramine) are also effective.

Behavioral Treatment

Behavioral therapy is considered as effective as pharmacotherapy in the treat- ment of OCD; best outcomes are often achieved when both are used simulta- neously. The technique, called exposure and response prevention (ERP), in- volves prolonged exposure to the ritual-eliciting stimulus and prevention of the relieving compulsion (e.g., the patient must touch the dirty floor without washing his or her hands). Relaxation techniques are employed to help the patient manage the anxiety that occurs when the compulsion is prevented.

Last Resort

In severe, treatment-resistant cases, electroconvulsive therapy (ECT) or surgery (cingulotomy) may be effective.

Posttraumatic Stress Disorder (PTSD)

PTSD is a response to a catastrophic (life-threatening) life experience in which the patient reexperiences the trauma, avoids reminders of the event, and experiences emotional numbing or hyperarousal.

DIAGNOSIS AND DSM-IV CRITERA

􏱦 Having experienced or witnessed a traumatic event (e.g., war, rape, or natural disaster). The event was potentially harmful or fatal, and the initial reaction was intense fear or horror.

􏱦 Persistent reexperiencing of the event (e.g., in dreams, flashbacks, or re- current recollections)

􏱦 Avoidance of stimuli associated with the trauma (e.g., avoiding a loca- tion that will remind him or her of the event or having difficulty recall- ing details of the event). Example: A woman will not enter parking lots after being raped in one.

􏱦 Numbing of responsiveness (limited range of affect, feelings of detach- ment or estrangement from others, etc.)

􏱦 Persistent symptoms of increased arousal (e.g., difficulty sleeping, out- bursts of anger, exaggerated startle response, or difficulty concentrating)

􏱦 Symptoms must be present for at least 1 month. COMORBIDITIES

Patients have a high incidence of associated substance abuse and depression.

PROGNOSIS

One half of patients remain symptom free after 3 months of treatment.

TREATMENT

Pharmacological

􏱦 TCAs—imipramine and doxepin

􏱦 SSRIs, MAOIs

􏱦 Anticonvulsants (for flashbacks and nightmares)

Other

􏱦 Psychotherapy

􏱦 Relaxation training

􏱦 Support groups, family therapy

Acute Stress Disorder (ASD)

DIAGNOSIS AND DSM-IV CRITERIA

The diagnosis of acute stress disorder is reserved for patients who experience a major traumatic event but have anxiety symptoms for only a short duration. To qualify for this diagnosis, the symptoms must occur within 1 month of the trauma and last for a maximum of 1 month. Symptoms are similar to those of PTSD.

PTSD VERSUS ACUTE STRESS DISORDER

PTSD

Event occurred at any time in past Symptoms last > 1 month

Acute Stress Disorder

Event occurred < 1 month ago Symptoms last < 1 month

TREATMENT

Same as treatment for PTSD (see above).

Generalized Anxiety Disorder (GAD)

Patients with GAD have persistent, excessive anxiety and hyperarousal for at least 6 months. They worry about general daily events, and their anxiety is difficult to control.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Excessive anxiety and worry about daily events and activities for at least 6 months

A 23-old-woman who was raped 5 months ago complains of recurrent thoughts of that event every time a coworker touches her. She states this has been happening for the past 2 months often accompanied by nightmares that wake her up at night. She feels extremely anxious when these thoughts “pop in” and lately has had trouble working at her job. Think: Posttraumatic stress disorder.

The presence of psychological symptoms after a stressful but non–life-threatening event suggests adjustment disorder (see below).

HIGH-YIELD FACTS

Anxiety and Adjustment

Addictive substances (benzodiazepines, etc.) should be avoided (if possible) in the treatment of PTSD because of the high rate of substance abuse in these patients.

Two weeks after witnessing a car accident in which his friend was killed, a 20-year- old male has stopped going to all his classes and has been extremely anxious. Think: Acute stress disorder.

A 36-year-old office clerk states that she constantly wonders if she is capable of doing her job and feels as if she is not good enough. She constantly worries about the mortgage payments, telephone bills, and her children’s education. This has been going on over the past few years. Think: Generalized anxiety disorder.

HIGH-YIELD FACTS

Anxiety and Adjustment

“Excessive anxiety” must cause significant distress in the person’s life and be present most days of the week for a diagnosis of GAD. The anxiety is free- floating, as it does not involve a specific person, event, or activity.

􏱦 It is difficult to control the worry.

􏱦 Must be associated with at least three of the following:

􏱦 Restlessness

􏱦 Fatigue

􏱦 Difficulty concentrating

􏱦 Irritability

􏱦 Muscle tension

􏱦 Sleep disturbance

EPIDEMIOLOGY

􏱦 Lifetime prevalence: 45%

􏱦 GAD is very common in the general population.

􏱦 Women are two times as likely to have GAD as men.

􏱦 Onset is usually before the age of 20; many patients report lifetime of

“feeling anxious.”

CLINICAL PRESENTATION

Most patients do not initially seek psychiatric help. Most seek out a specialist because of their somatic complaints that accompany this disorder, such as muscle tension or fatigue.

ETIOLOGY

Not completely understood, but biological and psychosocial factors contribute

COMORBIDITIES

Fifty to 90% of patients with GAD have a coexisting mental disorder, espe- cially major depression, social or specific phobia, or panic disorder.

PROGNOSIS

GAD is chronic, with lifelong, fluctuating symptoms in 50% of patients. The other half of patients will fully recover within several years of therapy.

TREATMENT

The most effective treatment approach is a combination of psychotherapy and pharmacotherapy.

Pharmacological

􏱦 Buspirone

􏱦 Benzodiazepines (usually clonazepam or diazepam)—should be tapered

off as soon as possible because of risk of tolerance and dependence

􏱦 SSRIs

􏱦 Venlafaxine (extended release)

Other

􏱦 Behavioral therapy 􏱦 Psychotherapy

􏰀 ADJUSTMENT DISORDERS

Adjustment disorders are not considered anxiety disorders. They occur when maladaptive behavioral or emotional symptoms develop after a stressful life event. Symptoms begin within 3 months after the event, end within 6 months, and cause significant impairment in daily functioning or interper- sonal relationships.

DIAGNOSIS AND DSM-IV CRITERIA

1. Development of emotional or behavioral symptoms within 3 months after a stressful life event. These symptoms produce either:

􏱦 Severe distress in excess of what would be expected after such an

event

􏱦 Significant impairment in daily functioning

2. The symptoms are not those of bereavement.

3. Symptoms resolve within 6 months after stressor has terminated.

Subtypes: Symptoms are coded based on a predominance of either depressed mood, anxiety, disturbance of conduct (such as aggression), or combinations of the above.

EPIDEMIOLOGY

􏱦 Adjustment disorders are very common.

􏱦 They occur twice as often in females.

􏱦 They are most frequently diagnosed in adolescents but may occur at any

age.

ETIOLOGY

Triggered by psychosocial factors

PROGNOSIS

May be chronic if the stressor is recurrent; symptoms resolve within 6 months of cessation of stressor (by definition).

TREATMENT

􏱦 Supportive psychotherapy (most effective)

􏱦 Group therapy

􏱦 Pharmacotherapy for associated symptoms (insomnia, anxiety, or de-

pression)

It is important to rule out medical conditions that produce anxiety states such as hyperthyroidism. Ask about caffeine intake.

In adjustment disorder, the stressful event is not life threatening (such as a divorce, death of a loved one, or loss of a job). In PTSD, it is.

HIGH-YIELD FACTS

Anxiety and Adjustment

NOTES

HIGH-YIELD FACTS

Anxiety and Adjustment

HIGH-YIELD FACTS IN

Personality Disorders

􏰀 DEFINITION

Personality is one’s set of stable, predictable emotional and behavioral traits. Personality disorders involve deeply ingrained, inflexible patterns of relating to others that are maladaptive and cause significant impairment in social or oc- cupational functioning. Patients with personality disorders lack insight about their problems; their symptoms are ego-syntonic. Personality disorders are Axis II diagnoses.

DIAGNOSIS AND DSM-IV CRITERIA

1. Pattern of behavior/inner experience that deviates from the person’s culture and is manifested in two or more of the following ways:

􏱦 Cognition

􏱦 Affect

􏱦 Personal relations

􏱦 Impulse control 2. The pattern:

􏱦 Is pervasive and inflexible in a broad range of situations

􏱦 Is stable and has an onset no later than adolescence or early adult-

hood

􏱦 Leads to significant distress in functioning

􏱦 Is not accounted for by another mental/medical illness or by use of a

substance

Each personality disorder is present in 1% of the population. Many patients with personality disorders will meet the criteria for more than one disorder. They should be classified as having all of the disorders for which they qualify.

􏰀 CLUSTERS

Personality disorders are divided into three clusters: Cluster A—schizoid, schizotypal, and paranoid:

􏱦 Patients seem eccentric, peculiar, or withdrawn.

􏱦 Familial association with psychotic disorders

Many people have odd tendencies and quirks; these are not pathological unless they cause significant distress or impairment in daily functioning.

Personality disorder criteria: CAPRI Cognition

Affect

Personal Relations Impulse control

Personality disorder clusters:

Cluster A: MAD

Cluster B: BAD

Cluster C: SAD

HIGH-YIELD FACTS

Personality Disorders

A 30-year-old male says that his wife has been cheating on him because he does not have a good enough job to provide for her needs. He also claims that on his previous job, his boss laid him off because he did a better job than his boss. Think: Paranoid personality disorder.

Cluster B—antisocial, borderline, histrionic, and narcissistic:

􏱦 Patients seem emotional, dramatic, or inconsistent.

􏱦 Familial association with mood disorders

Cluster C—avoidant, dependent, and obsessive–compulsive:

􏱦 Patients seem anxious or fearful.

􏱦 Familial association with anxiety disorders

Personality disorder not otherwise specified (NOS) includes disorders that do not fit into clusters A, B, or C (including passive–aggressive personality disorder).

ETIOLOGY

Biological, genetic, and psychosocial factors contribute to the development of personality disorders. The prevalence of personality disorders in monozygotic twins is several times higher than in dizygotic twins.

TREATMENT

Personality disorders are generally very difficult to treat, especially since few patients are aware that they need help. The disorders tend to be chronic and lifelong. In general, pharmacologic treatment has limited usefulness (see indi- vidual exceptions below) except in treating coexisting symptoms of depres- sion, anxiety, and the like. Psychotherapy and group therapy are usually the most helpful.

􏰀 CLUSTER A

Paranoid, schizoid, and schizotypal. These patients are perceived as being ec-

centric and “weird.”

Paranoid Personality Disorder (PPD)

Patients with PPD have a pervasive distrust and suspiciousness of others and often interpret motives as malevolent. They tend to blame their own prob- lems on others and seem angry and hostile.

DIAGNOSIS AND DSM-IV CRITERIA

Diagnosis requires a general distrust of others, beginning by early adulthood and present in a variety of contexts. At least four of the following must also be present:

1. Suspicion (without evidence) that others are exploiting or deceiving him or her

2. Preoccupation with doubts of loyalty or trustworthiness of acquain- tances

3. Reluctance to confide in others

4. Interpretation of benign remarks as threatening or demeaning

5. Persistence of grudges

6. Perception of attacks on his or her character that are not apparent to

others; quick to counterattack

7. Recurrence of suspicions regarding fidelity of spouse or lover

EPIDEMIOLOGY

􏱦 Prevalence: 0.5 to 2.5%

􏱦 Men are more likely to have PPD than women.

􏱦 Higher incidence in family members of schizophrenics

DIFFERENTIAL DIAGNOSIS

Paranoid schizophrenia: Unlike patients with schizophrenia, patients with paranoid personality disorder do not have any fixed delusions and are not frankly psychotic, although they may have transient psychosis under stressful situa- tions.

COURSE AND PROGNOSIS

􏱦 Some patients with PPD may eventually be diagnosed with schizophre- nia.

􏱦 The disorder usually has a chronic course, causing lifelong marital and job-related problems.

TREATMENT

Psychotherapy is the treatment of choice. Patients may also benefit from an- tianxiety medications or short course of antipsychotics for transient psychosis.

Schizoid Personality Disorder

Patients with schizoid personality disorder have a lifelong pattern of social withdrawal. They are often perceived as eccentric and reclusive. They are quiet and unsociable and have a constricted affect. They have no desire for close relationships and prefer to be alone.

DIAGNOSIS AND DSM-IV CRITERIA

A pattern of voluntary social withdrawal and restricted range of emotional ex- pression, beginning by early adulthood and present in a variety of contexts. Four or more of the following must also be present:

1. Neither enjoying nor desiring close relationships (including family) 2. Generally choosing solitary activities

3. Little (if any) interest in sexual activity with another person

4. Taking pleasure in few activities (if any)

5. Few close friends or confidants (if any)

6. Indifference to praise or criticism

7. Emotional coldness, detachment, or flattened affect

EPIDEMIOLOGY

􏱦 Prevalence: Approximately 7%

􏱦 Men are two times as likely to have schizoid personality disorder as

women.

􏱦 There is not an increased incidence of schizoid personality disorder in

families with history of schizophrenia.

DIFFERENTIAL DIAGNOSIS

􏱦 Paranoid schizophrenia: Unlike patients with schizophrenia, patients with schizoid personality disorder do not have any fixed delusions, al- though these may exist transiently in some patients.

HIGH-YIELD FACTS

Unlike with avoidant personality disorder, patients with schizoid personality disorder prefer to be alone.

Personality Disorders

A 45-year-old scientist works in the lab most of the day and has no friends, according to his coworkers. He expresses no desire to make friends and is content with his single life. He has no evidence of a thought disorder. Think: Schizoid personality disorder.

HIGH-YIELD FACTS

􏱦 Schizoidisanandroid. 􏱦 Schizotypicalbitthe

Bible.

A 35-year-old man dresses in a space suit every Tuesday and Thursday. He has computers set up in his basement to “detect the precise time of alien invasion.” He has no evidence of auditory or visual hallucinations. Think: Schizotypal personality disorder.

Personality Disorders

􏱦 Schizotypal personality disorder: Patients with schizoid personality disor- der do not have the same eccentric behavior or magical thinking seen in patients with schizotypal personality disorder.

COURSE

Usually chronic course, but not always lifelong

TREATMENT

Similar to paranoid personality disorder:

􏱦 Psychotherapyisthetreatmentofchoice;grouptherapyisoftenbeneficial.

􏱦 Low-dose antipsychotics (short course) if transiently psychotic, or anti-

depressants if comorbid major depression is diagnosed

Schizotypal Personality Disorder

Patients with schizotypal personality disorder have a pervasive pattern of ec- centric behavior and peculiar thought patterns. They are often perceived as strange and eccentric.

DIAGNOSIS AND DSM-IV CRITERIA

A pattern of social deficits marked by eccentric behavior, cognitive or percep- tual distortions, and discomfort with close relationships, beginning by early adulthood and present in a variety of contexts. Five or more of the following must be present:

1. Ideas of reference (excluding delusions of reference)

2. Odd beliefs or magical thinking, inconsistent with cultural norms 3. Unusual perceptual experiences (such as bodily illusions)

4. Suspiciousness

5. Inappropriate or restricted affect

6. Odd or eccentric appearance or behavior

7. Few close friends or confidants

8. Odd thinking or speech (vague, stereotyped, etc.)

9. Excessive social anxiety

Magical thinking may include:

􏱦 Belief in clairvoyance or telepathy

􏱦 Bizarre fantasies or preoccupations

􏱦 Belief in superstitions

Odd behaviors may include involvement in cults or strange religious practices.

EPIDEMIOLOGY

􏱦 Prevalence: 3.0%

􏱦 More prevalent in monozygotic than dizygotic twins

DIFFERENTIAL DIAGNOSIS

􏱦 Paranoid schizophrenia: Unlike patients with schizophrenia, patients with schizotypal personality disorder are not frankly psychotic (though they can become transiently so under stress).

􏱦 Schizoid personality disorder: Patients with schizoid personality disorder do not have the same eccentric behavior seen in patients with schizo- typal personality disorder.

COURSE

Course is chronic or patients may eventually develop schizophrenia.

TREATMENT

􏱦 Psychotherapy is the treatment of choice.

􏱦 Short course of low-dose antipsychotics if necessary (for transient psy-

chosis)

􏰀 CLUSTER B

Includes antisocial, borderline, histrionic, and narcissistic personality disor-

ders. These patients are often emotional, impulsive, and dramatic.

Antisocial Personality Disorder

Patients diagnosed with antisocial personality disorder refuse to conform to social norms and lack remorse for their actions. They are impulsive, deceitful, and often violate the law. However, they often appear charming and normal to others who meet them for the first time and do not know their history.

DIAGNOSIS AND DSM-IV CRITERIA

Pattern of disregard for others and violation of the rights of others since age 15. Patients must be at least 18 years old for this diagnosis; history of behav- ior as a child/adolescent must be consistent with conduct disorder (see chap- ter on Psychiatric Disorders in Children). Three or more of the following should be present:

1. Failure to conform to social norms by committing unlawful acts

2. Deceitfulness/repeated lying/manipulating others for personal gain 3. Impulsivity/failure to plan ahead

4. Irritability and aggressiveness/repeated fights or assaults

5. Recklessness and disregard for safety of self or others

6. Irresponsibility/failure to sustain work or honor financial obligations 7. Lack of remorse for actions

EPIDEMIOLOGY

􏱦 Prevalence: 3% in men and 1% in women

􏱦 Higher incidence in poor urban areas and in prisoners

􏱦 Genetic component: Five times increased risk among first-degree rela-

tives

DIFFERENTIAL DIAGNOSIS

Drug abuse: It is necessary to ascertain which came first. Patients who began abusing drugs before their antisocial behavior started may have behavior at- tributable to the effects of their addiction.

COURSE

Usually has a chronic course, but some improvement of symptoms may occur as the patient ages. Many patients have multiple somatic complaints, and co- existence of substance abuse and/or major depression is common.

HIGH-YIELD FACTS

Antisocial personality disorder begins in childhood as conduct disorder. Patient may have a history of being abused (physically or sexually) as a child or a history of hurting animals or starting fires. It is often associated with violations of the law.

Personality Disorders

A 30-year-old unemployed male has been accused of killing three senior citizens after robbing them. He is surprisingly charming in the interview. In his adolescence, he was arrested several times for stealing cars and assaulting other kids. Think: Antisocial personality disorder.

HIGH-YIELD FACTS

Borderline personality: IMPULSIVE

Impulsive

Moody

Paranoid under stress Unstable self image

Labile, intense relationships Suicidal

Inappropriate anger Vulnerable to abandonment Emptiness

The name borderline comes from the patient’s being on the borderline of neurosis and psychosis.

A 23-year-old medical student attempted to slit her wrist because things did not work out with a guy she was going out with over the past 3 weeks. She states that guys are jerks and “not worth her time.” She often feels that she is “alone in this world.” Think: Borderline personality disorder.

Personality Disorders

Patients commonly use defense mechanism of splitting—they view others as all good or all bad. (Clinical example: “You are the only doctor who has ever helped me. Every doctor I met before you was horrible.”)

TREATMENT

Psychotherapy is the treatment of choice. Pharmacotherapy may be used to treat symptoms of anxiety or depression, but use caution due to high addictive potential of these patients.

Borderline Personality Disorder (BPD)

Patients with BPD have unstable moods, behaviors, and interpersonal rela- tionships. They feel alone in the world and have problems with self-image. They are impulsive and may have a history of repeated suicide attempts/ges- tures or episodes of self-mutilation.

DIAGNOSIS AND DSM-IV CRITERIA

Pervasive pattern of impulsivity and unstable relationships, affects, self-image, and behaviors, present by early adulthood and in a variety of contexts. At least five of the following must be present:

1. Desperate efforts to avoid real or imagined abandonment

2. Unstable, intense interpersonal relationships

3. Unstable self-image

4. Impulsivity in at least two potentially harmful ways (spending, sexual

activity, substance use, etc.)

5. Recurrent suicidal threats or attempts or self-mutilation

6. Unstable mood/affect

7. General feeling of emptiness

8. Difficulty controlling anger

9. Transient, stress-related paranoid ideation or dissociative symptoms

EPIDEMIOLOGY

􏱦 Prevalence: 1 to 2%

􏱦 Women are two times as likely to have BPD as men.

􏱦 10% suicide rate

DIFFERENTIAL DIAGNOSIS

Schizophrenia: Unlike patients with schizophrenia, patients with borderline personality disorder do not have frank psychosis (may have transient psy- chosis, however, if decompensate under stress).

COURSE

Usually has a stable, chronic course. High incidence of coexisting major de- pression and/or substance abuse; increased risk of suicide (often because pa- tients will make suicide gestures and kill themselves by accident).

TREATMENT

􏱦 Psychotherapy is the treatment of choice—behavior therapy, cognitive therapy, social skills training, and the like.

􏱦 Pharmacotherapy to treat psychotic or depressive symptoms as necessary Histrionic Personality Disorder (HPD)

Patients with HPD exhibit attention-seeking behavior and excessive emo- tionality. They are dramatic, flamboyant, and extroverted but are unable to

form long-lasting, meaningful relationships. They are often sexually inappro- priate and provocative.

DIAGNOSIS AND DSM-IV CRITERIA

Pattern of excessive emotionality and attention seeking, present by early adulthood and in a variety of contexts. At least five of the following must be present:

1. Uncomfortable when not the center of attention

2. Inappropriately seductive or provocative behavior

3. Uses physical appearance to draw attention to self

4. Has speech that is impressionistic and lacking in detail 5. Theatrical and exaggerated expression of emotion

6. Easily influenced by others or situation

7. Perceives relationships as more intimate than they actually are

EPIDEMIOLOGY

􏱦 Prevalence: 2 to 3%

􏱦 Women are more likely to have HPD than men.

DIFFERENTIAL DIAGNOSIS

Borderline personality disorder: Patients with BPD are more likely to suffer from depression and to attempt suicide. HPD patients are generally more functional.

COURSE

Usually has a chronic course, with some improvement of symptoms with age

TREATMENT

􏱦 Psychotherapy is the treatment of choice.

􏱦 Pharmacotherapy to treat associated depressive or anxious symptoms as

necessary

Narcissistic Personality Disorder (NPD)

Patients with NPD have a sense of superiority, a need for admiration, and a lack of empathy. They consider themselves “special” and will exploit others for their own gain. Despite their grandiosity, however, these patients often have fragile self-esteems.

DIAGNOSIS AND DSM-IV CRITERIA

Pattern of grandiosity, need for admiration, and lack of empathy beginning by early adulthood and present in a variety of contexts. Five or more of the fol- lowing must be present:

1. Exaggerated sense of self-importance

2. Preoccupied with fantasies of unlimited money, success, brilliance, etc.

3. Believes that he or she is “special” or unique and can associate only

with other high-status individuals

4. Needs excessive admiration

5. Has sense of entitlement

6. Takes advantage of others for self-gain

Histrionic patients often use defense mechanism of regression—they revert to childlike behaviors.

A 33-year-old scantily clad woman comes to your office complaining that her fever feels like “she is burning in hell.” She vividly describes how the fever has affected her work as a teacher. Think: Histrionic personality disorder.

HIGH-YIELD FACTS

Personality Disorders

A 48-year-old company CEO is rushed to the ED after an automobile accident. He does not let the residents operate on him and requests the Chief of Trauma Surgery because he is “vital to the company.” He makes several business phone calls in the ED to stay on “top of his game.” Think: Narcissistic personality disorder.

Pharmacotherapy has been shown to be more useful in borderline personality disorder than in any other personality disorder.

HIGH-YIELD FACTS

Personality Disorders

A 30-year-old postal worker rarely goes out with her coworkers and often makes excuses when they ask her to join them because she is afraid they will not like her. She wishes to go out and meet new people but according to her, she is too ”shy.” Think: Avoidant personality disorder.

7. Lacks empathy

8. Envious of others or believes others are envious of him or her 9. Arrogant or haughty

EPIDEMIOLOGY

Prevalence: < 1% DIFFERENTIAL DIAGNOSIS

Antisocial personality disorder: Both types of patients exploit others, but NPD patients want status and recognition, while antisocial patients want material gain or simply the subjugation of others. Narcissistic patients become de- pressed when they don’t get the recognition they think they deserve.

COURSE

Usually has a chronic course; higher incidence of depression and midlife crises since these patients put such a high value on youth and power.

TREATMENT

􏱦 Psychotherapy is the treatment of choice.

􏱦 Antidepressants or lithium may be used as needed (for mood swings if a

comorbid mood disorder is diagnosed).

􏰀 CLUSTER C

Includes avoidant, dependent, and obsessive–compulsive personality disor-

ders. These patients appear anxious and fearful.

Avoidant Personality Disorder

Patients with avoidant personality disorder have a pervasive pattern of social inhibition and an intense fear of rejection. They will avoid situations in which they may be rejected. Their fear of rejection is so overwhelming that it affects all aspects of their lives. They avoid social interactions and seek jobs in which there is little interpersonal contact. These patients desire companion- ship but are extremely shy and easily injured.

DIAGNOSIS AND DSM-IV CRITERIA

A pattern of social inhibition, hypersensitivity, and feelings of inadequacy since early adulthood, with at least four of the following:

1. Avoids occupation that involves interpersonal contact due to a fear of criticism and rejection

2. Unwilling to interact unless certain of being liked

3. Cautious of intrapersonal relationships

4. Preoccupied with being criticized or rejected in social situations

5. Inhibited in new social situations because he or she feels inadequate

6. Believes he or she is socially inept and inferior

7. Reluctant to engage in new activities for fear of embarrassment

EPIDEMIOLOGY

􏱦 Prevalence: 1 to 10%

􏱦 Sex ratio not known

DIFFERENTIAL DIAGNOSIS

Schizoid personality disorder: Patients with avoidant personality disorder de- sire companionship but are extremely shy, whereas patients with schizoid personality disorder have no desire for companionship.

Social phobia (social anxiety disorder): See chapter on Anxiety and Adjust- ment Disorders. Both disorders involve fear and avoidance of social situa- tions. If the symptoms are an integral part of the patient’s personality and have been evident since before adulthood, personality disorder is the more likely diagnosis. Social phobia involves a fear of embarrassment in a particular setting (speaking in public, urinating in public, etc.), whereas avoidant personality disorder is an overall fear of rejection and a sense of inadequacy. However, a patient can have both disorders concurrently and should carry both diagnoses if criteria for each are met.

Dependent personality disorder: Avoidant personality disorder patients cling to relationships, similar to dependent personality disorder patients; how- ever, avoidant patients are slow to get involved, whereas dependents ac- tively and aggressively seek relationships.

COURSE

􏱦 Course is usually chronic.

􏱦 Particularly difficult during adolescence, when attractiveness and social-

ization are important

􏱦 Increased incidence of associated anxiety and depressive disorders

TREATMENT

􏱦 Psychotherapy, including assertiveness training, is most effective.

􏱦 Beta blockers may be used to control autonomic symptoms of anxiety, and selective serotonin reuptake inhibitors (SSRIs) may be prescribed

for major depression.

Dependent Personality Disorder (DPD)

Patients with DPD have poor self-confidence and fear separation. They have an excessive need to be taken care of and allow others to make decisions for them. They feel helpless when left alone.

DIAGNOSIS AND DSM-IV CRITERIA

A pattern of submissive and clinging behavior due to excessive need to be taken care of. At least five of the following must be present:

1. Difficulty making everyday decisions without reassurance from others 2. Needs others to assume responsibilities for most areas of his or her life 3. Cannot express disagreement because of fear of loss of approval

4. Difficulty initiating projects because of lack of self-confidence

5. Goes to excessive lengths to obtain support from others 6. Feels helpless when alone

7. Urgently seeks another relationship when one ends

8. Preoccupied with fears of being left to take care of self

Schizoid patients prefer to be alone. Avoidant patients want to be with others but are too scared of rejection.

HIGH-YIELD FACTS

Personality Disorders

A 40-year-old man who lives with his parents has trouble deciding on how to go about having his car fixed. He calls his father at work several times to ask very trivial things. He has been unemployed over the past 3 years. Think: Dependent personality disorder.

HIGH-YIELD FACTS

Many people with debilitating illnesses can develop dependent traits. However, to be diagnosed with DPD, the features must manifest before early adulthood.

Personality Disorders

A 40-year-old secretary has been recently fired because of her inability to prepare some work projects in time. According to her, they were not in the right format and she had to revise them six times, which led to the delay. This has happened before but she feels that she is not given enough time. Think: Obsessive– compulsive personality disorder.

EPIDEMIOLOGY

􏱦 Prevalence: Approximately 1%

􏱦 Women are more likely to have DPD than men.

DIFFERENTIAL DIAGNOSIS

􏱦 Avoidant personality disorder: See discussion above.

􏱦 Borderline and histrionic personality disorder: Patients with DPD usually

have a long-lasting relationship with one person on whom they are de- pendent. Patients with borderline and histrionic personality disorders are often dependent on other people, but they are unable to maintain a long-lasting relationship.

COURSE

􏱦 Usually has a chronic course

􏱦 Often, symptoms decrease with age and/or with therapy.

􏱦 Patients are prone to depression, particularly after loss of person on

whom they are dependent.

TREATMENT

􏱦 Psychotherapy is the treatment of choice.

􏱦 Pharmacotherapy may be used to treat associated symptoms of anxiety

or depression.

Obsessive–Compulsive Personality Disorder (OCPD)

Patients with OCPD have a pervasive pattern of perfectionism, inflexibility, and orderliness. They get so preoccupied with unimportant details that they are often unable to complete simple tasks in a timely fashion. They appear stiff, serious, and formal with constricted affect. They are often successful pro- fessionally but have poor interpersonal skills.

DIAGNOSIS AND DSM-IV CRITERIA

Pattern of preoccupation with orderliness, control, and perfectionism at the expense of efficiency, present by early adulthood and in a variety of contexts. At least four of the following must be present:

1. Preoccupation with details, rules, lists, and organization such that the major point of the activity is lost

2. Perfectionism that is detrimental to completion of task

3. Excessive devotion to work

4. Excessive conscientiousness and scrupulousness about morals and

ethics

5. Will not delegate tasks

6. Unable to discard worthless objects

7. Miserly

8. Rigid and stubborn

EPIDEMIOLOGY

􏱦 Prevalence unknown

􏱦 Men are more likely to have OCPD than women.

􏱦 Occurs most often in the oldest child

􏱦 Increased incidence in first-degree relatives

DIFFERENTIAL DIAGNOSIS

􏱦 Obsessive–compulsive disorder (OCD): Patients with OCPD do not have the recurrent obsessions or compulsions that are present in obsessive–compulsive disorder. In addition, the symptoms of OCPD are ego-syntonic rather than ego-dystonic (as in OCD). That is, OCD pa- tients are aware that they have a problem and wish that their thoughts and behaviors would go away.

􏱦 Narcissistic personality disorder: Both personalities involve assertiveness and achievement, but NPD patients are motivated by status, whereas OCD patients are motivated by the work itself.

COURSE

􏱦 Unpredictable course

􏱦 Some patients later develop obsessions or compulsions (OCD), some

develop schizophrenia or major depressive disorder, and others may im- prove or remain stable.

TREATMENT

􏱦 Psychotherapy is the treatment of choice. Group therapy and behavior therapy may be useful.

􏱦 Pharmacotherapy may be used to treat associated symptoms as necessary.

􏰀 PERSONALITY DISORDER NOT OTHERWISE SPECIFIED (NOS)

This diagnosis is reserved for personality disorders that do not fit into cate- gories A, B, or C. It includes passive–aggressive personality disorder, depres- sive personality disorder, sadomasochistic personality disorder, and sadistic personality disorder. Only passive–aggressive personality disorder will be dis- cussed briefly here.

Passive–Aggressive Personality Disorder

Passive–aggressive personality disorder was once a separate personality disor- der like those listed above but was relegated to the NOS category when DSM- IV was published. Patients with this disorder are stubborn, inefficient procras- tinators. They alternate between compliance and defiance and passively resist fulfillment of tasks. They frequently make excuses for themselves and lack as- sertiveness. They attempt to manipulate others to do their chores, errands, and the like, and frequently complain about their own misfortunes. Psy- chotherapy is the treatment of choice.

HIGH-YIELD FACTS

Personality Disorders

An overweight woman starts a diet, loses 5 pounds, and then says she’s taking a “break” from the diet because she “hasn’t been feeling well.” Think: passive–aggressive personality disorder.

NOTES

HIGH-YIELD FACTS

Personality Disorders

HIGH-YIELD FACTS IN

Substance-Related Disorders

􏰀 SUBSTANCE ABUSE DIAGNOSIS AND DSM-IV CRITERIA

Abuse is a pattern of substance use leading to impairment or distress for at least 1 year with one or more of the following manifestations:

1. Failure to fulfill obligations at work, school, or home

2. Use in dangerous situations (i.e., driving a car)

3. Recurrent substance-related legal problems

4. Continued use despite social or interpersonal problems due to the sub-

stance use

􏰀 SUBSTANCE DEPENDENCE DIAGNOSIS AND DSM-IV CRITERIA

Dependence is substance use leading to impairment or distress manifested by at least three of the following within a 12-month period:

1. Tolerance (see definition below)

2. Withdrawal (see definition below)

3. Using substance more than originally intended

4. Persistent desire or unsuccessful efforts to cut down on use

5. Significant time spent in getting, using, or recovering from substance

6. Decreased social, occupational, or recreational activities because of

substance use

7. Continued use despite subsequent physical or psychological problem

(e.g., drinking despite worsening liver problems)

A diagnosis of substance dependence supercedes a diagnosis of substance abuse.

EPIDEMIOLOGY

􏱦 Lifetime prevalence of substance abuse or dependence in the United States: Approximately 17%

􏱦 More common in men than women

Know how to distinguish substance abuse from dependence.

Addiction is not considered a scientific term. Instead, use the word dependence when appropriate.

HIGH-YIELD FACTS

Substance-Related Disorders

Alcohol is the most common co-ingestant in drug overdoses.

Use the CAGE questionnaire to screen for EtOH abuse.

􏱦 Caffeine, alcohol, and nicotine are the most commonly used substances. 􏱦 Depressive symptoms are common among persons with substance abuse

or dependence.

WITHDRAWAL AND TOLERANCE

Withdrawal

The development of a substance-specific syndrome due to the cessation of substance use that has been heavy and prolonged

Tolerance

The need for increased amounts of the substance to achieve the desired effect or diminished effect if using the same amount of the substance

􏰀 ACUTE INTOXICATION AND WITHDRAWAL

The intoxicated patient, or one experiencing withdrawal, can present several problems in both diagnosis and treatment. Since it is common for addicts to abuse several drugs at once, the clinical presentation is often confusing, and signs/symptoms may be atypical; always be on the lookout for polysubstance abuse.

􏰀 ALCOHOL (EtOH)

Alcohol activates gamma-aminobutyric acid (GABA) and serotonin receptors in the central nervous system (CNS) and inhibits glutamate receptors. GABA receptors are inhibitory, and thus alcohol has a sedating effect.

Alcohol is the most commonly abused substance in the United States. Seven to 10% of Americans are alcoholics.

METABOLISM

Alcohol is metabolized in the following manner:

1. Alcohol → acetaldehyde (enzyme: alcohol dehydrogenase)

2. Acetaldehyde → acetic acid (enzyme: aldehyde dehydrogenase)

There is upregulation of these enzymes in heavy drinkers. Asian people often have less aldehyde dehydrogenase; the resultant buildup of acetaldehyde causes flushing and nausea.

SCREENING FOR ABUSE

The CAGE questionnaire is used to screen for alcohol abuse. Two or more “yes” answers are considered a positive screen; one “yes” answer should arouse suspicion of abuse:

1. Have you ever wanted to cut down on your drinking?

2. Have you ever felt annoyed by criticism of your drinking?

3. Have you ever felt guilty about drinking?

4. Have you ever taken a drink as an “eye opener” (to prevent the

shakes)?

Alcohol Intoxication

The absorption and elimination rates of alcohol are variable and depend on many factors, including age, sex, body weight, speed of consumption, the pres- ence of food in the stomach, chronic alcoholism, the presence of advanced cirrhosis, and the state of nutrition.

In addition to the above factors, the effects of EtOH also depend on the blood alcohol level (BAL). The values in the following table refer to the BALs of the novice drinker rather than the chronic alcoholic. This is because the lat- ter generate a tolerance to the effects of EtOH and, therefore, may not experi- ence a given effect until the BAL is significantly higher. In most states, the le- gal limit for intoxication is 80 to 100 mg/dL.

CLINICAL PRESENTATION

Effects

Decreased fine motor control Impaired judgment and coordination Ataxic gait and poor balance Lethargy; difficulty sitting upright Coma in the novice drinker Respiratory depression

DIFFERENTIAL DIAGNOSIS

BAL

20–50 mg/dL 50–100 mg/dL 100–150 mg/dL 150–250 mg/dL 300 mg/dL

400 mg/dL

More than 50% of adults with BAL > 150 mg/dL (0.15 mg%) show obvious signs of intoxication.

Hypoglycemia, hypoxia, mixed EtOH–drug overdose, ethylene glycol or methanol poisoning, hepatic encephalopathy, psychosis, and psychomotor seizures

DIAGNOSTIC EVALUATION

Serum EtOH level or an expired air breathalyzer can determine the extent of intoxication. A computed tomographic (CT) scan of the head may be neces- sary to rule out subdural hematoma or other brain injury.

TREATMENT

Intoxication (Acute)

􏱦 Ensure adequate airway, breathing, and circulation. Monitor elec- trolytes and acid–base status.

􏱦 Obtain finger-stick glucose level to exclude hypoglycemia.

􏱦 Thiamine (to prevent or treat Wernicke’s encephalopathy), naloxone (to reverse the effects of any opioids that may have been ingested), and

folate are also administered.

The liver will eventually metabolize alcohol without any other interventions provided that a reliable airway is maintained; a severely intoxicated patient may require intubation while he or she is recovering.

Gastrointestinal evacuation (e.g., gastric lavage and charcoal) has no role in the treatment of EtOH overdose but may be used in mixed EtOH–drug overdose.

Recall that methanol, ethanol, and ethylene glycol can each cause metabolic acidosis with increased anion gap.

HIGH-YIELD FACTS

Substance-Related Disorders

Thiamine, glucose, and naloxone should be given to patients who present with altered mental status.

HIGH-YIELD FACTS

Substance-Related Disorders

EtOH withdrawal symptoms usually begin in 6 to 24 hours and last 2 to 7 days. Mild: Irritability, tremor, insomnia

Moderate: Diaphoresis, fever, disorientation Severe: Grand mal seizures, DTs

Delirium tremens carries a 15 to 20% mortality rate but occurs in only 5% of patients that are hospitalized for EtOH withdrawal. It is a medical emergency and should be treated with adequate doses of benzodiazepines.

Dependence (Long Term)

1. Alcoholics Anonymous—self-help group

2. Disulfiram (Antabuse)—aversive therapy; inhibits aldehyde dehydro-

genase, causing violent retching when the person drinks

3. Psychotherapy and selective serotonin reuptake inhibitors (SSRIs)

4. Naltrexone—though an opioid antagonist, helps reduce cravings for

EtOH

Alcohol Withdrawal

The pathophysiology of the alcohol withdrawal syndrome is poorly under- stood but is related to the chronic depressant effect of EtOH on the central nervous system. When long-term EtOH consumption ceases, the depressant effect is terminated, and CNS excitation occurs.

CLINICAL PRESENTATION

The earliest symptoms of EtOH withdrawal begin between 6 and 24 hours af- ter the patient’s last drink and depend on the duration and quantity of EtOH consumption. Patients experiencing mild withdrawal may be irritable and complain of insomnia. Those in more severe withdrawal may experience fever, disorientation, seizures, or hallucinations.

The signs and symptoms of the alcohol withdrawal syndrome include insom- nia, anxiety, tremor, irritability, anorexia, tachycardia, hyperreflexia, hyper- tension, fever, seizures, hallucinations, and delirium.

Delirium tremens (DTs) is the most serious form of EtOH withdrawal and of- ten begins within 72 hours of cessation of drinking. While only 5% of patients hospitalized for EtOH withdrawal develop DTs, there is a roughly 15 to 20% mortality rate if left untreated. In addition to delirium, symptoms of DTs may include visual or tactile hallucinations, gross tremor, autonomic instability, and fluctuating levels of psychomotor activity.

DIAGNOSTIC EVALUATION

Accurate and frequent assessment of vital signs is essential, as autonomic in- stability may occur in cases of severe withdrawal and DTs. Careful attention must be given to the level of consciousness, and the possibility of trauma should be investigated. Signs of hepatic failure (e.g., ascites, jaundice, caput medusae, coagulopathy) may be present.

DIFFERENTIAL DIAGNOSIS

Alcohol-induced hypoglycemia, acute schizophrenia, drug-induced psychosis, encephalitis, thyrotoxicosis, anticholinergic poisoning, and withdrawal from other sedative–hypnotic type drugs

TREATMENT

􏱦 Tapering doses of benzodiazepines (chlordiazepoxide, lorazepam)

􏱦 Thiamine, folic acid, and a multivitamin to treat nutritional deficien-

cies

􏱦 Magnesium sulfate for postwithdrawal seizures

Long-Term Complications of Alcohol Intake

Wernicke–Korsakoff syndrome is caused by thiamine (vitamin B1) deficiency resulting from the poor diet of alcoholics. Wernicke’s encephalopathy is acute and can be reversed with thiamine therapy:

1. Ataxia

2. Confusion

3. Ocular abnormalities (nystagmus, gaze palsies)

If left untreated, Wernicke’s encephalopathy may progress into Korsakoff’s syndrome, which is chronic and often irreversible.

1. Impaired recent memory 2. Anterograde amnesia

3. +/− Confabulation

Confabulation: Making up answers when memory has failed

􏰀 COCAINE

Cocaine blocks dopamine reuptake from the synaptic cleft, causing a stimu- lant effect. Dopamine plays a role in behavioral reinforcement (“reward” sys- tem of the brain).

Cocaine Intoxication

CLINICAL PRESENTATION

Cocaine intoxication often produces euphoria, increased or decreased blood pressure, tachycardia or bradycardia, nausea, dilated pupils, weight loss, psy- chomotor agitation or depression, chills, and sweating. It may also cause respi- ratory depression, seizures, arrhythmias, and hallucinations (especially tac- tile). Since cocaine is an indirect sympathomimetic, intoxication mimics the fight-or-flight response.

Cocaine’s vasoconstrictive effect may result in myocardial infarction (MI) or cerebrovascular accident (CVA).

DIFFERENTIAL DIAGNOSIS

Amphetamine or phencyclidine (PCP) intoxication, sedative withdrawal

DIAGNOSTIC EVALUATION

Urine drug screen (positive for 3 days, longer in heavy users)

TREATMENT

Intoxication

1. For mild-to-moderate agitation: Benzodiazepines

2. For severe agitation or psychosis: Haloperidol

3. Symptomatic support (i.e., control hypertension, arrhythmias)

All patients with altered mental status should

be given thiamine

before glucose or Wernicke–Korsakoff syndrome may be precipitated. Thiamine is a coenzyme used in carbohydrate metabolism.

HIGH-YIELD FACTS

Substance-Related Disorders

Cocaine overdose can cause death secondary to cardiac arrhythmia, seizure, or respiratory depression.

HIGH-YIELD FACTS

Substance-Related Disorders

Dependence

1. Psychotherapy, group therapy

2. Tricyclic antidepressants (TCAs)

3. Dopamine agonists (amantadine, bromocriptine)

Cocaine Withdrawal

Abrupt abstinence is not life threatening but produces a dysphoric “crash”: malaise, fatigue, depression, hunger, constricted pupils, vivid dreams, psy- chomotor agitation or retardation

TREATMENT

Usually supportive—let patient sleep off crash.

􏰀 AMPHETAMINES

Classic amphetamines: Dextroamphetamine (Dexedrine), methylphenidate (Ritalin), methamphetamine (Desoxyn, ice, speed, “crystal meth,” “crack”)

Substituted (“designer”) amphetamines: MDMA (ecstasy), MDEA (eve)

Classic amphetamines release dopamine from nerve endings, causing a stimu- lant effect. They are used medically in the treatment of narcolepsy, attention deficit hyperactivity disorder (ADHD), and depressive disorders. Designer am- phetamines release dopamine and serotonin from nerve endings and have both stimulant and hallucinogenic properties.

Amphetamine Intoxication

CLINICAL PRESENTATION

Amphetamine intoxication causes symptoms similar to those of cocaine (see above).

DIFFERENTIAL DIAGNOSIS

Cocaine or PCP intoxication. Chronic use in high doses may cause a psy- chotic state that is similar to schizophrenia.

DIAGNOSTIC EVALUATION

Urine drug screen (positive for 1 to 2 days). A negative routine drug screen does not rule out amphetamine use, since most assays are not of adequate sen- sitivity. A negative drug screen can never completely rule out substance abuse or dependence.

TREATMENT

Similar to cocaine (see above)

Amphetamine Withdrawal

Similar to cocaine withdrawal (see above)

􏰀 PHENCYCLIDINE (PCP)

PCP, or “angel dust,” is a hallucinogen that antagonizes N-methyl-D-aspartate (NMDA) glutamate receptors and activates dopaminergic neurons. Ketamine is similar to PCP. Both were developed as anesthetic agents.

PCP Intoxication

Intoxication with PCP causes recklessness, impulsiveness, impaired judgment, assaultiveness, rotatory nystagmus, ataxia, hypertension, tachycardia, muscle rigidity, and high tolerance to pain. Overdose can cause seizures or coma.

TREATMENT

􏱦 Monitor blood pressure, temperature, and electrolytes.

􏱦 Acidify urine with ammonium chloride and ascorbic acid.

􏱦 Benzodiazepines or dopamine antagonists to control agitation and anxi-

ety

􏱦 Diazepam for muscle spasms and seizures

􏱦 Haloperidol to control severe agitation or psychotic symptoms

DIFFERENTIAL DIAGNOSIS

Acute psychotic states, schizophrenia

DIAGNOSTIC EVALUATION

Urine drug screen (positive for > 1 week). Creatine phosphokinase (CPK) and aspartate aminotransferase (AST) are often elevated.

PCP Withdrawal

No withdrawal syndrome, but “flashbacks” may occur

􏰀 SEDATIVES-HYPNOTICS

These drugs are highly abused in the United States since they are more readily available than other drugs such as cocaine or opioids. Benzodiazepines (BDZs) are commonly used in the treatment of anxiety disorders and are therefore ob- tained easily via prescription. They potentiate the effects of GABA by in- creasing the frequency of chloride channel opening. Barbiturates are used in the treatment of epilepsy and as anesthetics, and they potentiate the effects of GABA by increasing the duration of chloride channel opening. At high doses they act as direct GABA agonists and have a lower margin of safety relative to BDZs. In combination BDZs and barbiturates are synergistic due to their complementary effect on GABA channel opening. Respiratory depression can occur as a complication.

Rotatory nystagmus is pathognomonic for PCP intoxicaton.

HIGH-YIELD FACTS

More than with other drugs, intoxication with PCP results in violence.

Substance-Related Disorders

Gamma-hydroxybutyrate (GHB, “Grievous Bodily Harm”) is a dose-specific CNS depressant that produces memory loss, respiratory distress, and coma. It is commonly used as a date-rape drug.

HIGH-YIELD FACTS

Flumazenil is a very short-acting BDZ antagonist. Use with caution when treating overdose, as it may precipitate seizures.

Substance-Related Disorders

In general, withdrawal from drugs that are sedating is life threatening, while withdrawal from stimulants and hallucinogens is not.

Dextromethorphan is a common ingredient in cough syrup.

Sedative-Hypnotic Intoxication

Intoxication with sedatives produces drowsiness, slurred speech, incoordina- tion, ataxia, mood lability, impaired judgment, nystagmus, respiratory depres- sion, and coma or death in overdose (especially barbiturates). Symptoms are augmented when combined with EtOH. Long-term sedative use causes depen- dence.

DIFFERENTIAL DIAGNOSIS

Alcohol intoxication, generalized cerebral dysfunction (i.e., delirium)

DIAGNOSTIC EVALUATION

Urine or serum drug screen (positive for 1 week), electrolytes, electrocardio- gram

TREATMENT

􏱦 Maintain airway, breathing, and circulation.

􏱦 Activated charcoal to prevent further gastrointestinal absorption

􏱦 For barbiturates only: Alkalinize urine with sodium bicarbonate to pro-

mote renal excretion.

􏱦 For benzodiazepines only: Flumazenil in overdose

􏱦 Supportive care—improve respiratory status, control hypotension

Sedative-Hypnotic Withdrawal

Abrupt abstinence after chronic use can be life threatening. While physiologi- cal dependence is more likely with short-acting agents, longer-acting agents can also cause withdrawal symptoms.

CLINICAL PRESENTATION

Symptoms of autonomic hyperactivity (tachycardia, sweating, etc.), insomnia, anxiety, tremor, nausea/vomiting, delirium, and hallucinations. Seizures may occur and can be life threatening.

TREATMENT

􏱦 Administration of a long-acting benzodiazepine such as chlorodiazepox- ide or diazepam, with tapering of the dose

􏱦 Tegretol or valproic acid may be used for seizure control.

􏰀 OPIATES

Examples: Heroin, codeine, dextromethorphan, morphine, methadone, meperidine (Demerol). These compounds stimulate opiate receptors (mu, kappa, and delta), which are normally stimulated by endogenous opiates and are involved in analgesia, sedation, and dependence. Opiates also have effects on the dopaminergic system, which mediates their addictive and rewarding properties. Endorphins and enkephalins are endogenous opiates.

Opiate Intoxication

Opiate intoxication causes drowsiness, nausea/vomiting, constipation, slurred speech, constricted pupils, seizures, and respiratory depression, which may progress to coma or death in overdose.

Meperidine and monoamine oxidase inhibitors taken in combination may cause the serotonin syndrome: Hyperthermia, confusion, hyper- or hypoten- sion, and muscular rigidity.

DIFFERENTIAL DIAGNOSIS

Sedative-hypnotic intoxication, severe EtOH intoxication

DIAGNOSTIC EVALUATION

Rapid recovery of consciousness following the administration of intravenous (IV) naloxone (opiate antagonist) is consistent with opiate overdose. Urine and blood tests remain positive for 12 to 36 hours.

TREATMENT

Intoxication

Ensure adequate airway, breathing, and circulation.

Overdose

Administration of naloxone or naltrexone (opiate antagonists) will improve respiratory depression but may cause severe withdrawal in an opiate-depen- dent patient. Ventilatory support may be required.

Dependence

􏱦 Oral methadone once daily, tapered over months to years

􏱦 Psychotherapy, support groups (Narcotics Anonymous, etc.)

Opiate Withdrawal

CLINICAL PRESENTATION

While not life threatening, abstinence in the opiate-dependent individual leads to an unpleasant withdrawal syndrome characterized by dysphoria, in- somnia, lacrimation, rhinorrhea, yawning, weakness, sweating, piloerection, nausea/vomiting, fever, dilated pupils, and muscle ache.

TREATMENT

Moderate symptoms: Clonidine and/or buprenorphine

Severe symptoms: Detox with methadone tapered over 7 days.

􏰀 HALLUCINOGENS

Examples: Psilocybin (mushrooms), mescaline, lysergic acid diethylamide (LSD). Pharmacological effects vary, but LSD is known to act on the seroton- ergic system. Tolerance to hallucinogens develops quickly but reverses rapidly after cessation. Hallucinogens do not cause physical dependence or with- drawal.

Classic triad of opioid overdose:

􏱦 Respiratorydepression

􏱦 Alteredmentalstatus

􏱦 Miosis

“Rebels Admire Morphine”

HIGH-YIELD FACTS

Meperidine is the exception to opioids producing miosis. “Demerol dilates pupils.”

Substance-Related Disorders

Eating poppy seed bagels or muffins can result in a urine drug screen that is positive for opioids.

Opiates are naturally occurring chemicals that bind at the opiate receptors. Opioids are synthetic chemicals that bind to these same opiate receptors (e.g., fentanyl)

Withdrawal from opiates is not life threatening.

HIGH-YIELD FACTS

Methyl pemolines (“92C-B,” “U4EUH,” “Nexus”) produce classic psychedelic distortion of senses, including feeling of harmony, anxiety, paranoia, and panic.

Ketamine (“special K”) can produce tachycardia and tachypnea with hallucinations at higher doses; also amnesia and numbed confusion.

Substance-Related Disorders

Hallucinogen Intoxication

Hallucinogens cause perceptual changes, papillary dilation, tachycardia, tremors, incoordination, sweating, and palpitations.

TREATMENT

Guidance and reassurance (“talking down” the patient) are usually enough. In severe cases, antipsychotics or benzodiazepines may be used.

Hallucinogen Withdrawal

No withdrawal syndrome is produced, but patients may experience “flash- backs” later in life (recurrence of symptoms due to reabsorption from lipid stores).

􏰀 MARIJUANA

The main active component in marijuana, or cannabis, is THC (tetrahydro- cannabinol). Cannabinoid receptors in the brain inhibit adenylate cyclase. Ef- fects are increased when used with EtOH.

Marijuana has been shown to successfully treat nausea in cancer patients and to increase appetite in AIDS patients. No dependence or withdrawal syn- drome has been shown.

Marijuana Intoxication

Marijuana causes euphoria, impaired coordination, mild tachycardia, con- junctival injection, dry mouth, and increased appetite.

Marijuana can be smoked or eaten. Marijuana cigarettes are sometimes dipped in embalming fluid, which causes cognitive dulling as a desired effect.

TREATMENT

Supportive and symptomatic

DIAGNOSTIC EVALUATION

Urine drug screen is positive for up to 4 weeks in heavy users (released from adipose stores).

Marijuana Withdrawal

CLINICAL PRESENTATION

No withdrawal syndrome, but mild irritability, insomnia, nausea, and de- creased appetite may occur in heavy users.

TREATMENT

Supportive and symptomatic

􏰀 INHALANTS

Examples: Solvents, glue, paint thinners, fuels, isobutyl nitrates (“rush,” “locker room,” “bolt”). Inhalants generally act as CNS depressants. User is typically an adolescent male.

Inhalant Intoxication

Inhalants may cause impaired judgment, belligerence, impulsivity, perceptual disturbances, lethargy, dizziness, nystagmus, tremor, muscle weakness, hypore- flexia, ataxia, slurred speech, euphoria, stupor, or coma. Overdose may be fatal secondary to respiratory depression or arrhythmias. Long-term use may cause permanent damage to CNS, peripheral nervous system (PNS), liver, kidney, and muscle.

TREATMENT

􏱦 Monitor airway, breathing, and circulation.

􏱦 Symptomatic treatment as needed

􏱦 Psychotherapy and counseling for dependent patients

DIAGNOSTIC EVALUATION

Serum drug screen (positive for 4 to 10 hours)

Inhalant Withdrawal

A withdrawal syndrome does not usually occur, but symptoms may include ir- ritability, nausea, vomiting, tachycardia, and occasionally hallucinations.

􏰀 CAFFEINE

Caffeine is the most commonly used psychoactive substance in the United States, usually in the form of coffee or tea. Caffeine acts as an adenosine an- tagonist, causing increased cyclic adenosine monophosphate (cAMP) and a stimulant effect via the dopaminergic system.

Caffeine Intoxication

CLINICAL PRESENTATION

Intoxication may occur with consumption of over 250 mg of caffeine. Signs and symptoms include anxiety, insomnia, twitching, rambling speech, flushed face, diuresis, gastrointestinal disturbance, and restlessness. Consumption of more than 1 gram of caffeine may cause tinnitus, severe agitation, and cardiac arrhythmias. In excess of 10 g, death may occur secondary to seizures and respiratory failure.

TREATMENT

Supportive and symptomatic

HIGH-YIELD FACTS

Substance-Related Disorders

One cup of coffee: 100 to 150 mg caffeine Onecupoftea:40to60 mg caffeine

HIGH-YIELD FACTS

Cigarette smoking during pregnancy is associated with low birth weight and persistent pulmonary hypertension of the newborn.

Substance-Related Disorders

Caffeine Withdrawal

Withdrawal symptoms resolve within 1 week and include headache, nausea/ vomiting, drowsiness, anxiety, or depression.

TREATMENT

Taper consumption of caffeine-containing products. Use analgesics to treat headaches. Rarely, a short course of benzodiazepines may be indicated to con- trol anxiety.

􏰀 NICOTINE

Nicotine is derived from the tobacco plant and stimulates nicotinic receptors in autonomic ganglia of the sympathetic and parasympathetic nervous sys- tems. Cigarette smoking poses many health risks, and nicotine is rapidly ad- dictive through its effects on the dopaminergic system.

Nicotine Intoxication

Nicotine acts as a CNS stimulant and may cause restlessness, insomnia, anxi- ety, and increased gastrointestinal motility. Tobacco users report improved at- tention, improved mood, and decreased tension.

TREATMENT

Cessation

Nicotine Withdrawal

Withdrawal causes intense craving, dysphoria, anxiety, increased appetite, ir- ritability, and insomnia.

TREATMENT

Smoking cessation with the aid of:

1. Behavioral counseling

2. Nicotine replacement therapy (gum, transdermal patch) 3. Zyban—antidepressant that helps reduce cravings

4. Clonidine

Relapse after abstinence is common.

HIGH-YIELD FACTS IN

Cognitive Disorders

􏰀 DEFINITION

Cognitive disorders affect memory, orientation, attention, and judgment. They result from primary or secondary abnormalities of the central nervous system. The main categories of cognitive disorders are:

􏱦 Dementia

􏱦 Delirium

􏱦 Amnestic disorders

􏰀 MINI MENTAL STATE EXAM (MMSE)

The MMSE is used to assess a patient’s current state of cognitive functioning. It can be used as a daily barometer to evaluate interval changes but should not be used to make a formal diagnosis. It tests orientation, registration, attention and calculation, recall, and language (Table 8-1).

MMSE scoring:

􏱦 Perfect score: 30

􏱦 Dysfunction: < 25

􏰀 DEMENTIA

Dementia is an impairment of memory and other cognitive functions without alteration in the level of consciousness. Most forms of dementia are progres- sive and irreversible. Dementia is a major cause of disability in the elderly. It affects memory, cognition, language skills, behavior, and personality.

EPIDEMIOLOGY

􏱦 Incidence increases with age.

􏱦 Twenty percent of people > age 80 have a severe form of dementia.

􏱦 Associations: Delusions and hallucinations occur in approximately 30%

of demented patients. Affective symptoms, including depression and anxiety, are seen in 40 to 50% of patients. Personality changes are also common.

The ability to distinguish between dementia (= memory impairment) and delirium (= sensorium impairment) is essential for both exam questions and clinical practice (see

Table 8-2).

HIGH-YIELD FACTS

Cognitive Disorders

Fifteen percent of demented patients have a treatable and potentially reversible condition.

Minimum workup to exclude reversible causes of dementia:*

􏱦 CBC

􏱦 Electrolytes

􏱦 TFTs

􏱦 VDRL/RPR

􏱦 B12 and folate levels

􏱦 BrainCTorMRI

TABLE 8-1. Performing the Mini Mental State Exam

1. Orientation

What is the date, month, year?

Where are we (state, city, hospital)?

2. Registration

Name three objects and repeat them.

3. Attention and calculation

Serial 7s (subtract 7 from 100 and continue subtracting 7 from each answer) or spell “world” backward.

4. Recall

Name the three objects above 5 minutes later.

5. Language

Name a pen and a clock. Say, “No ifs, ands, or buts.” Three-step command:

Take a pencil in your right hand, put in your left hand, then put it on the floor.

6. Read and obey the following:

Close your eyes. Write a sentence. Copy design.

TOTAL

ETIOLOGY

The most common causes of dementia are:

1. Alzheimer’s disease (50 to 60%)

2. Vascular dementia (10 to 20%)

3. Major depression (“pseudodementia”)

DIFFERENTIAL DIAGNOSIS

Psychiatric

􏱦 Depression (pseudodementia) 􏱦 Delirium

􏱦 Schizophrenia

􏱦 Malingering

Organic

5 points

5 points 3 points 5 points

3 points

2 points 1 points 3 points

1 point 1 point 1 point

30 points

1. Structural: Benign forgetfulness of normal aging, Parkinson’s disease, Huntington’s disease, Down’s syndrome, head trauma, brain tumor, normal pressure hydrocephalus, multiple sclerosis, subdural hematoma

2. Metabolic: Hypothyroidism, hypoxia, malnutrition (B12, folate, or thi- amine deficiency), Wilson’s disease, lead toxicity

3. Infectious: Lyme disease, HIV dementia, Creutzfeldt–Jakob disease, neurosyphilis, meningitis, encephalitis

Drugs

􏱦 Alcohol (chronic and acute), phenothiazines, anticholinergics, seda- tives

CLINICAL SCENARIOS OF DEMENTIA IN THE EXAM

Scenario

Dementia with stepwise increase in severity + focal neurological signs

Dementia + cogwheel rigidity + resting tremor

Dementia + ataxia + urinary incontinence + dilated cerebral ventricles

Dementia + obesity + coarse hair + constipation + cold intolerance

Dementia + diminished position and vibration sensation + megaloblasts on CBC

Dementia + tremor + abnormal liver function tests (LFTs) + Kayser– Fleischer rings

Dementia + diminished position and vibration sensation + Argyll– Robertson Pupils (Accommodation Response Present, response to light absent)

􏰀 DELIRIUM

Think

Multi-infarct dementia

Lewy body dementia Parkinson’s disease

Normal pressure hydrocephalus

Hypothyroidism

Vitamin B12 deficiency

Wilson’s disease

Neurosyphilis

Confirmatory/Diagnostic Tests

CT/MRI

Clinical

CT/MRI

T4, thyroid-stimulating hormone (TSH)

Serum B12

Ceruloplasmin

Cerebrospinal fluid fluorescent treponemal antibody absorption test

(CSF FTA-ABS) or CSF VDRL

HIGH-YIELD FACTS

Cognitive Disorders

The hallmark of delirium is waxing/waning of consciousness. It can be caused by virtually any medical disorder, and there is a high mortality rate if un- treated. It can last from days to weeks, and can also be chronic.

DSM-IV TREATMENT CRITERIA

The two types of delirium are:

1. Quiet: patient may seem depressed or exhibit symptoms similar to fail- ure to thrive; an MMSE must be done to distinguish from depression and other diagnostic criteria

2. Agitated: obvious pulling out lines; may hallucinate TREATMENT

􏱦 Rule out life-threatening causes

􏱦 Treat reversible causes, for example, hypothyroidism, electrolyte imbal-

ance, urinary tract infections

􏱦 Antipsychotics first line: quetiapine (Seroquel) is excellent to use; also

haloperidol PO/IM (do not use IV unless on cardiac monitor as it can cause torsades)

Differential for delirium: AEIOU TIPS Alcohol

Electrolytes

Iatrogenic (anticholinergics, benzodiazepines, anti- epileptics, blood pressure medicines, insulin, hypoglycemics, narcotics, steroids, H2 receptor blockers, NSAIDs, antibiotics, antiparkinsonians)

Oxygen hypoxia (bleeding, central venous, pulmonary) Uremia/hepatic encephalopathy

Trauma

Infection

Poisons

Seizures (post-ictal)

Differential between dementia and delirium is given in Table 8-2.

HIGH-YIELD FACTS

Cognitive Disorders

APHASia is a disorder of language, speaking, and understanding PHRASES. APRAXia: Can’t do PRACticed movements like tying a shoe.

AgNOSia: Can’t recognize things that were previously KNOWN (he used to know what a pencil was, but now he can’t name it).

􏱦 Positive/negative use of benzodiazepines; can cause paradoxical disinhi- bition, respiratory depression, increased risk for falls

􏱦 1:1 nursing for safety

􏱦 Frequently reorient patient.

􏱦 Avoid napping.

􏱦 Keep lights on, shades open during the day.

􏱦 In your orders, write “hold for sedation” after medication order so med-

ications are not given when already sedated and calm.

Delirium

Clouding of consciousness

Acute onset

Lasts 3 days to 2 weeks

Orientation impaired

Immediate/recent memory impaired Visual hallucinations common Symptoms fluctuate, often worse at night Usually reversible

Awareness reduced

EEG changes (fast waves or generalized slowing)

Alzheimer’s Disease

Dementia

Loss of memory/intellectual ability

Insidious onset

Lasts months to years

Orientation often impaired

Recent and remote memory impaired Hallucinations less common Symptoms stable throughout day 15% reversible

Awareness clear

No EEG changes

TABLE 8-2. Delirium Versus Dementia

Most common dementia (80% of all dementias)

EPIDEMIOLOGY

􏱦 Incidence: 5% of all people > 65; 15 to 25% of all people > 85

􏱦 More common in women than men

􏱦 Average life expectancy: 8 years after diagnosis

􏱦 Forty percent of patients have a family history of Alzheimer’s.

CLINICAL MANIFESTATIONS

Hallmarks: Gradual progressive decline of cognitive functions, especially memory and language. Personality changes and mood swings are very com- mon.

DIAGNOSIS AND DSM-IV CRITERIA

Memory impairment plus at least one of the following:

􏱦 Aphasia—disorder of language affecting speech and understanding

􏱦 Apraxia—inability to perform purposeful movements (e.g., copying a

picture)

􏱦 Agnosia—inability to interpret sensations correctly (visual agnosia—in-

ability to recognize a previously known object)

􏱦 Diminished executive functioning—problems with planning, organiz-

ing, and abstracting

Personality/mood changes: Depression, anxiety, anger, and suspiciousness are common. Psychotic symptoms such as paranoia are common.

NEUROPHYSIOLOGY

Alzheimer’s patients have decreased levels of acetylcholine (due to loss of noradrenergic neurons in the locus ceruleus of the brainstem) and of norepi- nephrine (due to preferential loss of cholinergic neurons in the basal nucleus of Meynert of the midbrain).

PATHOLOGY

Gross

􏱦 Diffuse atrophy with enlarged ventricles and flattened sulci

Microscopic

􏱦 Senile plaques composed of amyloid protein

􏱦 Neurofibrillary tangles derived from Tau proteins

􏱦 Neuronal and synaptic loss

TREATMENT

􏱦 No cure or truly effective treatment

􏱦 Physical and emotional support, proper nutrition, exercise, and supervi-

sion

􏱦 NMDA receptor antagonists: memantine

􏱦 Cholinesterase inhibitors to help slow progression:

􏱦 Tacrine (Cognex)

􏱦 Donepezil (Aricept)

􏱦 Rivastigmine (Exelon)

􏱦 Treatment of symptoms as necessary:

􏱦 Low-dose, short-acting benzodiazepines for anxiety

􏱦 Low-dose antipsychotics for agitation/psychosis (e.g., quetiapine)

􏱦 Antidepressants for depression (if the patient fulfills criteria for major

depression)

Vascular Dementia

Caused by microvascular disease in the brain that produces multiple small in- farcts. A substantial infarct burden must accumulate before dementia develops.

CLINICAL MANIFESTATIONS

Disease manifestations of vascular dementia are identical to Alzheimer’s. Memory impairment and at least one of the following must be present:

1. Aphasia

2. Apraxia

3. Agnosia

4. Diminished executive functioning

Personality changes: Depression, anger, and suspiciousness are common. Psy- chotic symptoms such as paranoia are also common.

Senile plaques and neurofibrillary tangles

are not unique to Alzheimer’s—they are also found in Down’s syndrome and normal aging.

Pathological examination of the brain (at autopsy) is the only way to definitively diagnose Alzheimer’s disease.

Cholinesterase inhibitors lead to a transient improvement in symptoms in only 25% of Alzheimer’s patients.

Classically, patients with vascular dementia have a stepwise loss of function, as the microinfarcts add up.

HIGH-YIELD FACTS

Cognitive Disorders

Mild cognitive impairment (MCI) is characterized by normal daily function but abnormal memory for age; most progress to Alzheimer’s.

HIGH-YIELD FACTS

Cognitive Disorders

Huntington’s Disease Hereditary Autosomal Dominant

Choreiform movement = Choreographed (dancelike)

VASCULAR DEMENTIA VERSUS ALZHEIMER’S

􏱦 Since vascular dementia is caused by small brain infarcts, patients also have focal neurological symptoms (such as hyperreflexia or paresthe- sias).

􏱦 Onset usually more abrupt than Alzheimer’s

􏱦 Greater preservation of personality

􏱦 Can reduce risk by modifying risk factors (such as smoking, hyperten-

sion, and diabetes)

DIAGNOSIS

Can be diagnosed readily by MRI

TREATMENT

􏱦 No cure or truly effective treatment

􏱦 Physical and emotional support, proper nutrition, exercise, and supervi-

sion

􏱦 Treatment of symptoms as necessary

Pick’s Disease/Frontotemporal Dementia (FTD)

A rare cause of slowly progressing dementia

CLINICAL MANIFESTATIONS

Hallmarks: Aphasia, apraxia, agnosia; difficult to distinguish from Alzheimer’s clinically, but personality and behavioral changes are more prominent early in the disease

PATHOLOGY

􏱦 Atrophy of frontotemporal lobes

􏱦 Pick bodies—intraneuronal inclusion bodies (not necessary for diagno-

sis of FTD)

TREATMENT

􏱦 No effective treatment

􏱦 Physical, emotional, and nutritional support

􏱦 Treat emotional/behavioral symptoms as needed.

Huntington’s Disease

Autosomal dominant genetic disorder that results in progressively disabling cognitive, physical, and psychological functioning, ultimately resulting in death after approximately 15 years

CLINICAL MANIFESTATIONS

􏱦 Onset: 35 to 50 years of age

􏱦 Hallmarks:

􏱦 Progressive dementia

􏱦 Bizarre choreiform movements (dancelike flailing of arms and legs)

􏱦 Muscular hypertonicity

􏱦 Depression and psychosis very common

PATHOLOGY

Trinucleotide repeat on short arm of chromosome 4; primarily affects basal ganglia

DIAGNOSIS

MRI shows caudate atrophy (and sometimes cortical atrophy). Genetic test- ing and MRI are diagnostic.

TREATMENT

There is no effective treatment available (supportive only).

Parkinson’s Disease

Progressive disease with prominent neuromal loss in substantia nigra, which pro- vides dopamine to the basal ganglia, causing physical and cognitive impairment. Approximately 30% of patients with Parkinson’s disease develop dementia.

CLINICAL MANIFESTATIONS

Characterized by:

1. Bradykinesia

2. Cogwheel rigidity

3. Resting tremor—“pill-rolling” tremor most common 4. Masklike facial expression

5. Shuffling gait

6. Dysarthria (abnormal speech)

Fifty percent of patients will suffer from depression. Dementia symptoms re- semble Alzheimer’s type. Muhammad Ali (advanced) and Michael J. Fox (early) both suffer from Parkinson’s.

ETIOLOGY

􏱦 Idiopathic (most common)

􏱦 Traumatic (e.g., Muhammad Ali)

􏱦 Drug- or toxin-induced

􏱦 Encephalitic (as in the book/movie Awakenings)

􏱦 Familial (rare)

PATHOLOGY AND PATHOPHYSIOLOGY

Loss of cells in the substantia nigra of the basal ganglia, which leads to a de- crease in dopamine and loss of the dopaminergic tracts

TREATMENT

Pharmacologic

􏱦 Levodopa—degraded to dopamine by dopadecarboxylase

􏱦 Carbidopa—peripheral dopadecarboxylase inhibitor prevents levodopa

from being converted to dopamine before it reaches the brain.

􏱦 Amantadine—mechanism unknown

􏱦 Anticholinergics—help relieve tremor

􏱦 Dopamine agonists (bromocriptine, etc.)

􏱦 Monoamine oxidase (MAO)-B inhibitors (selegiline)—inhibit break-

Cortical dementias include Alzheimer’s, Pick’s, and CJD and are marked by decline in intellectual functioning. Subcortical dementias include Huntington’s, Parkinson’s, NPH, and multi-infarct dementia and have more prominent affective and movement symptoms.

Levodopa crosses the blood–brain barrier (BBB). Carbidopa does not. Carbidopa prevents conversion of levodopa to dopamine in the periphery. Once levodopa crosses BBB, it is free to be converted to dopamine.

down of dopamine

Amantadine emancipates dopamine.

HIGH-YIELD FACTS

Cognitive Disorders

HIGH-YIELD FACTS

PRions are PRoteinaceous infectious particles that are normally expressed by healthy neurons of the brain. Accumulations of abnormal forms of prions are responsible for disease.

Cognitive Disorders

EEG in CJD: Periodic sharp waves/spikes Pathology of CJD: Spongiform changes

Surgical

Thalamotomy or pallidotomy may be performed if no longer responsive to pharmacotherapy.

Creutzfeldt–Jakob Disease (CJD)

A rapidly progressive, degenerative disease of the central nervous system (CNS) caused by a prion. CJD may be inherited, sporadic, or acquired. A small percentage of patients have become infected through corneal trans- plants.

CLINICAL MANIFESTATIONS

Hallmarks: Rapidly progressive dementia 6 to 12 months after onset of symp- toms. More than 90% of patients have myoclonus (sudden spasms of muscles). Extrapyramidal signs, ataxia, and lower motor neuron signs are also common. There is a long latency period between exposure and disease onset.

Other prion diseases:

􏱦 Kuru

􏱦 Gerstmann–Straussler syndrome

􏱦 Fatal familial insomnia

􏱦 Bovine spongiform encephalopathy (“mad cow disease”)

PATHOLOGY

Spongiform changes of cerebral cortex, neuronal loss, and hypertrophy of glial cells

DIAGNOSIS

Definitive—pathological demonstration of spongiform changes of brain tissue Probable—the presence of both rapidly progressive dementia and periodic generalized sharp waves on electroencephalogram (EEG) plus at least two of the following clinical features:

􏱦 Myoclonus

􏱦 Cortical blindness

􏱦 Ataxia, pyramidal signs, or extrapyramidal signs

􏱦 Muscle atrophy

􏱦 Mutism

TREATMENT AND COURSE

No treatment; relentless course, progressing to death usually within a year

Normal Pressure Hydrocephalus (NPH)

NPH is a reversible cause of dementia. Patients have enlarged ventricles with increased CSF pressure. The etiology is either idiopathic or secondary to ob- struction of CSF reabsorption sites due to trauma, infection, or hemorrhage.

CLINICAL MANIFESTATIONS

Clinical triad:

1. Gait disturbance (often appears first) 2. Urinary incontinence

3. Dementia (mild, insidious onset)

TREATMENT

Relieve increased pressure with shunt. Of the clinical triad, the dementia is least likely to improve.

􏰀 DELIRIUM

Delirium is an acute disorder of cognition related to impairment of cerebral metabolism. Unlike demented patients, delirious patients have a rapid onset of symptoms, periods of altered levels of consciousness, and potential rever- sal of symptoms with treatment of the underlying cause.

Delirious patients appear confused and have a fluctuating course with lucid intervals. They may be either stuporous or agitated, and perceptual distur- bances (e.g., hallucinations) are common. Patients are often anxious, inco- herent, and unable to sleep normally.

ETIOLOGY

Common causes of delirium include:

􏱦 CNS injury or disease

􏱦 Systemic illness

􏱦 Drug abuse/withdrawal

􏱦 Hypoxia

Additional causes of delirium include:

􏱦 Fever

􏱦 Sensory deprivation

􏱦 Medications (anticholinergics, steroids, antipsychotics, antihyperten-

sives, insulin, etc.)

􏱦 Postop

􏱦 Electrolyte imbalances

DIFFERENTIAL DIAGNOSIS

Dementia, fluent aphasia (Wernicke’s), acute amnestic syndrome, psychosis, depression, malingering

TREATMENT

􏱦 First and foremost: Treat the underlying cause!

􏱦 Provide physical and sensory support.

􏱦 Treat drug withdrawal.

􏱦 Treat symptoms of psychosis (low-dose antipsychotic) and insomnia

(sedative-hypnotic).

Clinical Scenarios of Delirium in the Exam

Since a delirium is not a primary pathophysiological process but secondary to another, it is helpful to consider various scenarios (like the following) and de- termine the proper diagnostic approach for the patient.

Delirium is common in intensive care unit setting/acute medical illness and has increased incidence in children and elderly.

HIGH-YIELD FACTS

Causes of delirium: I’M DELIRIOUS

Impaired delivery (of brain substrates, such as vascular insufficiency due to stroke) Metabolic

Drugs

Endocrinopathy

Liver disease Infrastructure (structural disease of cortical neurons) Renal failure

Infection

Oxygen

Urinary tract infection Sensory deprivation

Cognitive Disorders

HIGH-YIELD FACTS

Treating a delirious patient is often a FEUD: Fluids/Nutrition Environment

Underlying cause Drug withdrawal

Cognitive Disorders

Avoid using benzodiazepines in delirious patients, as they will often exacerbate the delirium.

Scenario

Delirium + hemiparesis or other focal neurological signs and symptoms

Delirium + elevated blood pressure + papilledema

Delirium + dilated pupils + tachycardia Delirium + fever + nuchal rigidity +

photophobia

Delirium + tachycardia + tremor + thyromegaly

Think

Cerebrovascular accident (CVA) or mass lesion

Hypertensive encephalopathy

Drug intoxication

Meningitis

Thyrotoxicosis

Confirmatory Diagnostic Tests

Brain CT/MRI

Urine toxicology screen Lumbar puncture

T4, TSH

􏰀 AMNESTIC DISORDERS

Amnestic disorders cause impairment of memory without other cognitive problems or altered consciousness. They always occur secondary to an under- lying medical condition. (See chapter on Dissociative Disorders for discussion of amnestic syndromes caused by psychiatric disorders.)

ETIOLOGY

Causes of amnestic disorders include:

􏱦 Hypoglycemia

􏱦 Systemic illness (such as thiamine deficiency)

􏱦 Hypoxia

􏱦 Head trauma

􏱦 Brain tumor

􏱦 CVA

􏱦 Seizures

􏱦 Multiple sclerosis

􏱦 Herpes simplex encephalitis

􏱦 Substance use (alcohol, benzodiazepines, medications)

COURSE AND PROGNOSIS

Variable depending on underlying medical cause:

Usually transient with full recovery: Seizures, medication-induced

Possibly permanent: Hypoxia, head trauma, herpes simplex encephalitis, CVA

TREATMENT

􏱦 Treatment of underlying cause

􏱦 Supportive psychotherapy if needed (to help patients accept their limits

and understand their course of recovery)

HIGH-YIELD FACTS IN

Geriatric Psychiatry

􏰀 INTRODUCTION

The geriatric population of the United States is growing faster than any other segment. Though the elderly are susceptible to the same Axis I disorders as younger adults, certain diagnoses are more prevalent in this population, such as cognitive disorders and major depression. Also, illnesses often have differ- ent clinical presentations in the elderly and may require unique treatments.

Approach to the Geriatric Patient

Geriatric patients should undergo the same psychiatric assessment as younger adults, including the mental status exam. In patients who suffer from cogni- tive disorders, family members or caretakers may need to be interviewed to obtain collateral information. A careful history of current medications should be taken, as drugs often produce adverse behavioral, cognitive, and psychiatric symptoms in the elderly, and elderly individuals may be taking multiple med- ications at the same time.

Normal Aging

Factors associated with normal aging include:

􏱦 Decreased muscle mass/increased fat

􏱦 Decreased brain weight/enlarged ventricles and sulci

􏱦 Impaired vision and hearing

􏱦 Minor forgetfulness (called benign senescent forgetfulness)

Stages of Dying

Normal emotional responses when facing death or loss of a body part include:

􏱦 Denial

􏱦 Anger (blaming others for illness)

􏱦 Bargaining (“I’ll never smoke or drink again if my cancer is cured.”)

􏱦 Depression

􏱦 Acceptance

Work up an elderly patient for major depression when he or she presents with memory loss.

HIGH-YIELD FACTS

Geriatric Psychiatry

Demented patients are more likely to confabulate when they do not know an answer, whereas depressed patients will just say they do not know: when pressed for an answer, depressed patients will often give the correct one.

Stages of dying may be experienced in any order and may occur simultane- ously. A person of any age who is dealing with loss or death experiences these same stages.

􏰀 MAJOR DEPRESSION

Major depression is a common mental disorder in the geriatric population, and the elderly are twice as likely to commit suicide as the general population. Depressive symptoms are present in 15% of nursing home residents.

Symptoms of major depression in the elderly often include problems with memory and cognitive functioning; because this clinical picture may be mis- taken for dementia, it is termed pseudodementia.

􏰀 PSEUDODEMENTIA

Pseudodementia is the presence of apparent cognitive deficits in patients with major depression. Patients may appear demented; however, their symptoms are only secondary to their underlying depression. It can be difficult to differ- entiate the two.

PSEUDODEMENTIA VERSUS DEMENTIA

See Table 9-1.

CLINICAL MANIFESTATIONS

Important clinical note: Depressed elderly patients often present with physi- cal symptoms, such as stomach pain, or with memory loss associated with pseudodementia. Always investigate a possible diagnosis of major depression when an elderly person presents with nonspecific complaints such as these.

Depressive symptoms include:

􏱦 Sleep disturbances (early morning awakenings)

􏱦 Decreased appetite and weight loss

􏱦 Feelings of worthlessness and suicidal ideation

􏱦 Lack of energy and diminished interest in activities

TABLE 9-1. Dementia Versus Pseudodementia (Depression)

Dementia

Onset is insidious

Patient delights in accomplishments

Sundowning common (increased confusion at night)

Will guess at answers (confabulate) Patient unaware of problems

Pseudodementia (Depression)

Onset is more acute Patient emphasizes failures Sundowning uncommon

Often answers “Don’t know” Patient is aware of problems

TREATMENT

􏱦 Supportive psychotherapy

􏱦 Psychodynamic psychotherapy if indicated

􏱦 Low-dose antidepressant medication (selective serotonin reuptake in-

hibitors [SSRIs] have the fewest side effects and are usually preferable to

tricyclics or monoamine oxidase [MAO] inhibitors).

􏱦 Electroconvulsive therapy (ECT) may be used in place of medication

(safe and effective in the elderly).

􏱦 Mirtazapine can potentially increase appetite; is also sedating, and

therefore good for insomnia.

􏱦 Methylphenidate can be used at low doses as an adjunct to antidepres-

sants for patients with psychomotor retardation; however, do not give in late afternoon or evening as it can cause insomnia.

􏰀 BEREAVEMENT

The elderly are more likely to experience losses of loved ones or friends. It is important to be able to distinguish normal grief reactions from pathological ones (depression).

Normal grief may involve:

􏱦 Feelings of guilt and sadness

􏱦 Mild sleep disturbance and weight loss

􏱦 Illusions (briefly seeing the deceased person or hearing his or her

voice—these tend to be culturally related, i.e., in some cultures this is

the norm, not the exception)

􏱦 Attempts to resume daily activities/work

􏱦 Symptoms that resolve within 1 year (worst symptoms within 2 months)

Abnormal grief (major depression) may involve:

􏱦 Feelings of severe guilt and worthlessness

􏱦 Significant sleep disturbance and weight loss

􏱦 Hallucinations or delusions

􏱦 No attempt to resume activities

􏱦 Suicidal ideation

􏱦 Symptomspersistmorethan1year(worstsymptomsmorethan2months).

􏰀 SLEEP DISTURBANCES

The incidence of sleep disorders increases with aging. Elderly people often re- port difficulty sleeping, daytime drowsiness, and daytime napping. The causes of sleep disturbances may include general medical conditions, environment, and medications, as well as normal changes associated with aging.

CHANGES IN SLEEP STRUCTURE

The structure of sleep changes normally with aging:

􏱦 Rapid eye movement (REM) sleep: Increased number of REM episodes

throughout the night. These episodes are redistributed throughout the sleep cycle and are shorter than normal. Total amount of REM sleep re- mains about the same as with younger adults.

The elderly are very sensitive to side effects of antidepressant medications, particularly anticholinergics.

HIGH-YIELD FACTS

Geriatric Psychiatry

HIGH-YIELD FACTS

Geriatric Psychiatry

􏱦 Non-REM sleep: Increased amount of stage 1 and 2 sleep with a de- crease in stage 3 and 4 sleep (deep sleep); increased awakening after sleep onset

DIFFERENTIAL DIAGNOSIS

Causes of sleep disorders in the elderly include:

􏱦 Primary sleep disorder (most common is primary insomnia; others in-

clude nocturnal myoclonus, restless leg syndrome, and sleep apnea)

􏱦 Other mental disorders

􏱦 General medical conditions

􏱦 Social/environmental factors (alcohol consumption, lack of daily struc-

ture, etc.)

TREATMENT

Sedative-hypnotic drugs are more likely to cause side effects when used by the elderly, including memory impairment, ataxia, paradoxical excitement, and rebound insomnia. Therefore, other approaches should be tried first, including alcohol cessation, increased structure of daily routine, elimination of daytime naps, and treatment of underlying medical conditions that may be exacerbat- ing sleep problems. If sedative-hypnotics must be prescribed, medications such as hydroxyzine (Vistaril) or zolpidem (Ambien) are safer than the more sedating benzodiazepines.

􏰀 ELDER ABUSE INCIDENCE

􏱦 Ten percent of all people > 65 years old; underreported by victims

􏱦 Perpetrator is usually a caregiver who lives with the victim.

TYPES

Physical abuse, sexual abuse, psychological abuse (threats, insults, etc.), ne- glect (withholding of care), and exploitation (misuse of finances)

􏰀 CARE FOR THE ELDERLY Restraints

Restraints are often overused in nursing homes and hospitals. Patients who are restrained suffer both physically and psychologically. Always try alterna- tives such as closer monitoring or tilted chairs.

Medications

Many older people are on multiple medications. They suffer from more side effects because of decreased lean body mass and impaired liver and kidney function. When confronted with a new symptom in an elderly patient on multiple medications, always try to remove a medication before adding one.

Nursing Homes

Provide care and rehabilitation for chronically ill and impaired patients as well as for patients who are in need of short-term care before returning to their prior living arrangements. Approximately half the patients stay on per- manently, and half are discharged after only a few months.

Old-Age Homes

Institutions in which the elderly can live for the rest of their lives, with no at- tempt to rehabilitate.

HIGH-YIELD FACTS

Geriatric Psychiatry

NOTES

HIGH-YIELD FACTS

Geriatric Psychiatry

HIGH-YIELD FACTS IN

Psychiatric Disorders in Children

􏰀 PSYCHIATRIC EXAMINATION OF A CHILD

In child psychiatry, it is important to consult multiple sources when gathering information:

􏱦 The child—young children usually report information in concrete terms but give accurate details about their emotional states.

􏱦 Parents—generally more reliable for information about the child’s con- duct, school performance, or problems with the law. Parents should be asked about the child’s developmental history and about issues with other family members (medical or psychiatric conditions, problems in family functioning, etc.).

􏱦 Teachers—may reveal important collateral information about the child’s conduct, academic performance, and peer relationships

􏱦 Child welfare/juvenile justice—if applicable Other Methods of Gathering Information

􏱦 Play, stories, drawing—help to assess conceptualization, internal states, experiences, and the like

􏱦 Kaufman Assessment Battery for Children (K-ABC)—intelligence test for ages 21⁄2 to 12

􏱦 Weschler Intelligence Scale for Children–Revised (WISC-R)—deter- mines intelligence quotient (IQ) for ages 6 to 16

􏱦 Peabody Individual Achievement Test (PIAT)—tests academic achievement

􏰀 MENTAL RETARDATION (MR)

Mental retardation is defined by the DSM-IV as:

􏱦 Significantly subaverage intellectual functioning with an IQ of 70 or

below

􏱦 Deficits in adaptive skills appropriate for the age group

􏱦 Onset must be before the age of 18.

HIGH-YIELD FACTS

Psychiatric Disorders in Children

Always rule out a hearing or visual deficit in the workup before diagnosing learning disorders.

EPIDEMIOLOGY

􏱦 Affects 2.5% of the population

􏱦 Approximately 85% of mentally retarded are mild cases

􏱦 Males affected twice as often as females

SUBCLASSIFICATIONS

Type of MR

Profound Severe Moderate Mild

CAUSES

Definition

IQ<25 IQ 25–40 IQ 40–50 IQ 50–70

% of MR

1to2%ofMR 3to4%ofMR 10% of MR 80% of MR

Most MR has no identifiable cause.

Genetic

􏱦 Down’s syndrome—trisomy 21 (1/700 live births)

􏱦 Fragile X syndrome—second most common cause of retardation; in-

volves mutation of X chromosome; affects males more than females

􏱦 Many others

Prenatal: Infection and Toxins (TORCH)

􏱦 Toxoplasmosis

􏱦 Other (syphilis, AIDS, alcohol/illicit drugs)

􏱦 Rubella (German measles)

􏱦 Cytomegalovirus (CMV)

􏱦 Herpes simplex

Perinatal

􏱦 Anoxia

􏱦 Prematurity

􏱦 Birth trauma

Postnatal

􏱦 Hypothyroidism

􏱦 Malnutrition

􏱦 Toxin exposure

􏱦 Trauma

􏰀 LEARNING DISORDERS

Learning disorders are defined by the DSM-IV as achievement in reading, mathematics, or written expression that is significantly lower than expected for chronological age, level of education, and level of intelligence. Learning disorders affect academic achievement or daily activities and cannot be ex- plained by sensory deficits, poor teaching, or cultural factors. They are often due to deficits in cognitive processing (abnormal attention, memory, visual perception, etc.).

Types of learning disorders include:

􏱦 Reading disorder

􏱦 Mathematics disorder

􏱦 Disorder of written expression

􏱦 Learning disorder not otherwise specified (NOS)

EPIDEMIOLOGY

Reading Disorder

􏱦 4% of school-age children

􏱦 Boys affected 3 to 4 times as often as girls

Mathematics Disorder

􏱦 5% of school-age children

􏱦 May be more common in girls

Disorder of Written Expression

􏱦 Affects 3 to 10% of school-age children

􏱦 Male-to-female ratio unknown

ETIOLOGY

Learning disorders may be caused by genetic factors, abnormal development, perinatal injury, and neurological or medical conditions.

TREATMENT

Remedial education tailored to the child’s specific needs

􏰀 DISRUPTIVE BEHAVIORAL DISORDERS

Disruptive behavioral disorders include conduct disorder and oppositional de-

fiant disorder.

Conduct Disorder

DIAGNOSIS AND DSM-IV CRITERIA

A pattern of behavior that involves violation of the basic rights of others or of social norms and rules, with at least three acts within the following categories during the past year:

1. Aggression toward people and animals 2. Destruction of property

3. Deceitfulness

4. Serious violations of rules

EPIDEMIOLOGY

􏱦 Prevalence: 6 to 16% in boys, 2 to 9% in girls

􏱦 Etiology involves genetic and psychosocial factors.

􏱦 Up to 40% risk of developing antisocial personality disorder in adulthood

􏱦 Increased incidence of comorbid attention deficit hyperactivity disorder

and learning disorders

􏱦 Increased incidence of comorbid mood disorders, substance abuse, and

HIGH-YIELD FACTS

in Children

Psychiatric Disorders

A 9-year-old boy’s mother has been called to school because her son has been hitting other children and stealing their pens. His mother reveals that he often pokes the cat they have at home with sharp objects. Think: Conduct disorder.

criminal behavior in adulthood

Conduct disorder is the most common diagnosis in outpatient child psychiatry clinics.

Unlike conduct disorder, ODD does not involve violation of the basic rights of others.

A 9-year-old boy’s mother has been called to school because her son is defiant toward the teachers and does not comply in any class activities. His behavior is appropriate toward his classmates. Think: Oppositional defiant disorder (ODD).

HIGH-YIELD FACTS

Psychiatric Disorders in Children

Two thirds of children with ADHD also have conduct disorder or ODD.

A 9-year-old boy’s mother has been called to school because her son has not been doing his homework. He claims he did not know about the assignments. He inturrupts other kids during class and according to the teacher, “never sits still.” Think: Attention deficit hyperactivity disorder (ADHD).

TREATMENT

A multimodal treatment approach is most effective. It is important to struc- ture the child’s environment with firm rules that are consistently enforced. In- dividual psychotherapy that focuses on behavior modification and problem- solving skills is often useful. Adjunctive pharmacotherapy may be helpful, including antipsychotics or lithium for aggression and selective serotonin re- uptake inhibitors (SSRIs) for impulsivity, irritability, and mood lability.

Oppositional Defiant Disorder (ODD)

DIAGNOSIS AND DSM-IV CRITERIA

At least 6 months of negativistic, hostile, and defiant behavior during which at least four of the following have been present:

1. Frequent loss of temper

2. Arguments with adults

3. Defying adults’ rules

4. Deliberately annoying people 5. Easily annoyed

6. Anger and resentment

7. Spiteful

8. Blaming others for mistakes or misbehaviors

EPIDEMIOLOGY

􏱦 Prevalence: 16 to 22% in children > age 6

􏱦 Usually begins by age 8

􏱦 Onset before puberty more common in boys; onset after puberty equal

in boys and girls

􏱦 Increased incidence of comorbid substance abuse, mood disorders, and

attention deficit hyperactivity disorder

􏱦 Remits in 25% of children; may progress to conduct disorder

TREATMENT

Treatment should involve individual psychotherapy that focuses on behavior modification and problem-solving skills as well as parenting skills training.

􏰀 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)

There are three subcategories of ADHD: Predominantly inattentive type, pre-

dominantly hyperactive–impulsive type, and combined type.

DIAGNOSIS AND DSM-IV CRITERIA

1. At least six symptoms involving inattentiveness, hyperactivity, or both that have persisted for at least 6 months:

􏱦 Inattention—problems listening, concentrating, paying attention to

details, or organizing tasks; easily distracted, often forgetful

􏱦 Hyperactivity–impulsivity—blurting out, interrupting, fidgeting,

leaving seat, talking excessively, and so on

2. Onset before age 7

3. Behavior inconsistent with age and development

EPIDEMIOLOGY

􏱦 3 to 5% prevalence in school-age children

􏱦 Three to five times more common in boys

􏱦 Increased incidence of comorbid mood disorders, personality disorders,

conduct disorder, and ODD

􏱦 Most cases remit in adolescence; 20% of patients have symptoms into

adulthood.

ETIOLOGY

The etiology of ADHD is multifactorial, including:

􏱦 Genetic factors (higher incidence in monozygotic twins than dizygotic)

􏱦 Prenatal trauma/toxin exposure (e.g., fetal alcohol syndrome, lead poi-

soning, etc.)

􏱦 Neurochemical factors (dysregulation of peripheral and central nor-

adrenergic systems)

􏱦 Neurophysiologicalfactors(canbedemonstratedincertainpatientswith

abnormal electroencephalogram [EEG] patterns or positron-emission to-

mography scans)

􏱦 Psychosocial factors (emotional deprivation, etc.)

TREATMENT

1. Pharmacotherapy:

􏱦 CNS stimulants—methylphenidate (Ritalin) is first-line therapy,

dextroamphetamine (Dexedrine), and pemoline (Cylert)

􏱦 SSRIs/tricyclic antidepressants (TCAs)—adjunctive therapy

2. Individual psychotherapy—with focus on behavior modification tech- niques

3. Parental counseling (education and parenting skills training)

4. Group therapy—to help patient improve social skills, self-esteem, etc.

􏰀 PERVASIVE DEVELOPMENTAL DISORDERS (PDD)

Pervasive developmental disorders are a group of conditions that involve problems with social skills, language, and behaviors. Impairment is noticeable at an early age of life and involves multiple areas of development.

Examples of PDD include:

􏱦 Autistic disorder

􏱦 Asperger’s disorder

􏱦 Rett’s disorder

􏱦 Childhood disintegrative disorder

Autistic Disorder

DIAGNOSIS AND DSM-IV CRITERIA

To diagnose autism, at least six symptoms from the following categories must be present:

1. Problems with social interaction (at least two):

􏱦 Impairment in nonverbal behaviors (facial expression, gestures, etc.)

􏱦 Failure to develop peer relationships

HIGH-YIELD FACTS

Ritalin is considered first- line therapy in ADHD; significant improvement is seen in 75% of patients.

in Children

Psychiatric Disorders

Depression in children and adolescents may be manifested primarily as irritableness instead of dysphoria. Otherwise, the criteria for the depressive disorders are the same as for adults.

A 3-year-old boy is brought in by his parents because they think he is deaf. According to the parents, he shows no interest in them or anyone around him and only speaks when spoken to directly. He often takes his toys and lines them up in a straight line. His hearing tests are normal. Think: Autism.

HIGH-YIELD FACTS

Psychiatric Disorders in Children

Unlike autistic disorder, children with Asperger’s disorder have normal language and cognitive development.

􏱦 Failure to seek sharing of interests or enjoyment with others

􏱦 Lack of social/emotional reciprocity

2. Impairments in communication (at least one)

􏱦 Lack of or delayed speech

􏱦 Repetitive use of language

􏱦 Lack of varied, spontaneous play, and so on

3. Repetitive and stereotyped patterns of behavior and activities (at least one)

􏱦 Inflexible rituals

􏱦 Preoccupation with parts of objects, and so on

EPIDEMIOLOGY

􏱦 Incidence of 0.02 to 0.05% in children under age 12

􏱦 Boys have 3 to 5 times higher incidence than girls

􏱦 Some familial inheritance

􏱦 Significant association with fragile X syndrome, tuberous sclerosis, men-

tal retardation, and seizures

􏱦 Autism may be apparent at an early age due to delayed developmental

milestones (social smile, facial expression, etc.). It almost always begins

before age 3.

􏱦 Seventy percent of patients with autism are mentally retarded (IQ <

70). Only 1 to 2% can function completely independently as adults.

ETIOLOGY

The etiology of autism is multifactorial, including:

􏱦 Prenatal neurological insults (from infections, drugs, etc.)

􏱦 Genetic factors (36% concordance rate in monozygotic twins)

􏱦 Immunological and biochemical factors

TREATMENT

There is no cure for autism, but various treatments are used to help manage symptoms and improve social skills:

􏱦 Remedial education

􏱦 Behavioral therapy

􏱦 Neuroleptics (to help control aggression, hyperactivity, and mood labil-

ity)

􏱦 SSRIs (adjunctive therapy to help control stereotyped and repetitive

behaviors)

􏱦 Some children benefit from stimulants.

Asperger’s Disorder

DIAGNOSIS AND DSM-IV CRITERIA

1. Impaired social interaction (at least two):

􏱦 Failure to develop peer relationships

􏱦 Impaired use of nonverbal behaviors (facial expression, gestures,

etc.)

􏱦 Lack of seeking to share enjoyment or interests with others

􏱦 Lack of social/emotional reciprocity

2. Restricted or stereotyped behaviors, interests, or activities (inflexi- ble routines, repetitive movements, preoccupations, etc.)

EPIDEMIOLOGY

􏱦 Incidence unknown

􏱦 Boys > girls

ETIOLOGY

Unknown etiology; may involve genetic, infectious, or perinatal factors

TREATMENT

Supportive treatment; similar to autistic disorder (see above). Social skills training and behavioral modification techniques may be useful.

Rett’s Disorder

Rett’s disorder is characterized by:

1. Normal prenatal and perinatal development

2. Normal psychomotor development during the first 5 months after birth

3. Normal head circumference at birth, but decreasing rate of head

growth between the ages of 5 and 48 months

4. Loss of previously learned purposeful hand skills between ages 5 and 30

months, followed by development of stereotyped hand movements

(such as hand wringing, hand washing, etc.)

5. Early loss of social interaction, usually followed by subsequent im-

provement

6. Problems with gait or trunk movements

7. Severely impaired language and psychomotor development

8. Seizures

9. Cyanotic spells

EPIDEMIOLOGY

􏱦 Onset between age 5 and 48 months

􏱦 Seen in girls predominantly

􏱦 Boys have variable phenotype, characterized predominantly by develop-

mental delay; many die in utero

􏱦 Rare

􏱦 Genetic testing is available ETIOLOGY

MECP2 gene mutation on X chromosome.

TREATMENT

Supportive

Childhood Disintegrative Disorder

DIAGNOSIS AND DSM-IV CRITERIA

1. Normal development in the first 2 years of life

2. Loss of previously acquired skills in at least two of the following areas:

􏱦 Language

􏱦 Social skills

Rett’s disorder is seen only in girls; early development appears normal, but diminished head circumference and stereotyped hand movements eventually ensue. Cognitive development never progresses beyond that of the first year of life.

HIGH-YIELD FACTS

in Children

Psychiatric Disorders

HIGH-YIELD FACTS

Tics in Tourette’s may be consciously suppressed for brief periods of time.

Psychiatric Disorders in Children

Both motor and vocal tics must be present to diagnose Tourette’s disorder. The presence of exclusive motor or vocal tics suggests a diagnosis of motor tic disorder or vocal tic disorder.

A 13-year-old boy has had uncontrollable blinking tics since he was 9 years old. Lately, he has noticed that he often involuntarily makes a barking noise that is very embarrassing. Think: Tourette’s disorder.

􏱦 Bowel or bladder control

􏱦 Play

􏱦 Motor skills

3. At least two of the following:

􏱦 Impaired social interaction

􏱦 Impaired use of language

􏱦 Restricted, repetitive, and stereotyped behaviors and interests

EPIDEMIOLOGY

􏱦 Onset age 2 to 10

􏱦 Four to eight times higher incidence in boys than girls

􏱦 Rare

ETIOLOGY

Unknown

TREATMENT

Supportive (similar to that of autistic disorder)

􏰀 TOURETTE’S DISORDER AND TIC DISORDERS

Tics are involuntary movements or vocalizations. Tourette’s disorder is the most severe tic disorder and is characterized by multiple daily motor or vocal tics with onset before age 18. Vocal tics may first appear many years after the motor tics. The most common motor tics involve the face and head, such as blinking of the eyes. Examples of vocal tics include:

􏱦 Coprolalia—repetitive speaking of obscene words (uncommon in children)

􏱦 Echolalia—exact repetition of words

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Multiple motor and vocal tics (both must be present)

􏱦 Tics occur many times a day, almost every day for > 1 year (no tic-free

period > 3 months)

􏱦 Onset prior to age 18

􏱦 Distress or impairment in social/occupational functioning

EPIDEMIOLOGY

􏱦 Occurs in 0.05% of children

􏱦 Three times more common in boys than girls

􏱦 Onset usually between ages 7 and 8

􏱦 High co-morbidity with obsessive–compulsive disorder and ADHD

ETIOLOGY

􏱦 Genetic factors—50% concordance rate in monozygotic versus 8% in dizygotic twins

􏱦 Neurochemical factors—impaired regulation of dopamine in the cau- date nucleus (and possibly impaired regulation of endogenous opiates and the noradrenergic system)

TREATMENT

􏱦 Pharmacotherapy—haloperidol or pimozide (dopamine receptor antag- onists)

􏱦 Supportive psychotherapy

􏰀 ELIMINATION DISORDERS Enuresis

Urinary continence is normally established before age 4. Enuresis is the invol- untary voiding of urine (bedwetting). Rule out medical conditions (urethritis, diabetes, seizures).

Primary—child never established urinary continence. Secondary—manifestation occurs after a period of urinary continence, most commonly between ages 5 and 8.

Diurnal—includes daytime episodes

Nocturnal—includes nighttime episodes

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Involuntary voiding after age 5

􏱦 Occurs at least twice a week for 3 months or with marked impairment

EPIDEMIOLOGY

Occurs in 7% of of 5-year-olds; prevalence decreases with age.

ETIOLOGY

􏱦 Genetic predisposition

􏱦 Small bladder or low nocturnal levels of antidiuretic hormone

􏱦 Psychological stress

TREATMENT

􏱦 Behavior modification (such as buzzer that wakes child up when sensor detects wetness)

􏱦 Pharmacotherapy—antidiuretics (DDAVP) or TCAs (such as imipra- mine).

Encopresis

Bowel control is normally achieved by the age of 4. Bowel incontinence can result in rejection by peers and impairment of social development. One must rule out conditions such as metabolic abnormalities (such as hypothyroidism), lower gastrointestinal problems (anal fissure, inflammatory bowel disease), and dietary factors.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Involuntary or intentional passage of feces in inappropriate places

􏱦 Must be at least 4 years of age

􏱦 Has occurred at least once a month for 3 months

The great majority of cases of enuresis spontaneously remit by age 7.

HIGH-YIELD FACTS

in Children

Psychiatric Disorders

HIGH-YIELD FACTS

Psychiatric Disorders in Children

EPIDEMIOLOGY

􏱦 Occurs in 1% of 5-year-old children

􏱦 Incidence decreases with age

􏱦 Associated with other psychiatric conditions, such as conduct disorder

and ADHD

ETIOLOGY

􏱦 Psychosocial stressors

􏱦 Lack of sphincter control

􏱦 Constipation with overflow incontinence

TREATMENT

􏱦 Psychotherapy, family therapy, and behavioral therapy

􏱦 Stool softeners (if etiology is constipation)

􏰀 OTHER CHILDHOOD DISORDERS Selective Mutism

Selective mutism is a rare condition that occurs more commonly in girls than in boys. It is characterized by not speaking in certain situations (such as in school). Onset is usually around age 5 or 6, and it may be preceded by a stress- ful life event. Treatment involves supportive psychotherapy, behavior therapy, and family therapy.

Separation Anxiety Disorder

Separation anxiety disorder involves excessive fear of leaving one’s parents or other major attachment figures. Children with this disorder may refuse to go to school or to sleep alone. They may complain of physical symptoms in order to avoid having to go to school. When forced to separate, they become ex- tremely distressed and may worry excessively about losing their parents for- ever.

Separation anxiety disorder affects up to 4% of school-age children and occurs equally in boys and girls. Onset is usually around age 7 and may be preceded by a stressful life event. Parents are often afflicted with anxiety disorders and may express excessive concern about their children. Treatment involves fam- ily therapy, supportive psychotherapy, and low-dose antidepressants.

Child Abuse

Child abuse includes physical abuse, emotional abuse, sexual abuse, and ne- glect. Doctors are legally required to report all cases of suspected child abuse to appropriate social service agencies. In cases of suspected abuse, children may be admitted to the hospital without parental consent in order to protect them.

Adults who were abused as children have an increased risk of developing anx- iety disorders, depressive disorders, dissociative disorders, substance abuse dis- orders, and posttraumatic stress disorder. They also have an increased risk of subsequently abusing their own children.

SEXUAL ABUSE

􏱦 Child sexual abuse most often involves a male who knows the child. The existence of true pedophilia in the abuser is rare.

􏱦 Children are most commonly sexually abused between the ages of 9 and 12.

􏱦 Twenty-five percent of women and 12% of men report having been sex- ually abused as children.

Evidence of sexual abuse in a child:

􏱦 Sexuallytransmitted

diseases

􏱦 Analorgenitaltrauma

􏱦 Knowledgeaboutspecific

sexual acts

(inappropriate for age)

􏱦 Initiationofsexual activity with others

􏱦 Sexualplaywithdolls (inappropriate for age)

HIGH-YIELD FACTS

in Children

Psychiatric Disorders

NOTES

HIGH-YIELD FACTS

Psychiatric Disorders in Children

100

HIGH-YIELD FACTS IN

Dissociative Disorders

􏰀 DEFINITION

Dissociative disorders are defined by a loss of memory, identity, or sense of self (one’s sense of self is the normal integration of one’s thoughts, behaviors, per- ceptions, feelings, and memory into a unique identity). Amnesia and feelings of detachment often arise suddenly and may be temporary in duration. Exam- ples of dissociative disorders include:

􏱦 Dissociative amnesia

􏱦 Dissociative fugue

􏱦 Dissociative identity disorder (multiple personality disorder)

􏱦 Depersonalization disorder

Unlike the amnesia present in amnestic disorders, symptoms of dissociative disorders are never due to an underlying medical condition or substance use. Instead, their onset is related to a stressful life event or personal problem. Many patients with dissociative disorders have a history of trauma or abuse during childhood. Amnesia secondary to medical conditions is found in the “amnestic disorders” (discussed in the cognitive disorders chapter).

􏰀 DISSOCIATIVE AMNESIA

Amnesia is a prominent symptom in all of the dissociative disorders except depersonalization disorder. However, the diagnosis of dissociative amnesia re- quires that amnesia be the only dissociative symptom present. Patients with this disorder are usually aware that they are having difficulty remembering but are not very troubled by it.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 At least one episode of inability to recall important personal informa- tion, usually involving a traumatic or stressful event

􏱦 The amnesia cannot be explained by ordinary forgetfulness.

􏱦 Symptoms cause significant distress or impairment in daily functioning and cannot be explained by another disorder, medical condition, or sub-

stance use.

101

The phenomenon of dissociation ranges from nonpathologic, such as the state of mind entered during hypnosis, to extremely pathological, as seen in multiple personality disorder.

Patients are often unable to recall their name or other important information but will remember obscure details. This is opposite to the type of memory loss usually found in dementia.

A 28-year-old woman is unable to recall any events of her rape in which she was hospitalized for 2 months. Think: Dissociative amnesia.

HIGH-YIELD FACTS

Abreaction is the strong reaction patients often get when retrieving traumatic memories.

Dissociative Fugue— Fugitives take off and form new identities.

Dissociative Disorders

Unlike dissociative amnesia, patients with dissociative fugue are not aware that they have forgotten anything.

102

EPIDEMIOLOGY

􏱦 Most common dissociative disorder

􏱦 More common in women than men

􏱦 More common in younger adults than older

􏱦 Increased incidence of comorbid major depression and anxiety disorders

COURSE AND PROGNOSIS

Many patients abruptly return to normal after minutes or days. Recurrences are uncommon.

TREATMENT

It is important to help patients retrieve their lost memories in order to pre- vent future recurrences. Hypnosis or administration of sodium amobarbital or lorazepam during the interview may be useful to help patients talk more freely. Subsequent psychotherapy is then recommended. Ativan is used more fre- quently than sodium amobarbital, as it is safer and better tolerated (lower risk of respiratory depression).

􏰀 DISSOCIATIVE FUGUE

Dissociative fugue is characterized by sudden, unexpected travel away from home, accompanied by the inability to recall parts of one’s past or identity. Patients often assume an entirely new identity and occupation after arriving in the new location. They are unaware of their amnesia and new identity, and they never recall the period of the fugue.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Sudden, unexpected travel away from home or work plus inability to re- call one’s past

􏱦 Confusion about personal identity or assumption of new identity

􏱦 Not due to dissociative identity disorder or the physiological effects of a

substance or medical disorder

􏱦 Symptoms cause impairment in social or occupational functioning.

EPIDEMIOLOGY

􏱦 Rare

􏱦 Predisposing factors include heavy use of alcohol, major depression, his-

tory of head trauma, and epilepsy

􏱦 Onset associated with stressful life event (dissociative fugue is often

viewed as a response to a life stressor or personal conflict)

COURSE AND PROGNOSIS

The fugue usually lasts a few hours to several days but may last longer. After the episode, the patient will assume his or her old identity without ever re- membering the time of the fugue.

TREATMENT

Similar to that of dissociative amnesia (see above)

􏰀 DISSOCIATIVE IDENTITY DISORDER (MULTIPLE PERSONALITY DISORDER)

A 40-year-old sanitation worker currently lives in Baltimore for the past 2 years. He moved from Miami where he owned a small restaurant for 10 years. When he is approached by a woman who claims to be his former neighbor from Miami, he has no memory of living there or owning a restaurant. Think: Dissociative fugue.

Personality involves the integration of one’s thoughts, feelings, and behavior into a sense of unique self. Patients with dissociative identity disorder have two or more distinct personalities that alternately control their behaviors and thoughts. Patients are often unable to recall personal information. While one personality is dominant, that personality is usually (but not always) unaware of events that occurred during prior personality states.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Presence of two or more distinct identities

􏱦 At least two of the identities recurrently take control of the person’s be-

havior.

􏱦 Inability to recall personal information of one personality when the

other is dominant

􏱦 Not due to effects of substance or medical condition

EPIDEMIOLOGY

􏱦 Women account for more than 90% of patients.

􏱦 Most patients have experienced prior trauma, especially childhood

physical or sexual abuse.

􏱦 Average age of diagnosis is 30.

􏱦 High incidence of comorbid major depression, anxiety disorders, bor-

derline personality disorder, and substance abuse. Up to one third of pa- tients attempt suicide.

COURSE AND PROGNOSIS

􏱦 Course is usually chronic with incomplete recovery.

􏱦 Worst prognosis of all dissociative disorders

􏱦 Patients with an earlier onset have a poorer prognosis.

TREATMENT

Hypnosis, drug-assisted interviewing, and insight-oriented psychotherapy; pharmacotherapy as needed if comorbid disorder develops (such as major de- pression)

􏰀 DEPERSONALIZATION DISORDER

Depersonalization disorder is characterized by persistent or recurrent feelings of detachment from one’s self, environment (derealization), or social situa- tion. Patients feel separated from their bodies and mental processes, as if they are outside observers. They are aware of their symptoms and often fear they are going crazy. Depersonalization is often accompanied by anxiety or panic.

Diagnosis requires that episodes be persistent or recurrent, as transient symp- toms of depersonalization are common in normal people during times of stress.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Persistent or recurrent experiences of being detached from one’s body or mental processes

􏱦 Reality testing remains intact during episode.

Symptoms of multiple personality dissorder may be similar to those seen in borderline personality disorder.

A 33-year-old nun is astounded when a man claims that he saw her at a local strip club the night before. She denies his accusations and has no memory of the event. Think: Dissociative identity disorder (multiple personality disorder).

HIGH-YIELD FACTS

Dissociative Disorders

103

HIGH-YIELD FACTS

A 30-year-old male says that he had an “out of this world” experience. He felt as if “he was watching his own life like a movie.” He knows this is not normal. Think: Depersonalization disorder.

Dissociative Disorders

104

􏱦 Causes social/occupational impairment, and cannot be accounted for by another mental or physical disorder

EPIDEMIOLOGY

􏱦 Approximately twice as common in women than men

􏱦 Average onset between ages 15 and 30

􏱦 Increased incidence of comorbid anxiety disorders and major depression

􏱦 Severe stress is a predisposing factor.

COURSE AND PROGNOSIS

Often chronic (with either steady or intermittent course), but may remit without treatment

TREATMENT

Antianxiety agents or selective serotonin reuptake inhibitors (SSRIs) to treat associated symptoms of anxiety or major depression

HIGH-YIELD FACTS IN

Somatoform Disorders and Factitious Disorders

􏰀 DEFINITION

Patients with somatoform disorders present with physical symptoms that have no organic cause. They truly believe that their symptoms are due to medical problems and are not consciously feigning symptoms.

Examples of somatoform disorders include:

􏱦 Somatization disorder

􏱦 Conversion disorder

􏱦 Hypochondriasis

􏱦 Pain disorder

􏱦 Body dysmorphic disorder

Primary and secondary gain often result from symptoms expressed in somato- form disorders, but patients are not consciously aware of gains and do not in- tentionally seek them.

Primary gain: Expression of unacceptable feelings as physical symptoms in order to avoid facing them

Secondary gain: Use of symptoms to benefit the patient (increased atten- tion from others, decreased responsibilities, avoidance of the law, etc.).

With the exception of hypochondriasis, somatoform disorders are more com- mon in women. One half of patients have comorbid mental disorders, espe- cially anxiety disorders and major depression.

􏰀 SOMATIZATION DISORDER

Patients with somatization disorder present with multiple vague complaints involving many organ systems. They have a long-standing history of numer- ous visits to doctors. Their symptoms cannot be explained by a medical disor- der.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 At least two gastrointestinal (GI) symptoms

􏱦 At least one sexual or reproductive symptom

When suspecting a somatoform disorder, one must always rule out organic causes of symptoms, including central nervous system (CNS) disease, endocrine disorders, and connective tissue disorders.

105

Five to 10% of patients presenting in primary care have a somatization disorder.

HIGH-YIELD FACTS

Somatization—So many physical complaints

A middle-aged woman presents to her primary care doctor with numerous symptoms involving several organ systems. She has been unwell or “sickly” since early adulthood or adolescence and describes herself as suffering. She is resistant to psychiatric referral. Think: Somatization disorder.

Somatoform Disorders

Conversion disorder: Patients convert psychiatric problems to a neurological problem and then spontaneously convert back to normal.

If conversion-like presentation is in older age, it is more likely a neurological deficit.

106

􏱦 At least one neurological symptom

􏱦 At least four pain symptoms

􏱦 Onset before age 30

􏱦 Cannot be explained by general medical condition or substance use

EPIDEMIOLOGY

􏱦 Incidence in females 5 to 20 times that of males

􏱦 Lifetime prevalence: 0.1 to 0.5%

􏱦 Greater prevalence in low socioeconomic groups

􏱦 Fifty percent have comorbid mental disorder.

􏱦 First-degree female relatives have 10 to 20% incidence.

􏱦 30% concordance in identical twins

COURSE AND PROGNOSIS

Usually chronic and debilitating. Symptoms may periodically improve and then worsen under stress.

TREATMENT

There is no cure, but management involves regularly scheduled frequent visits to a primary care practitioner, since these patients will usually not agree to see a psychiatrist. Secondary gain should be minimized. Medications should be used with caution and only with a clear indication; they are usually ineffec- tive, and patients tend to be erratic in their use. Relaxation therapy, hypnosis, and individual and group psychotherapy are sometimes helpful.

􏰀 CONVERSION DISORDER

Patients have at least one neurological symptom (sensory or motor) that can- not be explained by a medical disorder. Onset is always preceded or exacer- bated by a psychological stressor, although the patient may not connect the two. Patients are often surprisingly calm and unconcerned (la belle indifference) when describing their symptoms, which may include blindness or paralysis.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 At least one neurological symptom

􏱦 Psychological factors associated with initiation or exacerbation of symp-

tom

􏱦 Symptom not intentionally produced

􏱦 Cannot be explained by medical condition or substance use

􏱦 Causes significant distress or impairment in social or occupational func-

tioning

􏱦 Not accounted for by somatization disorder or other mental disorder

􏱦 Not limited to pain or sexual symptom

Common Symptoms

􏱦 Shifting paralysis

􏱦 Blindness

􏱦 Mutism

􏱦 Paresthesias

􏱦 Seizures

􏱦 Globus hystericus (sensation of lump in throat)

EPIDEMIOLOGY

􏱦 Common disorder

􏱦 20 to 25% incidence in general medical settings

􏱦 Two to five times more common in women than men

􏱦 Onset at any age, but most often in adolescence or early adulthood

􏱦 Increased incidence in low socioeconomic groups

􏱦 High incidence of comorbid schizophrenia, major depression, or anxiety

disorders

DIFFERENTIAL DIAGNOSIS

Must rule out underlying medical cause, as 50% of these patients eventually receive medical diagnoses

COURSE

Symptoms resolve within 1 month. Twenty-five percent will eventually have future episodes, especially during times of stress. Symptoms may spontaneously resolve after hypnosis or sodium amobarbital interview if the psychological trigger can be uncovered during the interview.

TREATMENT

Insight-oriented psychotherapy, hypnosis, or relaxation therapy if needed. Most patients spontaneously recover.

􏰀 HYPOCHONDRIASIS

Hypochondriasis involves prolonged, exaggerated concern about health and possible illness. Patients either fear having a disease or are convinced that one is present. They misinterpret normal bodily symptoms as indicative of disease.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Patients fear that they have a serious medical condition based on misin- terpretation of normal body symptoms.

􏱦 Fears persist despite appropriate medical evaluation.

􏱦 Fears present for at least 6 months

EPIDEMIOLOGY

􏱦 Men affected as often as women

􏱦 Average age of onset: 20 to 30

􏱦 Eighty percent have coexisting major depression or anxiety disorder.

DIFFERENTIAL DIAGNOSIS

􏱦 Must rule out underlying medical condition

􏱦 Somatization disorder—hypochondriacs are worried about disease,

whereas patients with somatization disorder are concerned about their

symptoms.

COURSE

Episodic—symptoms may wax and wane periodically. Exacerbations occur commonly under stress. Up to 50% of patients improve significantly.

A 20-year-old woman visits her doctor stating that she has been blind since the previous day. She seems calm and indifferent. The blindness began 1 week following her son’s death. Her neurological exam is normal, and nerve studies reveal no retinal problems. Think: Conversion disorder.

HIGH-YIELD FACTS

A 30-year-old male visits the medical clinic with concerns about colon cancer. He has had intermittent abdominal pain for the past year and has seen several doctors. He had a normal upper GI series, colonoscopy, and computed tomography (CT) scan. After each test came back normal, he was initially reassured but then began worrying again a short time later. On this visit, copies of his prior evaluations and physical exams are unremarkable. When he is confronted with the idea of seeing a mental health professional, he storms out of the office and seeks another physician. Think: Hypochondriasis.

107

Somatoform Disorders

A 20-year-old single female visits a plastic surgeon requesting a nose job because her nose is “huge and ugly.” She says everyone stares at her because of her repulsive face, so she rarely goes out. On inspection, her nose appears perfectly normal and small. After the procedure, she is unhappy with the result and still insists her nose is large. Think: Body dysmorphic disorder.

HIGH-YIELD FACTS

Somatoform Disorders

108

TREATMENT

No cure exists, but management involves frequently scheduled visits to one primary care doctor who oversees the patient’s care. Patients are usually resis- tant to psychotherapy. Group therapy or insight-oriented psychotherapy may be helpful if patient is willing.

􏰀 BODY DYSMORPHIC DISORDER

Patients with body dysmorphic disorder are preoccupied with body parts that they perceive as flawed or defective. Though their physical imperfections are either minimal or completely imagined, patients view them as severe and grotesque. They are extremely self-conscious about their appearance and spend significant time trying to correct perceived flaws with makeup, dermato- logical procedures, or plastic surgery.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Preoccupation with an imagined defect in appearance or excessive con- cern about a slight physical anomaly

􏱦 Must cause significant distress in the patient’s life EPIDEMIOLOGY

􏱦 More common in women than men

􏱦 More common in unmarried than married persons

􏱦 Average age of onset: Between 15 and 20

􏱦 Ninety percent have coexisting major depression.

􏱦 Seventy percent have coexisting anxiety disorder.

􏱦 Thirty percent have coexisting psychotic disorder.

COURSE AND PROGNOSIS

Usually chronic; symptoms wax and wane in intensity.

TREATMENT

Surgical or dermatological procedures are routinely unsuccessful in pleasing the patient. Selective serotonin reuptake inhibitors (SSRIs) reduce symptoms in 50% of patients.

􏰀 PAIN DISORDER

Patients with pain disorder have prolonged, severe discomfort without ade- quate medical explanation. The pain often co-exists with a medical condition but is not directly caused by it. Patients often have a history of multiple visits to doctors. Pain disorder can be acute (< 6 months) or chronic (> 6 months).

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Patient’s main complaint is of pain at one or more anatomic sites.

􏱦 The pain causes significant distress in the patient’s life.

􏱦 The pain has to be related to psychological factors.

􏱦 The pain is not due to a true medical disorder.

EPIDEMIOLOGY

􏱦 Women are two times as likely as men to have pain disorder.

􏱦 Average age of onset: 30 to 50

􏱦 Increased incidence in first-degree relatives

􏱦 Increased incidence in blue-collar workers

􏱦 Patients have higher incidence of major depression, anxiety disorders, and substance abuse.

DIFFERENTIAL DIAGNOSIS

􏱦 Must rule out underlying medical condition

􏱦 Hypochondriasis and malingering

COURSE

Abrupt onset and increase in intensity for first several months; usually a chronic and disabling course

TREATMENT

Analgesics are not helpful, and patients often become dependent on them. SSRIs, transient nerve stimulation, biofeedback, hypnosis, and psychotherapy may be beneficial.

􏰀 FACTITIOUS DISORDER

Patients with factitious disorder intentionally produce medical or psychologi- cal symptoms in order to assume the role of a sick patient. Primary gain is a prominent feature of this disorder (see definition p. 105).

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Patients intentionally produce signs of physical or mental disorders.

􏱦 They produce the symptoms to assume the role of the patient (primary

gain).

􏱦 There are no external incentives (such as monetary reward, etc.)

􏱦 Either predominantly psychiatric complaints or predominantly physical

complaints

Commonly Feigned Symptoms

􏱦 Psychiatric—hallucinations, depression

􏱦 Medical—fever (by heating the thermometer), abdominal pain, seizures,

skin lesions, and hematuria

RELATED DISORDERS

Münchhausen syndrome—another name for factitious disorder with pre- dominantly physical complaints. These patients may take insulin, con- sume blood thinners, or mix feces in their urine in order to produce symp- toms of medical disease. In addition, they will often demand specific medications. They are very skilled at feigning symptoms necessitating hospitalization.

Münchhausen syndrome by proxy—intentionally producing symptoms in someone else who is under one’s care (usually one’s children) in order to assume the sick role by proxy

A 40-year-old female is referred to an orthopedist for severe ankle pain since a minor ankle injury while playing tennis 10 months ago. Physical exam, x-ray, and magnetic resonance imaging (MRI) reveal no abnormality. Think: Pain disorder.

HIGH-YIELD FACTS

A 30-year-old male medical laboratory assistant is admitted to the hospital for fever and bacteremia. The patient requires a central venous line because of poor venous access. Multiple blood cultures reveal unusual organisms in the blood, and a total of eight different organisms are isolated over the course of his stay. The patient locks himself in the bathroom for extended periods of time, and his room is full of half-empty soda cans. Upon careful inspection of his room, one can is noted to have a syringe in it. When the patient is confronted with the hypothesis that he has been injecting himself with contaminated syringes, he signs out of the hospital. Think: Factitious disorder.

109

Somatoform Disorders

HIGH-YIELD FACTS

A 50-year-old male claims to have headaches, severe back pain, knee pain, and blurry vision since a minor car accident 8 weeks ago. Physical exam and medical workup reveal no abnormalities. After the patient receives a $75,000 settlement, his symptoms disappear.

Think: Malingering.

Somatoform Disorders

110

EPIDEMIOLOGY

􏱦 > 5% of all hospitalized patients

􏱦 Increased incidence in males

􏱦 Higher incidence in hospital and health care workers (who have

learned how to feign symptoms)

􏱦 Associated with higher intelligence, poor sense of identity, and poor

sexual adjustment

Many patients have a history of child abuse or neglect. Inpatient hospitaliza- tion resulting from abuse provided a safe, comforting environment, thus link- ing the sick role with a positive experience.

COURSE AND PROGNOSIS

Repeated and long-term hospitalizations are common.

TREATMENT

No effective treatment exists, but it is important to avoid unnecessary proce- dures and to maintain a close liaison with the patient’s primary medical doc- tor. Patients who are confronted while in the hospital usually leave.

􏰀 MALINGERING

Malingering involves the feigning of physical or psychological symptoms in order to achieve personal gain. Common external motivations include avoid- ing the police, receiving room and board, obtaining narcotics, and receiving monetary compensation.

PRESENTATION

Patients usually present with multiple vague complaints that do not conform to a known medical condition. They often have a long medical history with many hospital stays. They are generally uncooperative and refuse to accept a good prognosis even after extensive medical evaluation. However, their symp- toms improve once their desired objective is obtained.

EPIDEMIOLOGY

􏱦 Common in hospitalized patients

􏱦 More common in men than women

􏰀 REVIEW OF DISTINGUISHING FEATURES

Somatoform disorders: Patients believe they are ill.

Factitious disorders: Patients pretend they are ill with no obvious external reward.

Malingering (most common): Patients pretend they are ill with obvious external incentive.

HIGH-YIELD FACTS IN

Impulse Control Disorders

􏰀 DEFINITION

Impulse control disorders are characterized by an inability to resist behaviors that may bring harm to oneself or to others. Patients may or may not try to suppress their impulses and may not feel remorse or guilt after they have acted out. Anxiety or tension is often experienced prior to the impulse, and relief or satisfaction results after the behavior is completed.

Impulse control disorders are not caused by another mental condition, general medical problem, or substance use.

􏰀 INTERMITTENT EXPLOSIVE DISORDER DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Failure to resist aggressive impulses that result in assault or property de- struction

􏱦 Level of aggressiveness is out of proportion to any triggering events Individual episodes of explosive behavior often remit quickly and sponta-

neously, and patients usually feel remorseful.

EPIDEMIOLOGY/ETIOLOGY

􏱦 More common in men than women

􏱦 Onset usually late teens or twenties

􏱦 Genetic, perinatal, environmental, and neurobiological factors may

play a role in etiology. Patients may have history of child abuse, head

trauma, or seizures.

􏱦 May progress in severity until middle age

TREATMENT

Treatment involves use of selective serotonin reuptake inhibitors (SSRIs), an- ticonvulsants, lithium, and propanolol. Individual psychotherapy is difficult and ineffective. Group therapy and/or family therapy may be useful.

111

Low levels of serotonin have been shown to be associated with impulsiveness and aggression.

HIGH-YIELD FACTS

One fourth of patients with bulimia nervosa have comorbid kleptomania.

Impulse Control Disorders

112

􏰀 KLEPTOMANIA

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Failure to resist urges to steal objects that are not needed for personal or monetary reasons

􏱦 Pleasure or relief is experienced while stealing

􏱦 Purpose of stealing is not to express anger and is not due to a hallucina-

tion or delusion

EPIDEMIOLOGY/ETIOLOGY

􏱦 More common in women than men

􏱦 Occurs in under 5% of shoplifters

􏱦 Symptoms often occur during times of stress.

􏱦 Increased incidence of comorbid mood disorders, eating disorders, and

obsessive–compulsive disorder

􏱦 Etiology may involve biological factors and childhood family dysfunc-

tion

􏱦 Course is usually chronic.

TREATMENT

Treatment may include insight-oriented psychotherapy, behavior therapy (sys- tematic desensitization and aversive conditioning), and SSRIs. There is some anecdotal evidence for naltrexone use.

􏰀 PYROMANIA

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 More than one episode of intentional fire setting

􏱦 Tension present before the act and pleasure or relief experienced after-

wards

􏱦 Fascination with or attraction to fire and its uses and consequences

􏱦 Purpose of fire setting not for monetary gain, expression of anger, mak-

ing a political statement, and is not due to a hallucination or delusion

EPIDEMIOLOGY/ETIOLOGY

􏱦 More common in men and mentally retarded individuals

􏱦 Prognosis better in children than adults (with treatment, children often

recover completely)

TREATMENT

Treatment involves use of behavior therapy, supervision, and SSRIs.

􏰀 PATHOLOGICAL GAMBLING DIAGNOSIS AND DSM-IV CRITERIA

Recurrent maladaptive gambling behavior, as shown by five or more of the fol- lowing:

1. Preoccupation with gambling

2. Need to gamble with increasing amount of money to achieve pleasure 3. Repeated and unsuccessful attempts to cut down on gambling

4. Restlessness or irritability when attempting to stop gambling

5. Gambling done to escape problems or relieve dysphoria

6. Returning to reclaim losses after gambling

7. Lying to therapist or family members to hide level of gambling

8. Committing illegal acts to finance gambling

9. Jeopardizing relationships or job because of gambling

10. Relying on others to financially support gambling EPIDEMIOLOGY/ETIOLOGY

􏱦 Prevalence: 1 to 3% of U.S. adults

􏱦 More common in men than women

􏱦 Increased incidence of mood disorders, anxiety disorders, and obses-

sive–compulsive disorder

􏱦 Predisposing factors include loss of a parent during childhood, inappro-

priate parental discipline during childhood, attention deficit hyperac- tivity disorder, and lack of family emphasis on budgeting or saving money.

􏱦 Etiology may involve genetic, biological, environmental, and neuro- chemical factors.

TREATMENT

Participation in Gamblers Anonymous (a 12-step program) is the most effec- tive treatment. After 3 months of abstinence from gambling, insight-oriented psychotherapy may be attempted. It is also important to treat comorbid mood disorders, anxiety disorders, and substance abuse problems.

􏰀 TRICHOTILLOMANIA DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Recurrent pulling out of one’s hair, resulting in visible hair loss

􏱦 Usually involves scalp, but can involve eyebrows, eyelashes, and facial

and pubic hair

􏱦 Tension present before the behavior, and pleasure or relief resulting af-

terwards

􏱦 Causes significant distress or impairment in daily functioning

EPIDEMIOLOGY/ETIOLOGY

􏱦 Seen in 1 to 3% of the population

􏱦 More common in women than men

􏱦 Onset usually during childhood or adolescence and occurs after stressful

event in one fourth of patients

HIGH-YIELD FACTS

Impulse Control Disorders

113

HIGH-YIELD FACTS

Impulse Control Disorders

114

􏱦 Etiology may involve biological factors, genetic factors, and environ- mental factors (such as problems in relationship with mother, recent loss of important object or figure, etc.)

􏱦 Increased incidence of co-morbid obsessive–compulsive disorder, obses- sive–compulsive personality disorder, mood disorders, and borderline personality disorder

􏱦 Course may be chronic or remitting; adult onset generally more difficult to treat

TREATMENT

􏱦 SSRIs, antipsychotics, lithium

􏱦 Hypnosis, relaxation techniques

􏱦 Behavioral therapy, including substituting another behavior and/or pos-

itive reinforcement (viewing hair pulling as simply a habit)

HIGH-YIELD FACTS IN

Eating Disorders

􏰀 DEFINITION

Eating disorders include anorexia nervosa, bulimia nervosa, and binge-eating disorder. Patients with anorexia or bulimia have a disturbed body image and use extensive measures to avoid gaining weight (vomiting, laxatives, excessive exercise, etc.). Binge eating may occur in all of the eating disorders.

􏰀 ANOREXIA NERVOSA

Patients with anorexia nervosa are preoccupied with their weight, their body image, and with being thin. There are two main subdivisions:

􏱦 Restrictive type: Eat very little and may vigorously exercise; more often withdrawn with obsessive–compulsive traits

􏱦 Binge eating/purging type: Eat in binges followed by purging, laxatives, excessive exercise, and/or diuretics; associated with increased incidence of major depression and substance abuse

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Body weight at least 15% below normal

􏱦 Intense fear of gaining weight or becoming fat

􏱦 Disturbed body image

􏱦 Amenorrhea

PHYSICAL FINDINGS AND COMPLICATIONS

Amenorrhea, electrolyte abnormalities (hypochloremic hyperkalemic alkalo- sis), hypercholesterolemia, arrhythmias, cardiac arrest, lanugo (fine body hair), melanosis coli (darkened area of colon secondary to laxative abuse), leukopenia, osteoporosis

EPIDEMIOLOGY

􏱦 10 to 20 times more common in women than men

􏱦 Occurs in up to 4% of adolescents and young adults (mainly females)

􏱦 Onset usually between ages 10 and 30

115

Anorexia nervosa involves low body weight, and this distinguishes it from bulimia.

Extremely thin, amenorrheic teenage girl whose mother says she eats very little, does aerobics for 2 hours a day, and ritualistically does 400 sit- ups every day (500 if she has “overeaten”)

Think: Anorexia nervosa.

Anorexia Versus Major Depression

Anorexia nervosa: Patients have good appetite but starve themselves due to distorted body image. They are often quite preoccupied with food, preparing it for others, etc., but do not eat it themselves.

Major depression: Patients usually have poor appetite, which leads to weight loss. These patients have no interest in food.

HIGH-YIELD FACTS

Eating Disorders

Unlike patients with anorexia nervosa, bulimic patients usually maintain a normal weight, and their symptoms are more ego- dystonic (distressing); they are therefore more likely to seek help.

Binge eating is defined by excessive food intake within a 2-hour period accompanied by a sense of lack of control.

116

􏱦 More common in developed countries and professions requiring thin physique (such as ballet or modeling)

􏱦 Etiology involves environmental, social, biological, and genetic factors

􏱦 Increased incidence of comorbid mood disorders

DIFFERENTIAL DIAGNOSIS

Medical condition (such as cancer), major depression, bulimia, or other men- tal disorder (such as somatization disorder or schizophrenia)

COURSE AND PROGNOSIS

􏱦 Variable course—may completely recover, have fluctuating symptoms with relapses, or progressively deteriorate

􏱦 Mortality approximately 10% due to starvation, suicide, or electrolyte disturbance

TREATMENT

Patients may be treated as outpatients unless they are more than 20% below ideal body weight, in which case they should be hospitalized.

Treatment involves behavioral therapy, family therapy, and supervised weight- gain programs. Some antidepressants may be useful as adjunctive treatment to promote weight gain, such as paroxetine or mirtazapine. Others promote weight loss, so it is important to check side effect profiles before prescribing.

􏰀 BULIMIA NERVOSA

Bulimia nervosa involves binge eating combined with behaviors intended to counteract weight gain, such as vomiting, use of laxatives or diuretics, or ex- cessive exercise. Patients are embarrassed by their bingeing and are overly concerned with body weight. However, unlike patients with anorexia, they usually maintain a normal weight (and may be overweight).

There are two subcategories of bulimia:

􏱦 Purging type—involves vomiting, laxatives, or diuretics

􏱦 Nonpurging type—involves excessive exercise or fasting

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Recurrent episodes of binge eating

􏱦 Recurrent, inappropriate attempts to compensate for overeating and

prevent weight gain (such as laxative abuse, vomiting, diuretics, or ex-

cessive exercise)

􏱦 The binge eating and compensatory behaviors occur at least twice a

week for 3 months.

􏱦 Perception of self-worth is excessively influenced by body weight and

shape.

PHYSICAL FINDINGS AND COMPLICATIONS

Hypochloremic hypokalemic alkalosis (with or without arrhythmias), esophagitis, dental erosion, calloused knuckles (from self-induced vomiting), and salivary gland hypertrophy

EPIDEMIOLOGY

􏱦 Affects 1 to 3% of adolescent and young females

􏱦 Significantly more common in women than men

􏱦 More common in developed countries

􏱦 High incidence of comorbid mood disorders, impulse control disorders,

and alcohol abuse/dependence

COURSE AND PROGNOSIS

􏱦 Better prognosis than anorexia nervosa

􏱦 Symptoms usually exacerbated by stressful conditions

􏱦 One half recover fully with treatment; one half have chronic course

with fluctuating symptoms

TREATMENT

Treatment may include individual psychotherapy, cognitive–behavioral ther- apy, group therapy, and pharmacotherapy (selective serotonin reuptake in- hibitors [SSRIs] are first-line, then tricyclic antidepressants [TCAs]).

􏰀 BINGE-EATING DISORDER

Obesity is defined as being at least 20% over ideal body weight. Over one half of all people in the United States are obese. Genetic factors, overeating, and lack of activity may all contribute to the development of obesity. Excess weight is associated with adverse effects on health, including increased risk of diabetes, hypertension, cardiac disease, and osteoarthritis.

Binge-eating disorder falls under the DSM-IV category of Eating Disorder NOS (not otherwise specified). Patients with this disorder suffer emotional distress over their binge eating, but they do not try to control their weight by purging or restricting calories, as do anorexics or bulimics.

DIAGNOSIS AND DSM-IV CRITERIA

􏱦 Recurrent episodes of binge eating (eating an excessive amount of food in a 2-hour period associated with a lack of control)

􏱦 Severe distress over binge eating

􏱦 Bingeing occurs at least 2 days a week for 6 months and is not associ-

ated with compensatory behaviors (such as vomiting, laxative use, etc.)

􏱦 Three or more of the following are present:

1. Eating very rapidly

2. Eating until uncomfortably full

3. Eating large amounts when not hungry

4. Eating alone due to embarrassment over eating habits 5. Feeling disgusted, depressed, or guilty after overeating

TREATMENT

Treatment involves individual psychotherapy and behavioral therapy with a strict diet and exercise program. Comorbid mood disorders or anxiety disor- ders should be treated as necessary.

A 20-year-old college student is referred by her dentist because of multiple dental caries. She is normal for her weight but feels that “she needs to lose 15 pounds.” She reluctantly admits to eating a large quantity of food in a short period of time and then inducing gagging. Think: Bulimia nervosa.

HIGH-YIELD FACTS

117

Eating Disorders

HIGH-YIELD FACTS

Eating Disorders

118

Pharmacotherapy may be used adjunctively to promote weight loss, including:

􏱦 Stimulants (such as phentermine and amphetamine)—suppress appetite

􏱦 Orlistat (Xenical)—inhibits pancreatic lipase, thus decreasing amount

of fat absorbed from gastrointestinal tract

􏱦 Sibutramine (Meridia)—inhibits reuptake of norepinephrine, sero-

tonin, and dopamine

HIGH-YIELD FACTS IN

Sleep Disorders

􏰀 DEFINITION

Sleep disorders are very common in the general population. Up to one third of people in the United States will experience a sleep disorder at some point in their lives. Causes of sleep disorders include:

􏱦 Medical conditions (pain, metabolic disorders, endocrine disorders, etc.)

􏱦 Physical conditions (obesity, etc.)

􏱦 Sedative withdrawal

􏱦 Use of stimulants (caffeine, amphetamines, etc.)

􏱦 Major depression (causes early morning awakening or hypersomnia)

􏱦 Mania or anxiety

􏱦 Neurotransmitter abnormalities:

􏱦 Elevated dopamine or norepinephrine causes decreased total sleep time

􏱦 Elevated acetylcholine causes increased total sleep time and in- creased proportion of rapid eye movement (REM) sleep

􏱦 Elevated serotonin causes increased total sleep time and increased proportion of delta wave sleep

Sleep disorders are classified as either primary (not due to another medical condition or substance use) or secondary (due to another medical condition or substance use).

Primary sleep disorders may be further subdivided into:

1. Dyssomnias—disturbances in the amount, quality, or timing of sleep

2. Parasomnias—abnormal events in behavior or physiology during sleep

􏰀 NORMAL SLEEP CYCLE See Table 15-1.

119

HIGH-YIELD FACTS

Sleep Disorders

When evaluating insomnia, be sure to ask about daily caffeine intake––both quantity and the times of day it is ingested.

A 40-year-old businessman states that over the past 2 years, he has trouble staying awake for more than 2 hours before falling asleep. He has a hard time sleeping through the night. Meanwhile, his performance at work is suffering. Think: Primary insomnia.

120

Stage

I. Non-REM Sleep

Eyes open, awake

Eyes closed, awake

Stage 1—Lightest sleep

Stage 2—Light sleep

Stage 3–4—Deep sleep (most restorative) II. REM Sleep

Cycles last 10–40 minutes and occur every 90 minutes; involve dreaming, lack of motor tone, erections.

Amount of REM sleep decreases with age.

REM rebound is an increase in amount

of REM sleep that occurs after a night of sleep deprivation. Slow-wave sleep is made up first.

EEG Wave Type

% of Sleep

75%

TABLE 15-1. Normal Sleep Cycle

Mixed frequency, desynchronized

Alpha waves (12% of people do not have alpha waves)

Loss of alpha waves 5% Sleep spindles and k-complexes 45% Delta waves (lowest frequency) 25%

Sawtooth waves Rapid eye movement

25%

􏰀 DYSSOMNIAS

Primary Insomnia

DIAGNOSIS

Difficulty initiating or maintaining sleep, resulting in daytime drowsiness or difficulty fulfilling tasks. Disturbance occurs three or more times per week for at least 1 month.

EPIDEMIOLOGY/ETIOLOGY

􏱦 Affects 30% of the general population

􏱦 Often exacerbated by anxiety and preoccupation with getting enough

sleep

TREATMENT

1. Sleep hygiene measures (first line):

􏱦 Maintain regular sleep schedule.

􏱦 Limit caffeine intake.

􏱦 Avoid daytime naps.

􏱦 Exercise early in day.

􏱦 Soak in hot tub prior to bedtime.

􏱦 Avoid large meals near bedtime.

􏱦 Remove disturbances such as TV and telephone from bedroom (bed-

room for sleep and sex only).

2. Pharmacotherapy (for short-term use): Benadryl, Ambien (zolpidem),

Sonata (zaleplon), Desyrel (trazodone)

Primary Hypersomnia

DIAGNOSIS

􏱦 At least 1 month of excessive daytime sleepiness or excessive sleep not attributable to medical condition, medications, poor sleep hygiene, in- sufficient sleep, or narcolepsy

􏱦 Usually begins in adolescence TREATMENT

􏱦 Stimulant drugs (amphetamines) are first line.

􏱦 Selective serotonin reuptake inhibitors (SSRIs) may be useful in some

patients.

Narcolepsy

DIAGNOSIS

Repeated, sudden attacks of sleep in the daytime for at least 3 months, associ- ated with:

1. Cataplexy—collapse due to sudden loss of muscle tone (occurs in 70% of patients); associated with emotion, particularly laughter

2. Short REM latency

3. Sleep paralysis—brief paralysis upon awakening (in 50% of patients)

4. Hypnagogic (as patient falls asleep or is falling asleep); hypnopompic

(as patient wakes up; dream persists); hallucinations (in approximately 30% of patients)

EPIDEMIOLOGY/ETIOLOGY

􏱦 Occurs in 0.02 to 0.16% of adult population

􏱦 Equal incidence in males and females

􏱦 Onset most commonly during childhood or adolescence

􏱦 May have genetic component

􏱦 Patients usually have poor nighttime sleep

TREATMENT

Timed daily naps plus stimulant drugs (amphetamines and methylphenidate). SSRIs or sodium oxalate for cataplexy.

Breathing-Related Disorders

DIAGNOSIS

Sleep disruption and excessive daytime sleepiness (EDS) caused by abnormal sleep ventilation from either obstructive or central sleep apnea

EPIDEMIOLOGY

􏱦 Up to 10% of adults

􏱦 More common in men and obese persons

􏱦 Associated with headaches, depression, pulmonary hypertension, and

sudden death in elderly and infants

􏱦 Obstructive sleep apnea (OSA): Strong correlation with snoring

􏱦 Central sleep apnea (CSA) correlated with heart failure

A 30-year-old woman says that despite getting an adequate amount of sleep during the night, she has trouble staying awake at work. During her lunch hour, she goes to the lounge and takes a nap, which does not refresh her. In the morning, she has trouble getting out of bed and is often confused. Think: Primary hypersomnia.

121

Although benzodiazepines are effective hypnotics, avoid use if possible due to risk of dependence.

HIGH-YIELD FACTS

Sleep Disorders

A 20-year-old college student complains that over the past 4 months, he falls asleep “out of the blue” in the daytime and then has trouble moving his body on awakening. He gets 9 hours of restless sleep every night and denies any substance abuse or significant medical illnesses. Think: Narcolepsy.

Two Concepts

to Distinguish

EDS vs. Fatigue: EDS is falling asleep when you don’t want to (e.g., near misses while driving, at a stop light, after a large meal). This is common with OSA.

Fatigue is being too tired to complete activities.

HIGH-YIELD FACTS

Sleep Disorders

Obstructive sleep apnea— respiratory effort is present, but ventilation disrupted by physical obstruction of airflow

Versus

Central sleep apnea— periodic cessation of respiratory effort

A 50-year-old obese male with hypertension states that he feels very tired and sleepy throughout the day despite getting an adequate amount of sleep during the nighttime. His wife tells you that even she has trouble sleeping due to his loud snoring. Think: Obstructive sleep apnea.

122

OSA RISK FACTORS

􏱦 Male gender

􏱦 Obesity

􏱦 Male shirt collar size ≥ 17

􏱦 Prior upper airway surgeries

􏱦 Deviated nasal septum

􏱦 “Kissing” tonsils

􏱦 Large uvula, tongue

􏱦 Retrognathia

TREATMENT

OSA: Nasal continuous positive airway pressure (nCPAP), weight loss, nasal surgery, or uvulopalatoplasty

CSA: Mechanical ventilation (such as b-PAP) with a backup rate

Circadian Rhythm Sleep Disorder

DIAGNOSIS

Disturbance of sleep due to mismatch between circadian sleep–wake cycle and environmental sleep demands. Subtypes include jet lag type, shift work type, and delayed sleep or advanced sleep phase type.

TREATMENT

􏱦 Jet lag type usually remits untreated after 2 to 7 days

􏱦 Light therapy may be useful for shift work type

􏱦 For shift life, delayed/advanced phase is better

􏱦 Melatonin can be given 51⁄2 hrs before desired bedtime

􏰀 PARASOMNIAS

Nightmare Disorder

DIAGNOSIS

􏱦 Repeated awakenings with recall of extremely frightening dreams

􏱦 Occurs during REM sleep and causes significant distress

EPIDEMIOLOGY

􏱦 Onset most often in childhood

􏱦 May occur more frequently during times of stress or illness

TREATMENT

Usually none, but tricyclics or other agents that suppress total REM sleep may be used

Night Terror Disorder

DIAGNOSIS

Repeated episodes of apparent fearfulness during sleep, usually beginning with a scream and associated with intense anxiety. Episodes usually occur during the first third of the night during stage 3 or 4 sleep (non-REM). Patients are not awake and do not remember the episodes.

EPIDEMIOLOGY/ETIOLOGY

􏱦 Usually occurs in children

􏱦 More common in boys than girls

􏱦 Prevalence: 1 to 6% of children

􏱦 Tends to run in families

􏱦 High association with comorbid sleepwalking disorder

TREATMENT

Usually none, but small doses of diazepam at bedtime may be effective (if nec- essary)

Sleepwalking Disorder (Somnambulism)

DIAGNOSIS

Repeated episodes of getting out of bed and walking, associated with blank stare and difficulty being awakened. Other motor activity may occur, such as getting dressed, talking, or screaming. Behavior usually terminates with pa- tient returning to bed, but patient may awaken with confusion for several minutes. Episodes occur during the first third of the night during stages 3 and 4 sleep and are never remembered.

EPIDEMIOLOGY/ETIOLOGY

􏱦 Onset usually between ages 4 and 8; peak prevalence at age 12

􏱦 More common in boys than girls and tends to run in families

TREATMENT

Measures to prevent injury in surrounding environment

123

Unlike patients with night terror disorder or sleepwalking disorder, patients with nightmare disorder fully awaken and remember the episode.

HIGH-YIELD FACTS

Sleep Disorders

NOTES

HIGH-YIELD FACTS

Sleep Disorders

124

HIGH-YIELD FACTS IN

Sexual Disorders

􏰀 SEXUAL RESPONSE CYCLE

There are several stages of normal sexual response in men and women:

1. Desire: The interest in sexual activity

2. Excitement: Begins with either fantasy or physical contact. It is charac-

terized in men by erections and in women by vaginal lubrication, cli- toral erection, labial swelling, and elevation of the uterus in the pelvis (tenting). Both men and women experience nipple erection and in- creased pulse and blood pressure.

3. Plateau: Characterized in men by increased size of the testicles, tight- ening of the scrotal sac, and secretion of a few drops of seminal fluid. Women experience contraction of the outer one third of the vagina and enlargement of the upper one third of the vagina. Facial flushing and increases in pulse, blood pressure, and respiration occur in both men and women.

4. Orgasm: Men ejaculate and women have contractions of the uterus and lower one third of the vagina.

5. Resolution: Muscles relax and cardiovascular state returns to baseline. Men have a refractory period during which they cannot be brought to orgasm; women have little or no refractory period.

􏰀 SEXUAL CHANGES WITH AGING

The desire for sexual activity does not usually change as people age. However, men usually require more direct stimulation of genitals and more time to achieve orgasm. The intensity of ejaculation usually decreases, and the length of refractory period increases.

After menopause, women experience vaginal dryness and thinning due to de- creased levels of estrogen. These conditions can be treated with hormone re- placement therapy or vaginal creams.

125

HIGH-YIELD FACTS

Sexual Disorders

Dopamine enhances libido; serotonin inhibits libido.

Problems with sexual desire may be due to stress, hostility toward a partner, poor self-esteem, abstinence from sex for a prolonged period, or unconscious fears about sex.

126

􏰀 DIFFERENTIAL DIAGNOSIS OF SEXUAL DYSFUNCTION

Problems with sexual functioning may be due to any of the following:

1. General medical conditions: Examples include history of atherosclero- sis (causing erectile dysfunction from vascular occlusion), diabetes (causing erectile dysfunction from vascular changes and peripheral neuropathy), and pelvic adhesions (causing dyspareunia in women).

2. Abnormal levels of gonadal hormones:

􏱦 Estrogen—decreased levels after menopause cause vaginal dryness

and thinning in women (without affecting desire).

􏱦 Testosterone—promotes libido (desire) in both men and women.

􏱦 Progesterone—inhibits libido in both men and women by blocking

androgen receptors; found in oral contraceptives, hormone replace-

ment therapy, and treatments for prostate cancer.

3. Medication side effects: antihypertensives, anticholinergics, antide-

pressants (especially selective serotonin reuptake inhibitors [SSRIs]), and antipsychotics (block dopamine) may contribute to sexual dys- function.

4. Substance abuse: Alcohol and marijuana enhance sexual desire by sup- pressing inhibitions. (However, long-term alcohol use decreases sexual desire.) Cocaine and amphetamines enhance libido by stimulating dopamine receptors. Narcotics inhibit libido.

5. Presence of a sexual disorder (see below).

6. Depression.

􏰀 SEXUAL DISORDERS

Sexual disorders are problems involving any stage of the sexual response cycle. They all share the following DSM-IV criteria:

􏱦 The disorder causes marked distress or interpersonal difficulty.

􏱦 The dysfunction is not caused by substance use or a general medical

condition.

The most common sexual disorders in women are sexual desire disorder and orgasmic disorder. The most common disorders in men are secondary erectile disorder and premature ejaculation. Psychological causes of sexual disorders include:

􏱦 Interpersonal problems with sexual partner

􏱦 Guilt about sexual activity (often in persons with religious or puritani-

cal upbringing)

􏱦 Fears (pregnancy, rejection, loss of control, etc.)

Disorders of Desire

􏱦 Hypoactive sexual desire disorder—absence or deficiency of sexual desire or fantasies (occurs in up to 20% of general population and is more common in women)

􏱦 Sexual aversion disorder—avoidance of genital contact with a sexual partner

Disorders of Arousal (Excitement and Plateau)

Stress, fear, fatigue, anxiety, and feelings of guilt may contribute to both erec- tile disorder in men and sexual arousal disorder in women.

􏱦 Male erectile disorder—inability to attain an erection. May be primary (never had one) or secondary (acquired after previous ability to main- tain erections). Secondary erectile disorder is common and occurs in 10 to 20% of men.

􏱦 Female sexual arousal disorder—inability to maintain lubrication until completion of sex act (high prevalence—up to 33% of women)

Disorders of Orgasm

Both male and female orgasmic disorders may be either primary (never achieved orgasm) or secondary (acquired). Causes may include relationship problems, guilt, stress, and so on.

􏱦 Female orgasmic disorder: Inability to have an orgasm after a normal ex- citement phase. The estimated prevalence in women is 30%.

􏱦 Male orgasmic disorder: Achieves orgasm with great difficulty, if at all; much lower incidence than impotence or premature ejaculation

􏱦 Premature ejaculation: Ejaculation earlier than desired time (before or immediately upon entering the vagina). High prevalence—up to 35% of all male sexual disorders; may be caused by fears, guilt, or perfor- mance anxiety

Sexual Pain Disorders

􏱦 Dyspareunia: Genital pain before, during, or after sexual intercourse; much higher incidence in women than men; often associated with vaginismus (see below)

􏱦 Vaginismus: Involuntary muscle contraction of the outer third of the vagina during insertion of penis or object (such as speculum or tam- pon); increased incidence in higher socioeconomic groups and in women of strict religious upbringing

􏰀 TREATMENT OF SEXUAL DISORDERS Dual Sex Therapy

Dual sex therapy utilizes the concept of the marital unit, rather than the indi- vidual, as the target of therapy. Couples meet with a male and female thera- pist together in four-way sessions to identify and discuss their sexual problems. Therapists suggest sexual exercises for the couple to attempt at home; activi- ties initially focus on heightening sensory awareness and progressively incor- porate increased levels of sexual contact. Treatment is short term.

Behavior Therapy

Behavior therapy approaches sexual dysfunction as a learned maladaptive be- havior. It utilizes traditional therapies such as systematic desensitization, where patients are progressively exposed to increasing levels of stimuli that

Male erectile disorder is commonly referred to as impotence. In men who have erections in the morning and during masturbation, the etiology is usually psychological rather than physical.

HIGH-YIELD FACTS

In young, sexually inexperienced men (who have shorter refractory periods), premature ejaculation disorder may resolve gradually over time without treatment.

Sexual Disorders

127

HIGH-YIELD FACTS

Sexual Disorders

128

provoke their anxiety. Eventually, patients are able to respond appropriately to the stimuli. Other forms of behavioral therapy include muscle relaxation techniques, assertiveness training, and prescribed sexual exercises to try at home.

Hypnosis

Most often used adjunctively with other therapies

Group Therapy

May be used as primary or adjunctive therapy

Analytically Oriented Psychotherapy

Individual, long-term therapy that focuses on feelings, fears, dreams, and in- terpersonal problems that may be contributing to sexual disorder

Others

Specific techniques for various dysfunctions:

Sexual desire disorder: Testosterone (if levels are low)

Erectile disorder: Yohimbine, sildenafil (Viagra), self-injection of vasoac- tive substances (such as alprostadil), vacuum pumps, constrictive rings, prosthetic surgery (last resort)

Female sexual arousal disorder: Release of clitoral adhesions (if necessary) Male orgasmic disorder: Gradual progression from extravaginal ejaculation (via masturbation) to intravaginal

Female orgasmic disorder: Masturbation (sometimes with vibrator) Premature ejaculation:

􏱦 The squeeze technique is used to increase the threshold of excitability.

When the man has been excited to near ejaculation, he or his sexual partner is instructed to squeeze the glans of his penis in order to prevent ejaculation. Gradually, he gains awareness about his sexual sensations and learns to achieve greater ejaculatory control.

􏱦 The stop–start technique involves cessation of all penile stimulation when the man is near ejaculation. This technique functions in the same manner as the squeeze technique.

􏱦 Pharmacotherapy: Side effects of drugs including SSRIs and tricyclics may prolong sexual response.

Dyspareunia: Gradual desensitization to achieve intercourse, starting with muscle relaxation techniques, progressing to erotic massage, and finally achieving sexual intercourse

Vaginismus: Women may obtain some relief by dilating their vaginas regu- larly with their fingers or a dilator.

􏰀 PARAPHILIAS

Paraphilias are sexual disorders characterized by engagement in unusual sexual activities (and/or preoccupation with unusual sexual urges or fantasies) for at least 6 months that cause impairment in daily functioning. Paraphilic fan- tasies alone are not considered disorders unless they are intense, recurrent, and interfere with daily life; occasional fantasies are considered normal com- ponents of sexuality (even if unusual).

Only a small percentage of people suffer from paraphilias. Most paraphilias oc- cur only in men, but sadism, masochism, and pedophilia may also occur in women. The most common paraphilias are pedophilia, voyeurism, and exhibi- tionism.

Examples of Paraphilias

􏱦 Pedophilia: Sexual gratification from fantasies or behaviors involving sexual acts with children (most common paraphilia)

􏱦 Voyeurism: Watching unsuspecting nude individuals (often with binoculars) in order to obtain sexual pleasure

􏱦 Exhibitionism: Exposure of one’s genitals to strangers

􏱦 Fetishism: Sexual preference for inanimate objects (e.g., shoes or

pantyhose)

􏱦 Transvestic fetishism: Sexual gratification in men (usually heterosex-

ual) from wearing women’s clothing (especially underwear)

􏱦 Frotteurism: Sexual pleasure in men from rubbing their genitals against unsuspecting women; usually occurs in a crowded area (such as subway)

􏱦 Masochism: Sexual excitement from being humiliated or beaten

􏱦 Sadism: Sexual excitement from hurting or humiliating another

􏱦 Necrophilia: Sexual pleasure from engaging in sexual activity with

dead people

􏱦 Telephone scatologia: Sexual excitement from calling unsuspecting

women and engaging in sexual conversations with them

COURSE AND PROGNOSIS

Poor prognostic factors are early age of onset, comorbid substance abuse, high frequency of behavior, and referral by law enforcement agencies (after arrest).

Good prognostic factors are self-referral for treatment, sense of guilt associated with the behavior, and history of otherwise normal sexual activity in addition to the paraphilia.

TREATMENT

􏱦 Insight-oriented psychotherapy: Most common method. Patients gain insight into the stimuli that cause them to act as they do.

􏱦 Behavior therapy: Aversive conditioning used to disrupt the learned abnormal behavior by coupling the impulse with an unpleasant stimulus such as an electric shock.

􏱦 Pharmacologic therapy: Antiandrogens have been used to treat hyper- sexual paraphilias in men.

129

HIGH-YIELD FACTS

Sexual Disorders

Biological sex is one’s physiological sex as determined by genetic or anatomic factors. Gender identity is one’s internal, subjective feeling of being either male or female and usually develops by age 3.

HIGH-YIELD FACTS

Sexual Disorders

130

􏰀 GENDER IDENTITY DISORDER

Gender identity disorder is commonly referred to as transsexuality. People with this disorder have the subjective feeling that they were born the wrong sex. They may dress as the opposite sex, take sex hormones, or undergo sex change operations.

Gender identity disorder is more common in men than women. It is associ- ated with an increased incidence of major depression, anxiety disorders, and suicide.

􏰀 HOMOSEXUALITY

Homosexuality is a sexual or romantic desire for people of the same sex. It is a normal variant of sexual orientation. It occurs in 3 to 10% of men and 1 to 5% of women. The etiology of homosexuality is unknown, but genetic or pre- natal factors may play a role.

Distress about one’s sexual orientation is considered a dysfunction that should be treated with individual psychotherapy and/or group therapy.

HIGH-YIELD FACTS IN

Psychotherapies

􏰀 PSYCHOANALYSIS AND RELATED THERAPIES

Psychoanalysis and its related therapies are derived from Sigmund Freud’s psy- choanalytic theories of the mind. Freud proposed that behaviors result from unconscious mental processes, including defense mechanisms and conflicts be- tween one’s ego, id, superego, and external reality. Since the time of Freud, many other psychoanalytic theories have been developed. Influential theorists have included Melanie Klein, Heinz Kohut, Michael Blaint, Margaret Mahler, and others.

Examples of psychoanalytic therapies include: 􏱦 Psychoanalysis

􏱦 Psychoanalytically oriented psychotherapy

􏱦 Brief dynamic therapy

􏱦 Interpersonal therapy

􏰀 FREUD’S THEORIES OF THE MIND Topographic Theories

1. Unconscious—includes repressed thoughts that are out of one’s aware- ness; involves primary process thinking (primitive, pleasure-seeking urges with no regard to logic or time, prominent in children and psy- chotics)

2. Preconscious—contains memories that are easy to bring into awareness

3. Conscious—involves current thoughts and secondary process thinking

(logical, mature, and can delay gratification)

Structural Theories

1. Id—unconscious; involves instinctual sexual/aggressive urges and pri- mary process thinking

2. Ego—serves as a mediator between the id and external environment and seeks to develop satisfying interpersonal relationships; uses defense mechanisms (see below) to control instinctual urges and distinguishes

131

Normal development:

􏱦 Idpresentatbirth

􏱦 Egopresentafterbirth 􏱦 Superegopresentby

age 6

HIGH-YIELD FACTS

Psychotherapies

132

fantasy from reality using reality testing. Problems with reality testing

occur in psychotic individuals. 3. Superego—moral conscience

􏰀 DEFENSE MECHANISMS

Defense mechanisms are used by the ego to protect oneself and relieve anxiety by keeping conflicts out of awareness. They are unconscious processes that are normal and healthy when used in moderation. However, excessive use of cer- tain defense mechanisms may be seen in some psychiatric disorders.

Defense mechanisms are often classified hierarchically. Mature defense mecha- nisms are healthy and adaptive, and they are seen in normal adults. Neurotic defenses are encountered in obsessive–compulsive patients, hysterical patients, and adults under stress. Immature defenses are seen in children, adolescents, psychotic patients, and some nonpsychotic patients. They are the most primi- tive defense mechanisms.

Mature Defenses

1. Altruism—performing acts that benefit others in order to vicariously experience pleasure

2. Humor—expressing feelings through comedy without causing discom- fort to self or others

3. Sublimation— satisfying socially objectionable impulses in an accept- able manner (thus channeling them rather than preventing them) (Clini- cal example: Person with unconscious urges to physically control others becomes a prison guard.)

4. Suppression—purposely ignoring an unacceptable impulse or emotion in order to diminish discomfort and accomplish a task (Clinical exam- ple: Nurse who feels nauseated by an infected wound puts aside feelings of disgust to clean wound and provide necessary patient care.)

Neurotic Defenses

1. Controlling—regulating situations and events of external environ- ment to relieve anxiety

2. Displacement—shifting emotions from an undesirable situation to one that is personally tolerable (Clinical example: Student who is angry at his mother talks back to his teacher the next day and refuses to obey her instructions.)

3. Intellectualization—avoiding negative feelings by excessive use of in- tellectual functions and by focusing on irrelevant details or inanimate objects (Clinical example: Physician dying from colon cancer describes the pathophysiology of his disease in detail to his 12-year-old son.)

4. Isolation of affect—unconsciously limiting the experience of feelings or emotions associated with a stressful life event in order to avoid anxi- ety (Clinical example: Woman describes the recent death of her beloved husband without emotion.)

5. Rationalization—creating explanations of an event in order to justify outcomes or behaviors and to make them acceptable. (Clinical example:

“My boss fired me today because she’s short-tempered and impulsive,

not because I haven’t done a good job.”)

6. Reaction formation—doing the opposite of an unacceptable impulse

(Clinical example: Man who is in love with his coworker insults her.)

7. Repression—preventing a thought or feeling from entering conscious- ness (Repression is unconscious, whereas suppression is a conscious

act.)

Immature Defenses

1. Acting out—giving in to an impulse, even if socially inappropriate, in order to avoid the anxiety of suppressing that impulse (Clinical exam- ple: Man who has been told his therapist is going on vacation “forgets” his last appointment and skips it.)

2. Denial—not accepting reality that is too painful (Clinical example: Woman who has been scheduled for a breast mass biopsy cancels her appointment because she believes she is healthy.)

3. Regression—performing behaviors from an earlier stage of develop- ment in order to avoid tension associated with current phase of devel- opment (Clinical example: Woman brings her childhood teddy bear to the hospital when she has to spend the night.)

4. Projection—attributing objectionable thoughts or emotions to others (Clinical example: Husband who is attracted to other women believes his wife is having an affair.)

Other Defense Mechanisms

1. Splitting—labeling people as all good or all bad (often seen in border- line personality disorder) (Clinical example: Woman who tells her doc- tor, “you and the nurses are the only people who understand me; all the other doctors are mean and impatient.”)

2. Undoing—attempting to reverse a situation by adopting a new behav- ior (Clinical example: Man who has had a brief fantasy of killing his wife by sabotaging her car takes the car in for a complete checkup.)

􏰀 PSYCHOANALYSIS

The goal of psychoanalysis is to resolve unconscious conflicts by bringing re- pressed experiences and feelings into awareness and integrating them into the patient’s personality. Psychoanalysis is therefore insight oriented. Patients best suited for psychoanalysis have the following characteristics: Under age 40, not psychotic, intelligent, and stable in relationships and daily living.

Psychoanalysis may be useful in the treatment of:

􏱦 Personality disorders

􏱦 Anxiety disorders

􏱦 Obsessive–compulsive disorder

􏱦 Problems coping with life events

􏱦 Anorexia nervosa

􏱦 Sexual disorders

􏱦 Dysthymic disorder

HIGH-YIELD FACTS

Beware when your patient thinks you’re so cool to talk to but hates the evil attending. That’s splitting. Impress your attending and point it out.

Psychotherapies

133

HIGH-YIELD FACTS

Psychotherapies

134

During treatment, the patient usually lies on a couch with the therapist seated out of view. Patients attend sessions four to five times a week for multiple years.

Important Concepts and Techniques Used in Psychoanalysis

Free association: the patient is asked to say whatever comes into his or her mind during therapy sessions. The purpose is to bring forth thoughts and feelings from the unconscious so that the therapist may interpret them. Dream interpretation: Dreams are seen to represent conflict between urges and fears. Interpretation of dreams by the psychoanalyst is used to help achieve therapeutic goals.

Therapeutic alliance: This is the bond between the therapist and the pa- tient, who work together toward a therapeutic goal.

Transference: Projection of unconscious feelings about important figures in the patient’s life onto the therapist. Interpretation of transference is used to help the patient gain insight and resolve unconscious conflict. (Ex- ample: Patient who has repressed feelings of abandonment by her father be- comes angry when her therapist is 5 minutes late for an appointment.) Countertransference: Projection of unconscious feelings about important figures in the therapist’s life onto the patient. The therapist must remain aware of countertransference issues, as they may interfere with his or her objectivity.

Psychoanalysis-Related Therapies

Examples of psychoanalysis-related therapies include:

1. Psychoanalytically oriented psychotherapy and brief dynamic psychotherapy: These employ similar techniques and theories as psychoanalysis, but they are briefer (weekly sessions for 6 months to 11⁄2 years) and involve face-to-face sessions between the therapist and patient (no couch).

2. Interpersonal therapy: Focuses on development of social skills to help treat certain psychiatric disorders. Treatment is short (weekly sessions for 3 to 6 months). Idea is to improve interpersonal relations.

3. Supportive psychotherapy: Purpose is to help patient feel safe during a diffi- cult time. Treatment is not insight oriented but instead focuses on empa- thy, understanding, and education. Supportive therapy is commonly used as adjunctive treatment in even the most severe mental disorders. Helps to build up the patient’s healthy defenses. Dependency is encouraged.

􏰀 BEHAVIORAL THERAPY

Behavioral therapy seeks to treat psychiatric disorders by helping patients change behaviors that contribute to their symptoms. It can be used to extin- guish maladaptive behaviors (such as phobias, sexual dysfunction, compul- sions, etc.) by replacing them with healthy alternatives.

Learning Theory

Behavioral therapy is based on learning theory, which states that behaviors can be learned by conditioning and can similarly be unlearned by deconditioning.

Conditioning

Classical conditioning: A stimulus can eventually evoke a conditioned re- sponse. (Example: Pavlov’s dog would salivate when hearing a bell because the dog had learned that bells were always followed by food.)

Operant conditioning: Behaviors can be learned when followed by positive or negative reinforcement. (Example: Skinner’s box—a rat happened upon a lever and received food; eventually it learned to press the lever for food [trial-and-error learning].)

Behavioral Therapy Techniques (Deconditioning)

Systemic desensitization: The patient performs relaxation techniques while being exposed to increasing doses of an anxiety-provoking stimulus. Gradually, he or she learns to associate the stimulus with a state of relax- ation. Commonly used to treat phobic disorders. (Example: A patient who has a fear of spiders is first shown a photograph of a spider, followed by a stuffed animal, a videotape, and finally a live spider.)

Flooding and implosion: Through habituation, the patient is confronted with a real (flooding) or imagined (implosion) anxiety-provoking stimulus and not allowed to withdraw from it until he or she feels calm and in con- trol. Relaxation exercises are used to help the patient tolerate the stimu- lus. Commonly used to treat phobic disorders. (Example: A patient who has a fear of flying is made to fly in an airplane [flooding] or imagine flying [implosion].)

Aversion therapy: A negative stimulus (such as an electric shock) is re- peatedly paired with a specific behavior to create an unpleasant response. Commonly used to treat addictions or paraphilias. (Example: An alcoholic patient is prescribed Antabuse, which makes him ill every time he drinks alcohol.)

Token economy: Rewards are given after specific behaviors to positively reinforce them. Commonly used to encourage showering, shaving, and other positive behaviors in disorganized or mentally retarded individuals. Biofeedback: Physiological data (such as heart rate or blood pressure mea- surements) are given to patients as they try to mentally control physiolog- ical states. Commonly used to treat migraines, hypertension, chronic pain, asthma, and incontinence. (Example: A patient is given her heart rate and blood pressure measurements during a migraine while being in- structed to mentally control visceral changes that affect her pain.)

􏰀 COGNITIVE THERAPY

Cognitive therapy seeks to correct faulty assumptions and negative feelings that exacerbate psychiatric symptoms. The patient is taught to identify mal- adaptive thoughts and replace them with positive ones. Most commonly used to treat depressive and anxiety disorders. May also be used for paranoid per- sonality disorder, obsessive–compulsive disorder, somatoform disorders, and eating disorders. Cognitive therapy can be more effective than medication.

HIGH-YIELD FACTS

Psychotherapies

135

HIGH-YIELD FACTS

Psychotherapies

136

Clinical Example of the Cognitive Theory of Depression

Faulty assumptions: If I were smart I would do well on tests. I must not be smart since I received average grades this semester.

Faulty assumptions lead to:

Negative thoughts: I am stupid. I will never amount to anything worth- while. Nobody likes a worthless person.

Negative thoughts then lead to: Psychopathology: Depression

􏰀 GROUP THERAPY

Three or more patients with a similar problem or pathology meet together with a therapist for group sessions. Any of the psychotherapeutic techniques may be employed, including psychoanalytical, behavioral, cognitive, educa- tional, and so on.

Certain groups are leaderless (including 12-step groups like Alcoholics Anony- mous) and do not have a therapist present to facilitate the group. These groups meet to discuss problems, share feelings, and provide support to each other.

Group therapy is especially useful in the treatment of substance abuse, adjust- ment disorders, and personality disorders. Advantages of group therapy over individual therapy include:

􏱦 Patients get immediate feedback from their peers.

􏱦 Patients may gain insight into their own condition by listening to oth-

ers with similar problems.

􏱦 If a therapist is present, there is an opportunity to observe interactions

between others who may be eliciting a variety of transferences.

􏰀 FAMILY THERAPY

Family therapy is useful as an adjunctive treatment in many psychiatric condi-

tions because:

1. A person’s problems usually affect the entire family. He or she may be viewed differently and treated differently after the development of psy- chopathology, and new tensions and conflicts within the family may arise.

2. Psychopathology may arise partly or entirely from dysfunction within the family unit. These conditions are most effectively treated with the entire family present.

The goals of family therapy are to reduce conflict, help members understand each other’s needs (mutual accommodation), and help the unit cope with inter- nally destructive forces. Boundaries between family members may be too rigid or too permeable, and “triangles” may result when two family members form an alliance against a third member. The therapist may assist in correcting these problems as well. (Example of boundaries that may be too permeable:

Mother and daughter smoke marijuana together and share intimate details about their sexual activities.)

􏰀 MARITAL THERAPY

Marital therapy is useful in the treatment of conflicts, sexual problems, and communication problems. Usually, the therapist sees the couple together (conjoint therapy), but they may be seen separately (concurrent therapy). In addition, each person may have a separate therapist and be seen individually (collaborative therapy). In the treatment of sexual problems, two therapists may each see the couple together (four-way therapy). Relative contraindica- tions include lack of motivation by one or both spouses and severe illness in one of the spouses, such as psychosis.

DIALECTICAL BEHAVIORAL THERAPY

Developed by Marsha Linehan, effectiveness demonstrated in research control study.

􏱦 Specific treatment for borderline personality disorder

􏱦 Teaches coping skills with both individual and group therapy

􏱦 1- to 2-year commitment required; treatment usually 2 to 3 times per

week

􏱦 Solution-focused therapy

􏱦 Main goals:

1. Reduce self-injurious behaviors

2. Decrease hospitalizations

􏱦 Key topics patient is taught to use in everyday life:

1. Mindfulness

2. Interpersonal effectiveness 3. Emotion regulation

4. Distress tolerance

HIGH-YIELD FACTS

137

Psychotherapies

NOTES

HIGH-YIELD FACTS

Psychotherapies

138

HIGH-YIELD FACTS IN

Psychopharmacology

􏰀 ANTIDEPRESSANTS

The major categories of antidepressants are:

􏱦 Tricyclic antidepressants (TCAs)

􏱦 Monoamine oxidase inhibitors (MAOIs)

􏱦 Selective serotonin reuptake inhibitors (SSRIs)

􏱦 Atypical antidepressants

All antidepressants are considered equally effective in treating major depres- sion but differ in safety and side effect profiles. About 70% of patients with major depression will respond to antidepressant medication. Antidepressants have no abuse potential and do not elevate mood.

Because of their safety and tolerability, SSRIs and atypical antidepressants have become the most common agents used to treat major depression. How- ever, the choice of a particular medication used for a given patient should be made based on:

􏱦 Patient’s symptoms

􏱦 Previous treatment responses by the patient or a family member to a

particular drug

􏱦 Medication side effect profile

􏱦 Comorbid conditions

􏱦 Risk of suicide

OTHER DISORDERS FOR WHICH ANTIDEPRESSANTS ARE USED

Obsessive–compulsive disorder (OCD): SSRIs, TCAs Panic disorder: SSRIs, TCAs, MAOIs

Eating disorders: SSRIs, TCAs, and MAOIs Dysthymia: SSRIs

Social phobia: MAOIs and SSRIs

Posttraumatic stress disorder: SSRIs, TCAs

Irritable bowel syndrome: SSRIs, TCAs

Enuresis: TCAs

Neuropathic pain: TCAs

Migraine headaches: TCAs, SSRIs, bupropion

Smoking cessation: Bupropion

Autism: SSRIs

Premenstrual dysphoric disorder: SSRIs

Depressive phase of manic depression: SSRIs, bupropion Insomnia: Mirtazapine, TCAs

Sympathomimetics

(amphetamine-based drugs) may be effective in patients who cannot tolerate or do not

respond to traditional antidepressant medications. However, they are used only rarely due to their addiction potential. Use should be short term and carefully monitored.

139

The hallmark of TCA toxicity is a widened QRS (>100 msec), used as threshold to treatment.

HIGH-YIELD FACTS

The mainstay of treatment for TCA overdose is IV sodium bicarbonate.

TCA side effects:

Anti-HAM (histamine, adrenergic, muscarinic)

Psychopharmacology

140

Tricyclic Antidepressants (TCAs)

TCAs inhibit the reuptake of norepinephrine and serotonin, increasing avail- ability in the synapse. They are rarely used as first-line agents because they have a higher incidence of side effects, require greater monitoring of dosing, and can be lethal in overdose.

Patients are usually started on low doses to allow acclimation to the common early anticholinergic side effects before achieving therapeutic doses. Examples of TCAs include:

􏱦 Imipramine (Tofranil)

􏱦 Amitriptyline (Elavil)

􏱦 Trimipramine (Surmontil)

􏱦 Nortriptyline (Pamelor)—least likely to cause orthostatic hypotension

􏱦 Desipramine (Norpramin)—least sedating, least anticholinergic side

effects

􏱦 Clomipramine (Anafranil)—most serotonin specific, useful in treat-

ment of OCD

􏱦 Doxepin (Sinequan) SIDE EFFECTS

The side effects of TCAs are mostly due to their lack of specificity and inter- action with other receptors.

1. Antihistaminic properties: Sedation

2. Antiadrenergic properties (cardiovascular side effects): Orthostatic hy-

potension (most life threatening), tachycardia, arrhythmias

3. Antimuscarinic effects: Dry mouth, constipation, urinary retention,

blurred vision, tachycardia

4. Weight gain

5. Lethal in overdose—must assess suicide risk!! A 1-week supply of

these drugs can be lethal in overdose.

6. Major complications—3Cs: Convulsions, coma, cardiotoxicity. Avoid

in patients with preexisting conduction abnormalities.

Monoamine Oxidase Inhibitors (MAOIs)

MAOIs prevent the inactivation of biogenic amines such as norepinephrine, serotonin, dopamine, and tyramine (an intermediate in the conversion of tyro- sine to norepinephrine). By irreversibly inhibiting the enzymes MAO-A and -B, MAOIs increase the amount of these transmitters available in synapses. MAO-A preferentially deactivates serotonin, and MAO-B preferentially de- activates norepinephrine/epinephrine. Both types also act on dopamine and tyramine.

MAOIs are not used as first-line agents because of the increased safety and tolerability of newer agents. However, MAOIs are considered very effective for certain types of refractory depression and in refractory panic disorder.

Examples: Phenelzine (Nardil), tranylcypromine (Parnate), isocarboxazid (Marplan)

SIDE EFFECTS

􏱦 Common side effects: Orthostatic hypotension, drowsiness, weight gain, sexual dysfunction, dry mouth, sleep dysfunction

􏱦 Serotonin syndrome occurs when SSRIs and MAOIs are taken together. Initially characterized by lethargy, restlessness, confusion, flushing, di- aphoresis, tremor, and myoclonic jerks. May progress to hyperthermia, hypertonicity, rhabdomyolysis, renal failure, convulsions, coma, and death. Wait at least 2 weeks before switching from SSRI to MAOI.

􏱦 Hypertensive crisis: Risk when MAOIs are taken with tyramine-rich foods or sympathomimetics. Foods with tyramine (red Chianti wine, cheese, chicken liver, fava beans, cured meats) cause a buildup of stored catecholamines.

Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs inhibit presynaptic serotonin pumps, leading to increased availability of serotonin in synaptic clefts. SSRIs all have similar efficacy and side effects de- spite structural differences. They are the most commonly prescribed antide- pressants due to several distinct advantages:

􏱦 Low incidence of side effects

􏱦 No food restrictions

􏱦 Much safer in overdose

SSRIs are also used in the treatment of some anxiety disorders, OCD, and premenstrual dysphoric disorder.

Examples of SSRIs include:

􏱦 Fluoxetine (Prozac)—longest half-life with active metabolites: Do not

need to taper

􏱦 Sertraline (Zoloft)—highest risk for gastrointestinal (GI) disturbances

􏱦 Paroxetine (Paxil)—most serotonin specific, most activating (stimu-

lant)

􏱦 Fluvoxamine (Luvox)—currently approved only for use in OCD

􏱦 Citalopram (Celexa)—used in Europe for 12 years prior to FDA ap-

proval in the United States

􏱦 Escitalopram (Lexapro)—levo enantiomer of citalopram; similar effi-

cacy, fewer side effects, much more expensive

SIDE EFFECTS

SSRIs have significantly fewer side effects than TCAs and MAOIs due to serotonin selectivity (they do not act on histamine, adrenergic, or muscarinic receptors).

Side effects of SSRIs include:

􏱦 Sexual dysfunction (25 to 30%)

􏱦 GI disturbance

􏱦 Insomnia

􏱦 Headache

􏱦 Anorexia, weight loss

􏱦 Serotonin syndrome when used with MAOIs (see above)

Atypical Antidepressants

Include serotonin/norepinephrine reuptake inhibitors (SNRIs), norepineph- rine/dopamine reuptake inhibitors (NDRIs), serotonin antagonist and reup- take inhibitors (SARIs), and norepinephrine and serotonin antagonists (NASAs)

First step when suspecting serotonin syndrome: Discontinue medication

141

Sympathomimetics may be found in over-the-counter cold remedies.

HIGH-YIELD FACTS

Psychopharmacology

HIGH-YIELD FACTS

Bupropion can lower seizure threshold. Use with caution in epileptics.

Trazodone causes priapism: tRAZodone will RAISE the bone.

Psychopharmacology

142

SNRIS

Venlafaxine (Effexor): Venlafaxine is especially useful in treating refractory depression and CAP. It has a very low drug interaction potential. Side effect profiles similar to SSRIs (see above). In addition, venlafaxine can increase BP; do not use in patients with untreated or labile BP. Potential withdrawal symptoms can be seen with 1–3 missed doses; not life threatening, but very uncomfortable (including flulike symptoms and electric-like shocks or zaps).

NDRIS

Bupropion (Wellbutrin): Bupropion is commonly used to aid in smoking ces- sation, and it is also useful in the treatment of seasonal affective disorder and adult attention deficit hyperactivity disorder (ADHD). Its most significant ad- vantage is its relative lack of sexual side effects as compared to the SSRIs. Bupropion’s dopaminergic effect in higher doses can exacerbate psychosis. Side effects are similar to SSRIs, with increased sweating and increased risk of seizures and psychosis at high doses. They are not optimal for patients with significant anxiety and are contraindicated in patients with seizure or active eating disorders and in those currently on an MAOI.

SARIS

Nefazodone (Serzone) and trazodone (Desyrel): These are especially useful in treatment of refractory major depression, major depression with anxiety, and insomnia (secondary to its sedative effects). Side effects include nausea, dizziness, orthostatic hypotension, cardiac arrhythmias, sedation, and pri- apism (sedation and priapism especially with trazodone).

NASAS

Mirtazapine (Remeron): Useful in the treatment of refractory major depres- sion, especially in patients who need to gain weight. Side effects include seda- tion, weight gain, dizziness, somnolence, tremor, and agranulocytosis. Maxi- mal sedative effect at doses of 15 mg and less; at higher doses, it increases norepinephrine upake and is therefore less sedating.

􏰀 ANTIPSYCHOTICS

Antipsychotics are used to treat psychotic disorders and psychotic symptoms associated with other psychiatric and medical illnesses. Traditional antipsy- chotics are classified according to potency and work by blocking dopamine re- ceptors. Atypical (newer) antipsychotics block both dopamine and serotonin receptors; however, their effect on dopamine is weaker, so they are associated with fewer side effects.

Traditional Antipsychotics

Low potency: Have a lower affinity for dopamine receptors and therefore a higher dose is required. Remember, potency refers to the action on dopamine receptors, not the level of efficacy.

􏱦 Chlorpromazine (Thorazine)

􏱦 Thioridazine (Mellaril)

These antipsychotics have a higher incidence of anticholinergic and antihis- taminic side effects than high-potency traditional antipsychotics. They have a lower incidence of extrapyramidal side effects (EPSEs) and neuroleptic malig- nant syndrome. (See below for detailed description of side effects.)

High potency: Have greater affinity for dopamine receptors, and therefore a relatively low dose is needed to achieve effect.

􏱦 Haloperidol (Haldol)

􏱦 Fluphenazine (Prolixin)

􏱦 Trifluoperazine (Stelazine)

􏱦 Perphenazine (Trilafon)

􏱦 Pimozide (Orap)

These antipsychotics have a higher incidence of EPSEs and neuroleptic ma- lignant syndrome than low-potency traditional antipsychotics (see below). They have a lower incidence of anticholinergic and antihistaminic side ef- fects.

Both traditional and atypical neuroleptics have similar efficacies in treating the presence of positive psychotic symptoms, such as hallucinations and delu- sions; atypical antipsychotics have been shown to be more effective in treat- ing negative symptoms (such as flattened affect and social withdrawal).

SIDE EFFECTS OF TRADITIONAL ANTIPSYCHOTICS

Side effects and sequelae of traditional antipsychotics include:

1. Antidopaminergic effects:

􏱦 Extrapyramidal side effects

􏱦 Parkinsonism—masklike face, cogwheel rigidity, pill-rolling tremor.

􏱦 Akathisia—subjective anxiety and restlessness, objective fidgeti-

ness

􏱦 Dystonia—sustained contraction of muscles of neck, tongue, eyes

(painful)

􏱦 Hyperprolactinemia—leading to decreased libido, galactorrhea,

gynecomastia, impotence, amenorrhea, osteoporosis

Treatment of EPSEs includes reducing dose of antipsychotic and administer- ing antiparkinsonian, anticholinergic, or antihistaminic medications, such as amantadine (Symmetrel), Benadryl, or benztropine (Cogentin).

2. Anti-HAM effects: Caused by actions on histaminic, adrenergic, and muscarinic receptors:

􏱦 Antihistaminic—results in sedation

􏱦 Anti–alpha adrenergic—results in orthostatic hypotension, cardiac ab-

normalities, and sexual dysfunction

􏱦 Antimuscarinic—anticholinergic effects: Dry mouth, tachycardia, uri-

nary retention, blurry vision, constipation

3. Weight gain

4. Elevated liver enzymes, jaundice

5. Ophthalmologic problems (irreversible retinal pigmentation with high

doses of Mellaril, deposits in lens and cornea with chlorpromazine)

6. Dermatologic problems, including rashes and photosensitivity (blue-

gray skin discoloration with chlorpromazine)

7. Seizures: Antipsychotics lower seizure thresholds. Low-potency an-

tipsychotics are more likely to cause seizures than high potency.

Haloperidol and fluphenazine are also available in long-acting forms (decanoate)— administer IM every 2 to 3 weeks for fluphenazine and 4to5weeksfor haloperidol.

Dopamine normally inhibits prolactin and acetylcholine secretion.

143

Tardive dyskinesia hypothesized to be caused by increase in number of dopamine receptors, causing lower levels of acetylcholine.

Young man admitted to hospital and put on antipsychotic becomes catatonic and will not get out of bed. Next step: Stop medications.

HIGH-YIELD FACTS

Psychopharmacology

Neuroleptic malignant syndrome: FALTER Fever

Autonomic instability Leukocytosis

Tremor Elevated CPK Rigidity

HIGH-YIELD FACTS

Psychopharmacology

Quetiapine and ziprasidone both have FDA approval for treatment of mania.

Patients on clozapine must have weekly blood draws to check white blood cell counts because it can cause agranulocytosis.

144

8. Tardive dyskinesia: Choreoathetoid (writhing) movements of mouth and tongue that may occur in patients who have used neuroleptics for more than 6 months. It most often occurs in older women. Though 50% of cases will spontaneously remit, untreated cases may be perma- nent.

Treatment involves discontinuation of current antipsychotic if clinically pos- sible (and sometimes administration of anxiolytics or cholinomimetics).

9. Neuroleptic malignant syndrome: Though rare, occurs most often in males early in treatment with neuroleptics. It is a medical emergency and has a 20% mortality rate if left untreated. It is often preceded by a catatonic state. It is characterized by:

Fever (most common presenting symptom)

Autonomic instability (tachycardia, labile hypertension, diaphoresis) Leukocytosis

Tremor

Elevated creatine phosphokinase (CPK)

Rigidity (lead pipe rigidity is considered almost universal)

Treatment involves discontinuation of current medications and administra- tion of supportive medical care (hydration, cooling, etc.). Sodium dantrolene, bromocriptine, and amantadine are also useful but are infrequently used be- cause of their own side effects. This is not an allergic reaction. Patient is not prevented from restarting the same neuroleptic at a later time.

Atypical Antipsychotics

Atypical antipsychotics block both dopamine and serotonin receptors and are associated with fewer side effects than traditional antipsychotics; in particu- lar, they rarely cause EPSEs, tardive dyskinesia, or neuroleptic malignant syn- drome. They are more effective in treating negative symptoms of schizophre- nia than traditional antipsychotics. Because they have fewer side effects and increased effectiveness in treating negative symptoms, these drugs are now first line in the treatment of schizophrenia.

EXAMPLES

Atypical antipsychotics include:

􏱦 Clozapine (Clozaril)

􏱦 Risperidone (Risperdal)

􏱦 Quetiapine (Seroquel)

􏱦 Olanzapine (Zyprexa)

􏱦 Ziprasidone (Geodon)

SIDE EFFECTS

􏱦 Some anti-HAM effects (antihistaminic, antiadrenergic, and antimus- carinic)

􏱦 1% incidence of agranulocytosis and 2 to 5% incidence of seizures with clozapine

􏱦 Olanzapine can cause hyperlipidemia, glucose intolerance, weight gain, and liver toxicity; monitor liver function tests (LFTs).

􏱦 Quetiapine has less propensity for weight gain but has been shown to cause cataracts in beagle dogs, so periodic (every 6 months) slit lamp examination is recommended.

􏰀 MOOD STABILIZERS

Mood stabilizers are also known as antimanics and are used to treat acute ma- nia and to help prevent relapses of manic episodes. Less commonly, they may be used for:

􏱦 Potentiation of antidepressants in patients with major depression refrac- tory to monotherapy

􏱦 Potentiation of antipsychotics in patients with schizophrenia

􏱦 Enhancement of abstinence in treatment of alcoholism

􏱦 Treatment of aggression and impulsivity (dementia, intoxication, men-

tal retardation, personality disorders, general medical conditions)

Mood stabilizers include lithium and two anticonvulsants, carbamazepine and valproic acid.

Lithium

Lithium is the drug of choice in the treatment of acute mania and as prophy- laxis for both manic and depressive episodes in bipolar disorder. Its exact mechanism of action is unknown, but it has been shown to alter neuronal sodium transport. (Lithium is in the same column as sodium in the periodic table.)

Lithium is secreted by the kidney, and its onset of action takes 5 to 7 days. Blood levels correlate with clinical efficacy. The major drawback of lithium is its high incidence of side effects and very narrow therapeutic index:

􏱦 Therapeutic range: 0.7 to 1.2 (Individual patients can become toxic even within this range.)

􏱦 Toxic: > 1.5

􏱦 Lethal: > 2.0

SIDE EFFECTS

Side effects of lithium include fine tremor, sedation, ataxia, thirst, metallic taste, polyuria, edema, weight gain, GI problems, benign leukocytosis, thyroid enlargement, hypothyroidism, and nephrogenic diabetes insipidus.

Toxic levels of lithium cause altered mental status, coarse tremors, convul- sions, and death. Clinicians need to regularly monitor blood levels of lithium, thyroid function (thyroid-stimulating hormone), and kidney function (glomerular filtration rate).

Carbamazepine (Tegretol)

Carbamazepine is an anticonvulsant that is especially useful in treating mixed episodes and rapid-cycling bipolar disorder. It is also used in the management of trigeminal neuralgia. It acts by blocking sodium channels and inhibiting ac- tion potentials. Its onset of action is 5 to 7 days.

SIDE EFFECTS

Side effects include skin rash, drowsiness, ataxia, slurred speech, leukopenia, hyponatremia, aplastic anemia, and agranulocytosis. It elevates liver en- zymes and has teratogenic effects when used during pregnancy (neural tube defects). Pretreatment complete blood count (CBC) and LFTs must be ob- tained and monitored regularly.

145

Antipsychotics may be used as adjuncts to mood stabilizers for behavioral control early in the course of a manic episode if psychotic symptoms are present.

HIGH-YIELD FACTS

Factors that affect Li+ levels:

􏱦 NSAIDs(↓)

􏱦 Aspirin

􏱦 Dehydration(↑)

􏱦 Saltdeprivation(↑)

􏱦 Impairedrenalfunction

(↑)

􏱦 Diuretics

Psychopharmacology

HIGH-YIELD FACTS

Psychopharmacology

BDZs can be lethal when mixed with alcohol.

146

Valproic Acid (Depakene)

Valproic acid is an anticonvulsant that is especially useful in treating mixed manic episodes and rapid-cycling bipolar disorder. Its mechanism of action is unknown, but it has been shown to increase central nervous system (CNS) levels of gamma-aminobutyric acid (GABA).

SIDE EFFECTS

Side effects include sedation, weight gain, alopecia, hemorrhagic pancreatitis, hepatotoxicity, and thrombocytopenia. It has teratogenic effects during preg- nancy (neural tube defects). Monitoring of LFTs and CBCs is necessary.

􏰀 ANXIOLYTICS/HYPNOTICS

Anxiolytics, including benzodiazepines, barbiturates, and buspirone, are the most widely prescribed psychotropic medications. In general, they all work by diffusely depressing the CNS, causing a sedative effect. Common indications for anxiolytics/hypnotics include:

􏱦 Anxiety disorders

􏱦 Muscle spasm

􏱦 Seizures

􏱦 Sleep disorders

􏱦 Alcohol withdrawal

􏱦 Anesthesia induction

Benzodiazepines (BDZs)

Benzodiazepines are first-line anxiolytics. Advantages include safety at high doses (as opposed to barbiturates). A significant limitation is imposed on the duration of BDZ use due to their potential for tolerance and dependence after prolonged use. Benzodiazepines work by potentiating the effects of GABA.

EXAMPLES OF BDZS

Long Acting (1 to 3 Days)

Chlordiazepoxide (Librium)—used in alcohol detoxification, presurgery anxiety

Diazepam (Valium)—rapid onset, used in treatment of anxiety and seizure control

Flurazepam (Dalmane)—rapid onset, treatment of insomnia

Intermediate Acting (10 to 20 Hours)

Alprazolam (Xanax)—treatment of panic attacks

Clonazepam (Klonopin)—treatment of panic attacks, anxiety Lorazepam (Ativan)—treatment of panic attacks, alcohol withdrawal Temazepam (Restoril)—treatment of insomnia

Short Acting (3 to 8 Hours)

Oxazepam (Serax)

Triazolam (Halcion)—rapid onset, treatment of insomnia

SIDE EFFECTS

Drowsiness, impairment of intellectual function, reduced motor coordination. Toxicity: Respiratory depression in overdose, especially when combined with alcohol

Zolpidem (Ambien)/Zaleplon (Sonata)

􏱦 Used for short-term treatment of insomnia

􏱦 Selectively bind to benzodiazepine binding site on GABA receptor

􏱦 No anticonvulsant or muscle relaxant properties

􏱦 No withdrawal effects

􏱦 Minimal rebound insomnia

􏱦 Little or no tolerance/dependence occurs with prolonged use

􏱦 Sonata—newer, has shorter half-life than Ambien

􏱦 Chemically not a BDZ, although same effect

Buspirone (BuSpar)

􏱦 Alternative to BDZ or venlafaxine for treating generalized anxiety dis- order

􏱦 Slower onset of action than benzodiazepines (takes 1 to 2 weeks for ef- fect)

􏱦 Anxiolytic action is at 5HT-1A receptor (partial agonist)

􏱦 Does not potentiate the CNS depression of alcohol (useful in alco-

holics)

􏱦 Low potential for abuse/addiction

Propranolol

This beta blocker is particularly useful in treating the autonomic effects of panic attacks or performance anxiety, such as palpitations, sweating, and tachycardia. It can also be used to treat akathisia (side effect of typical an- tipsychotics).

􏰀 SIDE EFFECTS IN A NUTSHELL

Most important facts to know for exam:

HAM side effects (antihistamine—sedation; antiadrenergic—hypotension; antimuscarinic—dry mouth, blurred vision, urinary retention)

􏱦 Found in TCAs and low-potency antipsychotics

Serotonin syndrome: Confusion, flushing, diaphoresis, tremor, myoclonic jerks, hyperthermia, hypertonicity, rhabdomyolysis, renal failure, and death

􏱦 Occurs when SSRIs and MAOIs are combined

􏱦 Treatment: Stop drugs

Hypertensive crisis: Caused by a buildup of stored catecholamines

􏱦 MAOIs plus foods with tyramine (red wine, cheese, chicken liver,

cured meats) or plus sympathomimetics Extrapyramidal side effects

􏱦 Parkinsonism—masklike face, cogwheel rigity, pill-rolling tremor

􏱦 Akathisia—restlessness and agitation

HIGH-YIELD FACTS

Psychopharmacology

147

HIGH-YIELD FACTS

Psychopharmacology

148

􏱦 Dystonia—sustained contraction of muscles of neck, tongue, eyes

􏱦 Occurs with high-potency traditional antipsychotics

􏱦 Reversible, occurs within days

􏱦 Can be life threatening (example—dystonia of the diaphragm causing

asphyxiation)

Hyperprolactinemia

􏱦 Occurs with high-potency traditional antipsychotics

Tardive dyskinesia: Choreoathetoid muscle movements, usually of mouth and tongue. More likely in women than men

􏱦 Occurs after years of antipsychotic use (particularly high-potency typi-

cal antipsychotics); can be irreversible

􏱦 Patients on antipsychotics should be monitored for this with various

screening exams (abnormal involuntary movement scale [AIMS], DISCUS) every 6 months.

Neuroleptic malignant syndrome: Fever, tachycardia, hypertension, tremor, elevated CPK, “lead pipe” rigidity

􏱦 Can be caused by all antipsychotics after short or long time (increased

with high-potency traditional antipsychotics)

􏱦 A medical emergency with 20% mortality rate

􏰀 SUMMARY OF MEDICATIONS THAT MAY CAUSE PSYCHIATRIC SYMPTOMS Psychosis

May be caused by sympathomimetics, analgesics, antibiotics (such as isoni- azid), anticholinergics, anticonvulsants, antihistamines, corticosteroids, and antiparkinsonian agents

Agitation/Confusion/Delirium

May be caused by antipsychotics, antidepressants, antiarrhythmics, antineo- plastics, corticosteroids, cardiac glycosides, NSAIDs, antiasthmatics, antibi- otics, antihypertensives, antiparkinsonian agents, and thyroid hormones

Depression

May be caused by antihypertensives, antiparkinsonian agents, corticosteroids, calcium channel blockers, NSAIDs, antibiotics, and peptic ulcer drugs

Anxiety

May be caused by sympathomimetics, antiasthmatics, antiparkinsonian agents, hypoglycemics, NSAIDs, and thyroid hormones

Sedation/Poor Concentration

May be caused by antianxiety agents/hypnotics, anticholinergics, antibiotics, and antihistamines

HIGH-YIELD FACTS IN

Legal Issues in Psychiatry

􏰀 CONFIDENTIALITY

All information regarding a doctor–patient relationship should be held confi-

dential except in the following situations:

1. When sharing relevant information with other staff members who are also treating the patient

2. If subpoenaed—physician must supply all requested information

3. If child abuse is suspected—obligated to report to the proper authori-

ties

4. If patient is an immediate danger to others—obligated to report to the

proper authorities (Tarasoff Duty)

5. If a patient is suicidal—physician may need to admit the patient, with

or without the patient’s consent, and share information with the hos- pital staff.

􏰀 ADMISSION TO A PSYCHIATRIC HOSPITAL

The two main categories of admission to a psychiatric hospital are:

1. Voluntary admission: Patient requests or agrees to be admitted to the psychiatric ward. The patient is first examined by a staff psychiatrist, who determines if he or she should be hospitalized.

2. Involuntary admission (also known as civil commitment): Patient is found by two staff physicians to be potentially harmful to self or others (suici- dal, homicidal, unable to care for self, etc.), so may be hospitalized against his or her will for a certain number of days (depending on laws of state). After the set number of days have passed, the case must be reviewed by an independent board to determine if continued hospital- ization is necessary. Patients must always be provided with a copy of the commitment (or “hold”) papers, have their rights explained to them, and must have any questions answered pertaining to the com- mitment.

149

The obligation of a physician to report patients who are potentially harmful to others is called the Tarasoff Duty, based on a legal case.

Patients who are admitted against their will retain legal rights and can contest their admission in court at any time.

Parens patriae is the legal doctrine that allows civil commitment for citizens unable to care for themselves.

HIGH-YIELD FACTS

Elements of informed consent: NARCC

􏱦 Name/purposeof

treatment

􏱦 Alternatives

􏱦 Risks/benefits

􏱦 Consequencesof

refusing

􏱦 Capacity(patientmust

have)

Informed consent for treatment of minors is not required from parents in: 􏱦 Obstetriccare

􏱦 TreatmentofSTDs

􏱦 Treatmentofsubstance

abuse

Legal Issues in Psychiatry

150

􏰀 INFORMED CONSENT

Informed consent is the process by which patients knowingly and voluntarily agree to a treatment or procedure. In order to make informed decisions, pa- tients must be given the following information:

􏱦 Name and purpose of treatment

􏱦 Potential risks and benefits

􏱦 Alternatives to the treatment

􏱦 Consequences of refusing treatment

In addition, opportunity must be given for the patient to ask questions, and he or she must have capacity to make an informed decision (see definition of ca- pacity below).

Situations That Do Not Require Informed Consent

Informed consent need not be obtained in the following cases:

􏱦 Lifesaving medical emergency

􏱦 Suicide or homicide prevention (hospitalization)

􏱦 Minors—must obtain consent from parents except when giving obstetric

care, treatment for sexually transmitted diseases (STDs), treatment for substance abuse (laws vary by state). In these cases, consent may be ob- tained from the minor directly, and information must be kept confiden- tial from parents.

Emancipated Minors

Emancipated minors are considered competent to give consent for all medical care without input from their parents. Minors are considered emancipated if they:

􏱦 Are self-supporting

􏱦 Are in the military

􏱦 Are married

􏱦 Have children

􏰀 COMPETENCE VERSUS CAPACITY

Competence and capacity are terms that refer to a patient’s ability to make in- formed treatment decisions. Competence is a legal term and can only be de- cided by a judge, whereas capacity is a clinical term and may be assessed by physicians.

Decisional capacity is task specific and can fluctuate over time; that is, a pa- tient may have capacity to make one treatment decision while lacking capac- ity to make others. It is therefore important to assess capacity on a treatment- specific basis.

Assessment of Capacity

A patient is considered to have decisional capacity if he or she meets the fol- lowing four criteria:

1. Can communicate a choice or preference

2. Understands the relevant information regarding treatment—purpose,

risks, benefits, and alternatives; patient must be able to explain this in-

formation to you

3. Appreciates the situation and its potential impact or consequences ac-

cording to his or her own value system and understands the ramifica-

tions of refusing treatment

4. Can logically manipulate information regarding the situation and

reach rational conclusions

Criteria for determining capacity may be more stringent if the consequences of a patient’s decision are very serious.

Assessing the Risk of Violence

The following factors increase the likelihood of a patient’s becoming violent:

􏱦 History of violence

􏱦 Specific threat with a plan

􏱦 History of impulsivity

􏱦 Psychiatric diagnosis

􏱦 Substance abuse

􏰀 COMPETENCE TO STAND TRAIL

A fundamental tenet to the U.S. Criminal Code is that people who are men- tally incompetent should not be tried. To stand trial, a person must:

􏱦 Understand the charges against him or her

􏱦 Have the ability to work with an attorney

􏱦 Understand possible consequences

􏱦 Be able to testify

􏰀 NOT GUILTY BY REASON OF INSANITY

In general, to be found not guilty by reason of insanity, one must have a mental illness, not understand right from wrong, and not understand consequences of actions at the time the act was committed. Depending on the state, one of the following statutory criteria must be met:

1. M’Naghten: This is the most stringent test and is standard in most ju- risdictions. It assesses whether the person understands the nature, con- sequences, and wrongfulness of his or her actions.

2. American Law Institute Model Penal Code: Cognitive prong determines whether the person understands the wrongfulness of his or her actions, and volitional prong assesses whether he or she is able to act in accor- dance with the law.

3. Durham: This is the most lenient test and is rarely used; it assesses whether the person’s criminal act has resulted from mental illness.

The most important factor in assessing a patient’s risk of violence is a history of violence.

HIGH-YIELD FACTS

Legal Issues in Psychiatry

151

Insanity:

Criteria vary from state to state.

Crime requires “evil intent” (mens rea) and an “evil deed” (actus reus).

HIGH-YIELD FACTS

4 Ds of malpractice: Dereliction (neglect) of a Duty that led Directly to Damages

Legal Issues in Psychiatry

152

􏰀 MALPRACTICE

Malpractice is considered a tort or civil wrong rather than a crime. To success- fully argue a case of malpractice against a physician, the patient must prove the following three conditions:

1. There is an established standard of care.

2. The physician breached his or her responsibility to the plaintiff.

3. The physician’s breach of responsibility caused injury or damage to the

plaintiff.

Compensatory damages are awarded to the patient as reimbursement for med- ical expenses, lost salary, or physical suffering. Punitive damages are awarded to the patient only in order to “punish” the doctor for gross negligence or carelessness.

SECTION III: CLASSIFIED

Awards

and Opportunities

for Students Interested in Psychiatry

􏰀 Membership and Subscriptions

􏰀 General Awards

􏰀 Awards for Minority

Students

􏰀 Websites of Interest

153

MEMBERSHIP AND SUBSCRIPTIONS

American Academy of Child & Adolescent Psychiatry Medical Student Membership

AACAP membership for med- ical students costs $35/year and includes the following benefits:

access of patients to child and

adolescent psychiatrists

􏱦 Representation in the AMA

House of Delegates

􏱦 AACAP home page—over 3

million hits per year

􏱦 Recruitment Kit and Code of

Ethics

􏱦 60 Committees, Task Forces,

Managed Care Help Line, and CPT Code Module and Support Line

AMERICAN PSYCHIATRIC ASSOCIATION LISTSERV FOR MEDICAL STUDENTS

The APA Education Listserv is a bidirectional method of com- munication between the APA, medical students, residents, resi- dency training directors, and others, to share information, comments, and suggestions of interest and concern to medical students and residents. To sub- scribe to this listserv, please visit APA’s website at http://www. psych.org or e-mail your request to join to ndelanoche@psych.org. Free registration for medical stu- dents at the Annual Meeting of the American Psychiatric Association.

2. Jeanne Spurlock Research Summer Fellowship in drug abuse and addiction to work with a research psychiatrist mentor, for minority (includ- ing Asian) students. Five awards of $2,500 each are available. Awards also cover attendance at the Annual Meeting.

American Academy

of Addiction Psychiatry Medical Student Memberships

The AAAP offers subsidized medical student memberships. Medical students are eligible for a 1-year membership in the American Academy of Addic- tion Psychiatry at the dis- counted rate of $45. Member- ship benefits include:

􏱦 Subscription to the quarterly, scholarly The American Jour- nal on Addictions

􏱦 Subscription to AAAP News, the official quarterly newslet- ter of the Academy

􏱦 Opportunities to meet and network with experienced ad- diction clinicians, researchers, and faculty

􏱦 Discounts for meetings and products

􏱦 Access to Members-Only Area of AAAP Web site

Contact: American Academy of Addiction Psychiatry, 7301 Mis- sion Road, Suite 252, Prairie Village, KS 66208; Fax: 913- 262-4311

3. James Comer Minority Re- search Fellowship to work with a research psychiatrist mentor. This award provides five awards of $2,200 each plus 5 days at the AACAP Annual Meeting.

4. Jeanne Spurlock Minority Clinical Fellowship. This award provides five $2,500

􏱦

􏱦 􏱦

Subscriptions to the monthly Journal (both hard copy and online versions) ($124) and AACAP News ($70)

Reduced fees for CME pro- grams: a 6-day Annual Meeting, a 2-day January Psychopharma- cology Update Institute, a 3-day Mid-Year Institute, and a 4-day Review Course for the Child Board Exams ($500)

Five new Facts for Families, bringing the total to 78. Also available in Spanish to use in your practice ($35) Guidelines regarding the use of psychiatrists’ signature ($10) Biographical Directory 2000 ($50), available for online search and update

JobSource: List your vitae for free, place an ad ($50) National initiative to educate policy makers about the need to improve services for chil- dren and adolescents with mental illnesses and to ensure

GENERAL AWARDS

American Academy of Child & Adolescent Psychiatry

AACAP offers four awards for medical students:

1. $2,200 stipend for underrep- resented minority students to work with a clinical psychia- trist mentor.

154

CLASSIFIED

fellowships for work during the summer with a child and adolescent psychiatrist men- tor plus 5 days at the AA- CAP Annual Meeting.

For more information, contact:

AACAP Office of Research and Training, 3615 Wisconsin Av- enue NW, Washington, DC 20016; Phone: 202-966-7300; Fax: 202-966-2891

American Psychiatric Association PMRTP Summer Training Award

for Underrepresented Minority Medical Students

The Program for Minority Re- search Training in Psychiatry (PMRTP) is a summer research fellowship funded by the Na- tional Institute of Mental Health and administered by the American Psychiatric Associa- tion (APA). The PMRTP is de- signed to increase the number of underrepresented minority men and women in the field of psychiatric research. Support is available for training opportuni- ties during an elective period (3- to 6-month rotation) or as a summer experience. Funding for a summer training experience is available to minority medical students enrolled in accredited schools. Trainees must be U.S. citizens or permanent residents. Preference in selection goes to the underrepresented minorities given priority by the U.S. De- partment of Health and Human Services in awarding supple- ments in biomedical and behav- ioral research. These include American Indians, Blacks/ African Americans, Hispanics, Pacific Islanders, or other ethnic or racial group members who have been found to be under- represented in biomedical or behavioral research nationally.

Contact: Request selection cri- teria, an application, or other information by writing to Ernesto A. Guerra, Project Manager, or by calling 1-800- 852-1390 or 202-682-6225; e-mail: eguerra@psych.org. You may also write to the Director of the PMRTP, James W. Thompson, MD, MPH.

AMERICAN SOCIETY

OF CLINICAL HYPNOSIS AWARDS

Cash awards and recognition for the best papers written by a stu- dent on the subject of hypnosis. Papers may be clinical, theoreti- cal, or the report of a research project. First prize will be $350, second prize $250, third prize $l50. There will be five hon- orable mentions of $50 each. Contact: American Society of Clinical Hypnosis, 130 East Elm Court, Suite 201, Roselle, IL 60172-2000; Phone: 630-980- 4740; Fax: 630-351-8490; E- mail: info@asch.net

Center for Chemical Dependency Treatment and Scaife Family Foundation Student Clerkship

Three-week clerkship involving both a clinical experience and a lecture series and providing information and experience, which will increase the aware- ness of the participants with re- spect to issues such as alcohol and other drug addiction, co- morbidity and chemical depen- dency, and intervention meth- ods for patients who abuse alcohol and other drugs. Con- tact: Dr. Janice Pringle, St. Francis Medical Center––Cen- ter for Chemical Dependency Treatment, 9th Floor, 400 45th

Street, East Building, Pittsburgh, PA 15201; Phone: 412-622-8069

JOSEPH COLLINS FOUNDATION AWARD

An award based on both finan- cial need and scholastic record and standing (upper half of class); a demonstrated interest in arts and letters or other cul- tural pursuits outside the field of medicine; indication of inten- tion to consider specializing in neurology, psychiatry, or becom- ing a general practitioner; evi- dence of good moral character. Average grant is $2,500. Con- tact: Joseph Collins Foundation Attn: Secretary-Treasurer

153 East 53rd Street New York, NY 10022

Thomas Detre Prize

Sponsored by the University of Pittsburgh, Department of Psy- chiatry. The prize is for the best paper in any area of general psy- chiatry. $300 prize

Puig–Antich Memorial Prize

Sponsored by the University of Pittsburgh, Department of Psy- chiatry, this prize is for the best paper in any area of child or adolescent psychiatry. $300 prize

PRESIDENT’S COMMITTEE ON MENTAL RETARDATION SCHOLARSHIP

Scholarship offered to graduate students for advanced study in the field of mental retardation. Students must be able to docu- ment an economic need and a significant amount of volunteer

155

CLASSIFIED

activity with mentally retarded persons. Contact: PCMR, 370 L’Enfant Promenade SW, Suite 701, Washington, DC 20447- 0001; Phone: 202-619-0634; Fax: 202-205-9519

American Medical Association Rock Sleyster Memorial Scholarship

This fund provides scholarships to be awarded to U.S. citizens enrolled in accredited American or Canadian medical schools. Scholarships are given annually to assist needy and deserving students studying medicine who aspire to specialize in psychiatry. All nominees must be rising se- niors. The award is $2,500. Con- tact: American Medical Associ- ation Education and Research Foundation, 515 North State Street, Chicago, IL 60610; Phone: 312-464-5357; Fax: 312- 464-5973; http://www.ama-assn.org

American Academy of Addiction Psychiatry

The American Academy of Ad- diction Psychiatry is pleased to announce the annual Medical Student Award. This award pro- vides a travel stipend for a med- ical student who is interested in the diagnosis, root causes, and treatment of addictive disorders. The award will be presented at the Annual Meeting and Sym- posium of the Academy. The re- cipient of the award will be in- vited to attend the AAAP Annual Meeting and Sympo- sium to receive the award. Reg- istration fees will be waived, and airfare and hotel costs will be paid for the Medical Student Award winner (up to $1,000). Interested students need to submit a curriculum vitae and a brief (less than 500 words) es- say about their interest and achievements in the addictions to: American Academy of Ad- diction Psychiatry, 7301 Mis- sion Road, Suite 252, Prairie

Village, KS 66208; Fax: 913- 262-4311

BETTY FORD SUMMER INSTITUTE FOR MEDICAL STUDENTS

The Summer Institute for Med- ical Students is a unique, quality learning experience for medical students wishing to gain greater understanding and insight into addictive disease and the recov- ery process. Mrs. Ford strongly shows her commitment to ex- panding the awareness of the health and human services pro- fessional community by endors- ing this program and making it available to medical students across the country. Contact: Dr. James West, Betty Ford Center Training Department, 39000 Bob Hope Drive, Rancho Mi- rage, CA 92270; Phone: 760- 773-4108; Toll free: 800-854- 9211, Ext. 4108; Fax: 760-773- 1508

National Medical Association Research Award

Symposium for minority resi- dents and medical students to present original research and writing in the areas of clinical practice, neuropharmacology, psychophysiology, or behavioral medicine. Travel expenses avail- able to selected participants. Contact: National Medical As- sociation, 1012 Tenth Street NW, Washington, DC 20001; Phone: 202-347-1895; Fax: 202- 842-3293

AWARDS FOR MINORITY STUDENTS

Fellowship in Academic Medicine for Minority Students

Sponsored by the National Medical Fellowships, Inc., and underwritten by Bristol-Myers Squibb, each year up to 35 stu- dents are selected as Academic Medicine Fellows by the Pro- gram Development Committee and awarded grants of $6,000 each. The stipend enables each student to spend 8 to 12 weeks on a research project of interest under the guidance of an expe-

rienced biomedical researcher who acts as the student’s mentor and who may use up to $2,000 of the fellowship grant to cover the costs of the internship. Con- tact: The Fellowship in Aca- demic Medicine for Minority Students, National Medical Fel- lowships, Inc., 5 Hanover Square, 5th Floor, New York, NY 10004; Phone: 212-483- 8880; http://www.nmf-online.org

156

CLASSIFIED

WEBSITES OF INTEREST

http://www.aaap.org/early/ faq.html

This Web site, hosted by the American Academy of Addic- tion Psychiatry, is a resource for medical students, residents, and early-career psychiatrists. It has answers to frequently asked ques- tions about a career in addiction psychiatry. This site also con- tains a mentor list of senior clini- cians with their e-mail addresses, information on fellowship train- ing, and other career info.

http://www.admsep.org/ studentelectives.html

This link contains the Associa- tion of Directors of Medical Student Education in Psychiatry (ADMSEP) National Psychia- try Rotation Electives Cata- logue. The purpose of these na- tional opportunity listings are to assist senior medical students in finding and learning more about elective rotations offered at sites other than their parent institu- tion.

http://www.vh.org/Providers /Lectures/EmergencyMed/ Psychiatr y/TOC.html

This site, hosted by Virtual Hospital, contains the Univer- sity of Iowa Hospitals and Clin- ics Emergency Psychiatry Ser- vice Handbook online.

http://www.aadprt.org/ public/students.html

Hosted by the American Associ- ation of Directors of Psychiatric Residency Training (AADPRT), here medical students can find useful information and links on the Match, including a list of linked psychiatry training pro- grams.

http://www.amsa.org/psych /mentors.cfm

Hosted by the American Med- ical Student Association, this site provides a list of psychiatry mentors for medical students.

http://members.aol.com/ aglpnat/homepage.htm

The Association of Gay and Les- bian Psychiatrists (AGLP) is a professional organization of psy- chiatrists, psychiatry residents, and medical students that serves as a voice for the concerns of lesbians and gay men within the psychiatric community. The Association is committed to fostering a more accurate under- standing of homosexuality, op- posing discriminatory practices against gay men and lesbians, and promoting supportive, well- informed psychiatric care for lesbian and gay patients. The organization provides opportuni- ties for affiliation and collabora- tion among psychiatrists who share these concerns.

157

CLASSIFIED